Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
SMR3B	"P-B, PRL3, PROL3"	ENSG00000171201	"Submaxillary gland androgen regulated protein 3B"	P02814	4	70370093-70390244	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2372	"salivary gland: 6520.0"	"Cell line enriched"	"Detected in single"	35	"EFO-21: 9.6"	"Cancer enriched"	"Detected in some"	22	"breast cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"	4500000	4500000																			"unprognostic (3.72e-1)"		0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	6520.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050402-70058845	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	1306	"salivary gland: 1826.6"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.0;SK-MEL-30: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077315	Approved				"Secreted to digestive system"					"HPA077315: "									"unprognostic (2.22e-1)"									0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1826.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.3	1.1	0.1	0.1	0.2	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0
PRH1	Pa	ENSG00000231887	"Proline rich protein HaeIII subfamily 1"		12	10824960-11171608	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	916	"salivary gland: 2360.8"	"Cell line enhanced"	"Detected in some"		"BJ: 2.1;BJ hTERT+ SV40 Large T+: 2.5;CAPAN-2: 5.5;HBF TERT88: 1.6;HSkMC: 2.0;U-87 MG: 1.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.85e-2)"	"unprognostic (7.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.68e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2360.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.2	1.7	1.2	0.3	1.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.0	2.5	0.0	0.6	5.5	0.7	0.0	0.0	0.3	0.0	0.6	1.6	0.2	0.0	0.0	0.0	1.4	1.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	1.2	0.5	0.0	0.3	0.2	0.7	0.1	0.0	0.2	0.4	0.8	0.0	1.1	0.2	1.7	1.6	0.0										
AC006518.7		ENSG00000284826			12	10881011-10884255	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	913	"salivary gland: 2376.3"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.2;hTCEpi: 1.3;MCF7: 1.2;RT4: 1.8;SiHa: 2.1;WM-115: 1.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2376.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.4	1.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0										
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028413-70036538	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	535	"salivary gland: 3346.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.4;HL-60: 4.8"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											CAB073541	Enhanced				"Secreted to digestive system"					"CAB073541: "																		0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	1.4	0.0	6.2	0.0	0.0	0.2	0.0	0.0	3346.6	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	3.3	0.3	0.1	0.1	1.2	0.6	2.2	1.2	0.5	1.0	0.4	1.1	1.3	0.5	0.5	0.0	0.3	0.4	0.2	0.0	0.6	0.6	0.1	1.6	1.7	0.8	0.2	0.8	0.0	0.3	0.1	4.4	0.7	0.3	0.9	0.6	0.0	4.8	3.5	0.3	0.8	0.1	0.0	0.6	0.6	3.0	0.5	0.6	1.2	2.3	1.2	1.4	2.9	0.8	0.6	0.3	0.6	2.0	1.1	1.1	0.8	0.9	2.1	1.2	0.0	1.2	1.8	1.1	0.9	1.9	2.3	0.7	1.1	1.5	2.5	2.2	0.7	0.5	0.5	1.1	0.3	1.0	0.8	0.4	0.4	1.2	1.0	0.6	2.0	0.5	1.2	0.6	0.5	0.4	0.1	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0
PRB4		ENSG00000230657	"Proline rich protein BstNI subfamily 4"		12	11307083-11310435	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	273	"salivary gland: 3472.8"	"Cell line enriched"	"Detected in single"	31	"CACO-2: 7.6"	"Group enriched"	"Detected in some"	10	"lung cancer: 2.0;melanoma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"															"unprognostic (1.05e-1)"				"unprognostic (8.25e-2)"				0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	12.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3472.8	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875935-23879750	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 1065.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;RPTEC TERT1: 3.7;RT4: 1.9;U-2 OS: 1.6"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"					"CAB024944: , HPA061449: AB_2684523"	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1065.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.8	0.0	0.6	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 669.3"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.4"									"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"					"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.5	0.2	2.4	0.3	0.5	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.2	1.2	0.1	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.2	0.5	0.0	0.7	0.1	0.4	0.5	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.4	0.0	0.3	0.2	0.2	0.2	0.2	0.4	0.1	0.3	0.1	0.0	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.2	0.2	2.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	265	"salivary gland: 1210.9"	"Group enriched"	"Detected in some"	5	"RT4: 4.8;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"					"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	1.2	0.1	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1210.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0
LPO	SPO	ENSG00000167419	Lactoperoxidase	P22079	17	58218548-58268518	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	262	"salivary gland: 345.7"	"Cell line enriched"	"Detected in some"	9	"THP-1: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028688	Enhanced	Supported			"Secreted to digestive system"					"HPA028688: AB_10601909"	"unprognostic (2.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.41e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.8	1.3	0.7	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.0	1.5	0.0	0.9	0.7	0.4	0.6	0.3	0.5	0.9	0.7	0.6	0.2	1.2	0.6	0.9	1.3	0.8	0.3	0.8	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0
CST2		ENSG00000170369	"Cystatin SA"	P09228	20	23823769-23826731	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	230	"salivary gland: 1538.3"	"Cell line enriched"	"Detected in some"	12	"RT4: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024963, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	110000	110000			"CAB024963: , HPA043706: AB_2678627, HPA044763: "	"unprognostic (1.57e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.82e-3)"	"unprognostic (6.43e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-11)"	"unprognostic (1.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	1.6	6.6	0.1	0.1	0.1	0.0	0.1	0.3	0.1	3.8	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.7	0.0	5.9	0.7	0.1	2.6	0.0	0.1	1538.3	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.8	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	38.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRB3	PRG	ENSG00000197870	"Proline rich protein BstNI subfamily 3"	Q04118	12	11265924-11269805	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"salivary gland: 2125.3"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 6.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"														"Secreted to digestive system"						"unprognostic (4.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-1)"		"unprognostic (7.46e-3)"		"unprognostic (4.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2125.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.5	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	162	"salivary gland: 5940.6"	"Cell line enhanced"	"Detected in single"		"HHSteC: 1.5"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"					"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.3	1.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5940.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	36.5	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RNASE8	RAE2	ENSG00000173431	"Ribonuclease A family member 8"	Q8TDE3	14	21057822-21058455	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	146	"salivary gland: 38.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRH2	Pr	ENSG00000134551	"Proline rich protein HaeIII subfamily 2"	P02810	12	10929236-10932341	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	128	"salivary gland: 2507.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;hTERT-HME1: 1.2;PC-3: 1.1"	"Cancer enriched"	"Detected in some"	11	"head and neck cancer: 11.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"						"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.43e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.1	0.1	0.1	0.0	0.2	3.8	0.0	0.1	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2507.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	4.6	2.9	0.0	0.0	0.4	0.3	0.1	0.2	0.5	0.9	0.2	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.7	0.4	0.1	0.0	0.3	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.2	0.0	0.0	0.3	0.3	0.8	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.7	0.2	0.9	0.4	0.3	0.7	0.1	0.2	0.3	0.5	0.1	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0
AMY1A	AMY1	ENSG00000237763	"Amylase, alpha 1A (salivary)"	P04745	1	103655290-103664554	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	100	"salivary gland: 654.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;SH-SY5Y: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	68000000	68000000			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: , HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0			0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	3.7	0.0	0.0	0.0		0.0	0.0		654.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.1	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7										
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	96	"breast: 91.1;salivary gland: 31.2"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.0"	"Group enriched"	"Detected in some"	15	"breast cancer: 35.3;lung cancer: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.1	0.0	0.1	0.1	0.1	0.0	91.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	31.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689040	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 705.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 6.6;RT4: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	2700000	2700000			"HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavourable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favourable (2.88e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	0.0	1.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	7.5	0.0	0.1	705.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.7	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	16.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRB2	"cP7, PRPPRB1, Ps"	ENSG00000121335	"Proline rich protein BstNI subfamily 2"	P02812	12	11391540-11501041	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 544.2"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.8"	"Cell type enriched"	"Detected in single"	23	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.2"														"Secreted to digestive system"										"unprognostic (1.36e-1)"	"unprognostic (1.01e-2)"		"unprognostic (2.61e-1)"	"unprognostic (2.07e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.51e-3)"			"unprognostic (1.97e-4)"	"unprognostic (1.51e-1)"			0.1	0.0	1.3	0.1	5.8	0.0	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	544.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.8	0.1	2.9	2.3	0.7	0.1	0.1	0.1	0.1
PRB1	"PM, PMF, PMS, PRB1L, PRB1M"	ENSG00000251655	"Proline rich protein BstNI subfamily 1"		12	11351823-11395566	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	80	"salivary gland: 605.6"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"																							0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0
MUCL1	SBEM	ENSG00000172551	"Mucin like 1"	Q96DR8	12	54830519-54858393	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	75	"breast: 283.5;salivary gland: 277.2;skin 1: 99.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 2.1;hTCEpi: 2.3;MCF7: 3.8;SK-BR-3: 9.7"	"Cancer enriched"	"Detected in many"	30	"breast cancer: 298.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"											HPA039093	Enhanced				"Secreted in other tissues"					"HPA039093: AB_10795577"	"unprognostic (2.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.34e-3)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"		"unprognostic (9.90e-2)"	2.9	0.0	0.1	0.1	0.1	0.0	283.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	277.2	0.1	0.2	99.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LACRT	LACRITIN	ENSG00000135413	Lacritin	Q9GZZ8	12	54630811-54634895	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	72	"salivary gland: 67.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	304	"breast cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"	460000	460000																					0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819148-50823787	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"pancreas: 742.6;salivary gland: 473.0"	"Cell line enriched"	"Detected in some"	23	"RPMI-8226: 28.8"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 10.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"B-cells: 10.9"														"Secreted to digestive system"	4300000	4300000				"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	2.5	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.1	0.1	0.1	0.1	742.6	0.0	0.1	0.1	0.1	0.2	1.9	0.1	473.0	0.1	0.1	1.8	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.2	0.2	0.2	0.1	0.1	10.9	0.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	10.9	0.0	0.0	0.2	3.8	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360761-70367158	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"salivary gland: 186.9"	"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044567	Enhanced				"Secreted to digestive system"					"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	186.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"salivary gland: 1237.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 5.3;U-2197: 4.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 15.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 15.4"					"Low region specificity"	"Detected in all"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	34000000	34000000			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1237.9	0.0	0.1	24.9	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.1	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1.0	1.5	5.3	0.6	0.5	1.5	0.4	0.1	0.8	0.6	0.6	0.8	1.9	1.0	0.4	2.0	1.9	0.0	1.0	0.9	0.1	0.6	0.7	3.3	0.1	0.8	1.0	1.5	1.1	0.7	1.4	0.6	0.3	0.2	1.0	1.0	0.9	0.2	0.9	0.3	1.4	0.8	0.3	2.7	1.4	4.6	1.2	1.4	0.5	1.7	0.6	1.8	1.3	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0.0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591817	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.7;WM-115: 4.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	41000	41000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	98.4	0.1	0.0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	189.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	54.2	0.2	0.0	0.0	0.1	122.6	1.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.3	0.1	0.3	0.3	0.2	0.0	1.0	0.3	0.4	0.5	0.1	0.0	0.0	0.8	0.9	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.1	0.5	0.2	0.4	1.0	0.3	0.2	0.3	0.0	6.7	0.7	0.1	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747553-23751268	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"salivary gland: 704.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 153.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	6600000	6600000			"CAB026769: , HPA043706: AB_2678627, HPA044763: "	"prognostic favourable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.8	0.1	0.1	0.3	7.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.1	0.1	15.2	0.0	0.1	704.2	0.1	0.1	4.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	1.6	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	153.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ASCL3	"bHLHa42, HASH3, Sgn1"	ENSG00000176009	"Achaete-scute family bHLH transcription factor 3"	Q9NQ33	11	8937579-8938211	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	37	"salivary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;CACO-2: 1.1;U-2 OS: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA027032	Uncertain									"HPA027032: AB_10602434"											"unprognostic (8.91e-2)"	"unprognostic (1.32e-1)"		"unprognostic (3.53e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	2.5	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4 (lacrimal)"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"salivary gland: 1184.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;HBEC3-KT: 1.3;Hep G2: 1.6;NB-4: 2.7;U-2 OS: 2.8;WM-115: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042133	Supported				"Secreted to digestive system"	25000000	25000000			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1184.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	20.0	38.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.4	1.5	1.3	0.0	0.1	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	2.7	0.6	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397882-70410194	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"breast: 19.1;salivary gland: 59.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	36000	36000			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829037	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6"	"Group enriched"	"Detected in some"	6	"U-266/70: 5.9;U-266/84: 1.7"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595762	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042801	Approved				"Secreted to digestive system"					"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.2	0.2	0.2	21.7	0.2	0.0	0.2	0.2	0.2	0.2	41.5	0.1	0.1	0.0	0.2	2.4	0.3	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	2.1	44.3	0.1	71.7	0.1	0.2	0.2	0.5	1.9	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.3	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
BHLHA15	"bHLHa15, BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211427-98212979	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"pancreas: 145.8;salivary gland: 95.2"	"Group enriched"	"Detected in some"	8	"Karpas-707: 16.7;RPMI-8226: 31.0;U-266/70: 37.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.2	0.8	0.2	0.0	0.1	0.1	0.2	0.3	1.2	0.0	3.5	0.9	0.1	0.1	0.4	0.1	0.8	0.1	0.3	0.2	0.3	4.7	0.5	1.8	0.1	0.0	0.0	145.8	0.0	0.4	0.0	0.0	1.6	0.1	0.0	95.2	6.8	0.4	0.2	0.8	0.0	0.1	1.9	6.2	0.1	0.0	0.0	0.2	1.2	2.7	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	1.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	16.7	0.0	0.3	0.0	0.0	0.5	0.5	0.2	0.0	31.0	0.0	0.0	1.8	0.7	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	37.1	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"salivary gland: 157.7"	"Cell line enriched"	"Detected in some"	17	"Hep G2: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA036279: , HPA036543: , HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	2.5	0.2	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.0	0.4	0.1	0.0	157.7	2.6	0.0	0.0	0.3	1.9	0.1	0.0	2.5	0.0	0.0	0.0	5.1	10.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"salivary gland: 1069.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 18.8;SK-BR-3: 17.4;T-47d: 15.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"									"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	1200000	1200000	Vesicles	Vesicles	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favourable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0	1.6	0.3	0.0	1069.4	0.2	0.1	0.8	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	78.5	3.7	0.2	0.2	0.0	1.1	1.7	11.4	1.1	0.4	1.7	0.0	0.8	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.2	0.0	1.5	0.0	3.1	0.0	0.0	0.0	6.3	1.8	1.6	1.2	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.1	2.6	0.2	18.8	0.0	0.3	0.1	3.6	0.0	0.0	5.9	0.1	4.4	0.0	0.0	0.0	17.4	0.0	15.9	0.0	2.2	0.0	0.4	1.3	0.0	0.0	0.3	0.2	0.2	4.5	0.2	1.7	6.7	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	1.1	7.3	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMY1B	AMY1	ENSG00000174876	"Amylase, alpha 1B (salivary)"	P04745	1	103687415-103696680	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"salivary gland: 302.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	68000000	68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.0	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	302.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;HBEC3-KT: 8.0;HDLM-2: 30.0;PC-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.4	0.9	0.0	1.7	1.4	2.3	1.2	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	8.0	1.2	8.0	0.0	30.0	5.3	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.7	0.0	1.2	0.0	2.0	0.8	0.1	4.5	0.5	0.0	0.1	12.9	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.8	4.0	0.9	3.4	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.0	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0"	"Group enriched"	"Detected in some"	27	"HEL: 8.1;HMC-1: 5.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Intracellular and membrane"					"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.8	0.0		0.0	0.0		3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0			0.2		0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2										
BPIFB6	"BPIL3, LPLUNC6"	ENSG00000167104	"BPI fold containing family B member 6"	Q8NFQ5	20	33031648-33044047	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"salivary gland: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043057	Uncertain				"Intracellular and membrane"					"HPA043057: AB_10796683"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 40.1;SiHa: 9.0;U-2 OS: 26.2;U-251 MG: 10.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058999			Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"			"Nuclear speckles"	"Nuclear speckles"	"HPA058999: "	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.1	0.0	0.0	0.0	4.7	26.2	0.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478793-34513805	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	11	"breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9"	"Group enriched"	"Detected in some"	8	"RT4: 17.4;T-47d: 33.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062706			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	48.8	0.0	0.0	0.5	0.0	0.0	72.2	0.6	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	6.5	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.0	1.4	0.0	0.0	85.1	86.9	0.0	3.5	0.0	1.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	3.5	1.0	5.8	1.2	0.5	0.5	2.0	1.8	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.0	0.0	0.0	3.0	0.0	33.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.0	0.3	0.2	0.5	1.8	0.3	0.2	0.3	0.4	0.3	0.5	0.4	0.4	0.9	0.7	1.8	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Group enriched"	"Detected in some"	10	"Daudi: 6.9;NB-4: 6.3"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"									HPA045108	Uncertain				"Intracellular and membrane"					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMAN1L	"ERGIC-53L, ERGL"	ENSG00000140506	"Lectin, mannose binding 1 like"	Q9HAT1	15	74812716-74825758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Daudi: 3.7;HEK 293: 2.3;SCLC-21H: 2.4;SK-BR-3: 2.4"	"Cancer enriched"	"Detected in single"	45	"prostate cancer: 2.2"	"Region enriched"	"Detected in some"	22	"cerebellum: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (4.51e-1)"							"unprognostic (2.44e-1)"		"unprognostic (4.26e-2)"	"unprognostic (3.09e-1)"			0.1	1.1	0.2	4.8	0.2	0.0	0.1	45.5	0.9	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.5	18.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	2.0	37.0	0.0	0.1	17.3	0.1	0.1	0.0	0.2	0.1	0.3	13.5	2.5	0.7	0.1	0.1	0.1	0.3	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.8	0.3	0.0	1.1	0.0	0.5	2.4	0.1	0.0	2.4	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	45.5	0.9	0.1	0.0	0.1	0.3	2.0	0.1
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499555	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"salivary gland: 129.5;skin 1: 212.5"	"Cell line enriched"	"Detected in some"	21	"A-431: 92.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		75000000	75000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favourable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	8.0	0.3	0.2	6.7	0.2	0.2	0.2	0.0	1.0	0.2	4.8	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226071-70235252	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 176.5;salivary gland: 452.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.6;HL-60: 2.4;K-562: 2.2;RH-30: 3.6;U-87 MG: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"					"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favourable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	0.4	0.4	0.4	95.4	0.4	0.0	9.7	0.4	0.4	0.4	1.0	0.0	0.0	0.0	0.4	0.0	1.9	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.5	124.7	0.4	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	452.5	0.0	0.5	0.4	3.7	0.0	0.4	12.1	0.4	0.4	0.0	0.4	0.5	35.9	176.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.2	0.0	0.0	0.0	0.2	9.6	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009499	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	41000	41000	"Golgi apparatus"	"Golgi apparatus"	"CAB009499: AB_2105095"	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.1	8.6	1.9	8.7	14.3	9.2	22.2	17.8	13.6	7.4	5.2	12.6	15.5	0.5	45.9	12.9	25.5	3.9	9.2	1.6	40.7	10.1	24.8	15.5	16.5	7.6	3.4	40.9	10.4	10.4	8.4	3.8	23.6	18.9	2.5	4.9	9.7	1.3	11.2	6.2	2.5	2.2	7.5	3.2	11.5	10.8	3.9	2.6	15.1	8.2	12.6	2.9	9.1	34.7	8.3	17.8	12.7	26.1	4.4	25.1	1.1	15.9	11.2	16.8	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"kidney: 48.1;salivary gland: 35.6"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.4"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA054059	Enhanced									"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.1	0.0	0.1	0.4	2.1	0.0	0.1	1.2	0.0	0.0	4.3	0.3	0.1	0.2	0.1	0.0	0.4	0.0	0.1	0.1	48.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	35.6	2.9	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	1.1	0.8	4.1	0.7	4.6	1.2	0.2	0.4	0.4	0.7	1.5	0.3	0.3	1.4	0.6	0.2	0.1	0.3	1.1	1.7	0.9	0.6	0.1	0.8	0.0	0.0	0.3	0.6	1.2	1.3	1.0	0.7	0.1	1.0	0.9	0.5	0.2	0.1	0.4	0.5	1.2	1.9	0.3	0.2	0.4	0.8	0.3	0.3	0.6	0.9	0.7	4.4	1.7	1.3	1.1	0.4	1.0	0.2	1.2	0.3	0.1	1.8	0.9	1.4	0.7	1.6	0.5	1.1	0.8	0.4	0.8	4.1	0.7	0.7	0.9	0.6	1.2	0.7	0.5	0.6	0.3	1.1	0.6	0.6	3.4	4.6	0.6	0.8	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518540-70532742	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.0;hTERT-HME1: 9.0;MCF7: 6.6"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"					"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.8	12.9	0.0	0.0	0.5	0.0	0.0	0.6	0.0	6.7	0.2	0.0	0.0	0.9	0.9	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	9.0	0.3	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.7;prostate: 28.2;salivary gland: 25.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.0;SK-BR-3: 4.0;T-47d: 2.6;WM-115: 1.4"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	10	"amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8"					"HPA014101, CAB022366"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB022366: , HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.5	3.7	13.2	0.8	22.0	0.5	3.2	0.2	34.7	0.6	1.3	0.5	0.0	1.0	0.7	0.6	0.8	0.8	0.7	0.6	14.2	1.7	0.7	0.6	2.9	0.6	1.4	14.0	0.5	1.2	1.0	0.1	0.8	0.1	28.2	1.3	1.3	25.3	0.6	0.6	2.6	1.3	0.6	0.3	0.6	1.9	0.6	1.8	0.0	0.8	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	22.0	0.2	34.7	14.2	1.7	1.4	14.0	0.1	1.8
TLX1	"HOX11, TCL3"	ENSG00000107807	"T cell leukemia homeobox 1"	P31314	10	101130505-101137789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 59.5;salivary gland: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;HEK 293: 3.0;K-562: 15.0;SCLC-21H: 2.5;SH-SY5Y: 3.7;SiHa: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"pons and medulla: 0.5"	"Region enriched"	"Detected in single"	20	"pons and medulla: 0.5"	HPA053185			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053185: "	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.06e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.06e-1)"	"unprognostic (7.35e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	19.5	0.0	0.1	0.0	0.6	0.0	0.0	59.5	0.0	0.1	0.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	3.7	2.5	0.0	0.0	0.1	0.4	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539211-100568219	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"salivary gland: 154.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced									"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favourable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	4.8	13.6	9.2	5.5	12.5	3.8	3.7	8.8	9.6	6.6	8.7	6.6	8.5	7.0	7.1	4.5	14.3	7.7	7.9	5.1	9.1	5.1	7.1	21.4	4.7	5.6	7.2	8.6	11.3	9.7	3.4	8.4	2.7	7.7	5.9	6.9	4.0	154.3	9.5	3.8	11.7	6.5	5.7	10.0	11.7	5.5	6.8	7.5	4.0	6.5	3.7	10.9	5.2	4.7	1.4	1.0	4.5	0.4	1.1	4.5	1.1	6.7	11.1	1.4	3.3	10.2	5.3	2.0	3.3	8.9	5.2	5.5	9.7	6.2	4.3	11.0	3.8	5.7	1.6	3.3	2.4	15.1	4.4	1.3	5.1	20.8	4.1	1.4	7.7	8.8	2.6	4.2	4.7	14.2	4.0	6.0	4.2	6.0	5.5	5.0	0.9	4.7	2.7	1.6	3.8	3.0	3.6	2.0	2.5	6.4	9.2	2.9	2.6	1.9	3.5	6.5	4.4	16.2	3.4	3.7	19.0	1.6	4.9	4.1	3.7	3.6	0.1	4.5	3.8	0.4	3.3	0.7	3.8	4.5	0.2	1.4	1.3	1.7	0.9	1.1	0.1	1.0	3.0	1.1	9.2	12.5	8.8	9.6	9.1	5.1	7.2	8.6	7.7	7.5
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.6;ASC TERT1: 30.9;fHDF/TERT166: 35.1;HHSteC: 19.9;HSkMC: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.3	0.4	0.2	9.4	22.6	30.9	0.5	14.0	9.0	1.8	4.8	0.5	0.0	0.0	0.5	35.1	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	19.9	1.7	0.0	25.0	1.1	4.7	8.9	1.0	0.7	12.6	3.6	0.0	0.0	0.1	0.5	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.1	2.0	14.9	0.1	1.4	1.3	0.0	0.7	15.7	4.1	0.0	5.7	6.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	4	"EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced									"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	15.0	0.0	0.0	5.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018029, HPA064555"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	3.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	2.9	0.1	0.0	0.0	0.0	35.0	1.2	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007600-33023709	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 218.0;salivary gland: 191.2"	"Cell line enriched"	"Detected in single"	552	"Hep G2: 67.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	68000	68000	Vesicles	Vesicles	"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favourable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	191.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.6	218.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCL28	"CCK1, MEC, SCYA28"	ENSG00000151882	"C-C motif chemokine ligand 28"	Q9NRJ3	5	43376645-43412391	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"salivary gland: 207.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.8;EFO-21: 8.4;SiHa: 18.9;SK-MEL-30: 10.4;T-47d: 25.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077434	Supported				"Secreted to blood"					"HPA077434: AB_2732346"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.85e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.20e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.53e-2)"	1.2	0.6	0.8	5.3	0.6	0.6	15.7	0.4	0.8	4.0	8.2	0.2	0.2	6.2	1.4	1.0	2.0	1.1	5.2	0.9	0.6	0.7	1.9	1.0	1.5	2.5	0.6	0.6	0.9	29.8	1.2	1.5	3.1	0.7	1.3	7.6	4.1	207.1	1.1	0.4	2.7	4.9	0.3	1.1	3.0	3.9	1.1	0.5	1.1	9.0	8.4	5.4	1.1	1.4	6.7	1.3	3.8	0.4	4.3	7.7	1.9	0.5	0.0	0.1	0.1	0.6	0.1	3.1	0.4	0.3	0.0	0.0	1.3	6.8	0.0	8.4	0.2	1.1	0.0	0.1	0.0	0.1	0.2	0.5	0.8	0.0	0.5	0.1	0.1	0.7	1.7	0.1	0.3	0.0	0.0	0.2	0.8	0.2	1.1	0.0	0.1	1.1	0.0	0.0	0.3	0.1	0.9	0.2	0.1	18.9	0.7	10.4	25.7	5.0	0.1	0.1	0.8	0.1	0.1	0.5	0.0	0.0	0.0	0.1	5.7	3.8	0.4	0.4	4.8	0.3	3.7	5.5	5.3	3.9	0.8	6.7	6.4	4.6	1.2	4.3	0.2	1.3	7.7	1.9	0.8	0.6	0.4	0.8	0.6	0.7	0.6	0.6	0.7	0.5
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Group enriched"	"Detected in some"	22	"Daudi: 29.1;REH: 14.6;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;RPMI-8226: 3.9;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 43.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	13	"cerebellum: 65.6"												"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	1.0	1.4	7.8	0.5	9.1	1.0	0.5	43.6	8.9	0.5	0.5	2.4	0.0	0.5	0.5	0.5	0.4	0.6	0.6	13.2	4.5	1.4	0.3	0.2	0.3	0.3	3.2	4.5	0.4	0.2	0.5	0.0	2.7	4.2	0.3	0.4	0.3	14.2	0.5	0.6	0.4	0.6	0.5	1.0	0.4	0.3	2.7	0.9	0.0	12.4	0.0	0.3	0.4	0.0	0.2	1.3	0.3	0.1	0.2	0.7	0.0	0.0	0.4	0.4	0.1	0.1	0.0	11.1	0.0	0.0	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.0	1.0	0.3	0.2	0.2	0.3	0.0	0.8	0.9	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.0	1.7	0.1	0.1	0.1	0.1	0.3	0.9	3.9	0.0	0.3	5.0	0.3	2.1	0.2	0.8	0.7	0.1	0.2	0.4	2.0	0.4	0.1	1.1	0.1	0.2	0.4	0.6	0.2	0.1	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.3	0.2	0.3	0.2	0.0	1.3	0.2	0.0	7.8	9.1	43.6	6.3	4.5	1.4	3.2	4.5	4.2	0.9
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206798870-206842981	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 11.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"					"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0			0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		6.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	11.6	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0.0	0.2	0.6	0.0	0.0										
KRT3	"CK3, K3"	ENSG00000186442	"Keratin 3"	P12035	12	52789685-52796117	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 15.9;tongue: 58.7"	"Group enriched"	"Detected in some"	6	"HaCaT: 13.3;HMC-1: 8.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									350000000	350000000				"unprognostic (1.03e-1)"	"unprognostic (2.68e-2)"		"unprognostic (2.42e-2)"		"unprognostic (2.75e-1)"		"unprognostic (9.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"			"unprognostic (3.89e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	58.7	0.9	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.4	0.1	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.0	0.2	1.7	0.0	0.1	1.1	0.3	0.3	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	4.4	0.1	0.1	0.7	16.8	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	6.4	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961870-49965681	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"salivary gland: 217.9;testis: 76.2"	"Group enriched"	"Detected in some"	9	"CAPAN-2: 11.2;REH: 12.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA065008	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favourable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	0.2	0.1	0.4	0.2	1.1	0.0	3.8	0.4	0.3	3.0	0.3	0.4	0.3	3.2	0.6	0.8	3.8	0.1	15.6	1.0	0.3	0.3	0.2	0.2	2.3	0.2	0.7	0.2	0.2	0.8	0.1	0.4	0.2	0.3	0.5	0.0	0.4	217.9	0.6	0.9	23.5	0.3	0.6	0.2	0.2	12.0	76.2	0.3	0.2	0.3	2.8	11.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.9	0.0	12.8	0.0	0.0	0.4	0.0	0.3	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.3	0.3	0.3	0.7	0.2	0.3	0.3
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	48.4	0.0	0.1	0.0	1.9	0.0	14.8	0.2	0.0	10.4	0.0	15.4	0.0	12.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34019448-34043832	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"salivary gland: 171.5"	"Cell line enriched"	"Detected in single"	199	"U-266/84: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"											"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	27000000	27000000	"Golgi apparatus"	"Golgi apparatus"	"HPA064996: AB_2685399, HPA066011: AB_2685597"	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	4.4	0.3	5.7	2.7	6.4	0.2	4.5	9.6	3.4	2.4	7.9	1.8	4.8	2.1	2.5	3.9	22.5	2.0	3.6	0.9	4.2	3.1	4.0	0.5	2.6	0.5	4.3	1.4	1.1	1.0	0.3	0.7	0.8	3.7	30.2	6.6	2.4	171.5	3.2	1.3	1.4	5.5	14.4	5.6	0.5	8.4	7.9	2.6	0.6	1.0	3.6	0.7	13.1	3.2	0.4	0.1	0.4	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	129.4	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.4	5.7	6.4	9.6	2.8	4.2	3.1	4.3	1.4	3.7	2.6
CHST6	MCDC1	ENSG00000183196	"Carbohydrate sulfotransferase 6"	Q9GZX3	16	75472052-75495384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 7.2;brain: 22.6;cervix, uterine: 18.6;intestine: 16.8;salivary gland: 20.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.1;CAPAN-2: 13.3;NTERA-2: 6.4;SK-MEL-30: 5.3;U-2 OS: 8.1;WM-115: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (2.28e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.80e-4)"	0.8	7.2	10.1	1.1	17.4	0.8	0.7	8.3	11.6	18.6	5.9	22.6	0.0	16.8	1.4	1.1	2.5	2.9	0.8	2.3	9.4	5.5	1.1	0.6	1.4	0.8	17.6	4.9	0.7	0.7	1.1	1.4	0.8	18.5	1.3	5.9	0.4	20.1	1.0	0.9	0.9	15.5	1.3	19.5	0.9	1.3	1.3	13.6	0.0	0.8	0.0	0.8	0.9	0.5	1.2	0.8	2.5	0.5	1.4	0.7	0.2	0.2	0.6	0.8	12.1	0.2	0.5	0.2	0.1	0.0	0.0	0.1	0.2	13.3	0.1	1.8	0.1	0.1	1.1	0.2	0.1	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	6.4	0.2	0.0	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.1	5.3	0.1	0.4	0.2	0.1	8.1	0.1	0.0	0.3	0.2	3.1	0.4	0.0	7.0	2.5	0.5	0.4	0.6	0.3	0.5	0.8	0.4	0.4	0.1	1.2	0.5	0.7	2.0	1.4	0.3	0.8	0.3	0.2	10.1	17.4	8.3	11.6	9.4	5.5	17.6	4.9	18.5	13.6
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 122.3;salivary gland: 130.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.5;LHCN-M2: 9.0;RH-30: 20.9"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 47.6;lung cancer: 18.0;pancreatic cancer: 33.3;stomach cancer: 76.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	7500000	7500000	"Centriolar satellite"	"Centriolar satellite"	"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.1	0.1	0.2	2.4	0.2	0.0	0.1	0.1	0.2	1.1	34.8	0.1	0.1	122.3	0.2	0.1	0.3	0.3	2.7	0.1	0.3	0.2	0.1	0.1	13.1	0.1	0.6	0.1	0.2	1.2	0.0	0.1	0.1	0.1	0.5	1.5	0.1	130.0	0.1	0.2	0.2	68.3	0.9	1.1	0.1	0.2	0.3	0.1	0.1	0.1	19.7	14.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.3	0.2	4.5	0.0	0.0	0.0	9.0	0.0	0.0	0.7	0.0	0.0	0.0	20.9	2.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.5	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.1	0.1	0.1
DNASE2B	DLAD	ENSG00000137976	"Deoxyribonuclease 2 beta"	Q8WZ79	1	84398532-84415018	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"salivary gland: 98.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.5;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.5;U-266/70: 1.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (2.24e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.62e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	16.2	0.1	0.2	0.1	2.2	0.1	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.6	0.1	0.2	13.0	1.2	0.3	0.0	0.3	0.4	0.0	0.4	0.1	0.2	2.9	0.3	0.0	98.7	0.1	1.8	0.0	0.1	0.1	1.7	0.5	0.6	0.3	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.3	0.6	0.3	0.0	0.2	0.0
DNER	"bet, UNQ26"	ENSG00000187957	"Delta/notch like EGF repeat containing"	Q8NFT8	2	229357629-229714558	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 39.4;U-138 MG: 66.4;U-87 MG: 39.3"	"Cancer enriched"	"Detected in many"	32	"glioma: 73.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017320	Enhanced					2700000	2700000			"HPA017320: AB_1847808"	"unprognostic (4.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.42e-4)"	"unprognostic (2.59e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.13e-3)"	1.7	45.6	25.4	2.2	26.8	1.3	3.1	19.5	85.2	2.2	2.3	38.4	0.0	1.6	2.1	5.7	1.5	4.1	1.5	6.8	23.9	36.8	9.7	1.3	2.0	1.5	39.8	15.2	1.6	1.9	1.7	9.6	1.5	30.0	2.8	2.2	2.5	46.1	1.6	1.3	2.5	1.9	2.2	26.4	1.3	8.3	2.0	30.4	0.0	1.4	0.0	2.1	1.4	0.2	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.1	0.1	0.0	0.0	0.3	2.2	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.7	2.4	1.7	39.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	3.6	0.0	0.4	0.0	3.7	0.0	7.9	0.6	0.2	0.0	0.2	0.0	0.0	0.0	66.4	0.0	2.2	9.9	0.0	0.0	0.0	39.3	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	25.4	26.8	19.5	26.6	23.9	36.8	39.8	15.2	30.0	30.4
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304749	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.8;salivary gland: 19.8"	"Cell line enhanced"	"Detected in some"		"AF22: 2.1;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.6;U-266/70: 1.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062660	Approved									"HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.7	2.2	8.1	1.0	17.8	0.5	0.6	0.5	17.6	1.5	2.2	2.7	0.1	1.7	1.7	1.2	1.1	2.8	0.9	1.3	10.7	6.3	0.9	0.7	0.7	0.5	2.5	7.8	0.9	0.5	0.5	1.3	0.5	1.8	0.9	1.1	1.7	19.8	2.8	0.5	0.7	1.9	1.1	2.1	0.5	0.9	0.7	2.4	0.0	2.9	0.0	0.6	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	17.8	0.5	17.6	10.7	6.3	2.5	7.8	1.8	2.4
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 1562.5"	"Cell line enriched"	"Detected in single"	6	"BJ hTERT+: 4.2"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006411	Enhanced				"Secreted to digestive system"					"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1562.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 108.4"	"Group enriched"	"Detected in some"	13	"CAPAN-2: 16.6;Hep G2: 6.2"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favourable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	6.4	0.1	0.1	0.0	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.1	108.4	0.1	0.1	1.9	0.1	0.1	0.1	0.1	17.8	0.1	0.1	0.2	0.4	1.1	2.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871973-17895174	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 31.5;salivary gland: 66.8;stomach 1: 32.7"	"Cell line enriched"	"Detected in some"	4	"BEWO: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 31.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022364, HPA049055"	Enhanced									"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.1	0.1	0.4	0.1	0.1	2.4	2.3	5.1	0.1	9.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	1.7	0.1	0.1	0.0	0.2	0.2	0.3	2.7	0.0	0.1	0.0	0.2	0.0	31.5	0.1	0.0	5.5	66.8	0.0	0.2	0.2	0.3	0.0	1.9	0.2	32.7	0.4	0.1	0.0	7.1	0.0	0.1	0.0	0.1	1.3	0.8	2.5	1.4	1.0	4.3	0.9	0.0	0.0	0.1	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.5	0.0	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	3.6	0.0	2.5	0.6	0.4	1.1	1.4	1.3	1.0	3.2	0.6	0.8	1.3	4.3	3.2	2.2	1.0	0.4	0.4	2.0	0.9	0.1	0.4	2.4	2.3	1.7	0.1	0.3	2.7	31.5	0.1
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 155.4;hTCEpi: 182.5;SiHa: 54.7;THP-1: 46.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	2600000	2600000	"Golgi apparatus"	"Golgi apparatus"	"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	155.4	0.0	11.6	0.0	5.6	0.0	0.7	0.0	0.0	20.8	0.0	30.0	0.0	0.0	0.8	182.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.6	0.0	0.0	0.0	31.6	1.2	0.0	0.0	54.7	11.7	0.1	0.2	46.2	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0
TCN1	"TC1, TCI"	ENSG00000134827	"Transcobalamin 1"	P20061	11	59852800-59866575	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 152.9;salivary gland: 172.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;HaCaT: 6.8;PC-3: 9.1;SiHa: 9.5;THP-1: 3.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 124.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	95	"basophil: 152.9"	"Lineage enriched"	"Detected in single"	1202	"granulocytes: 152.9"					"Low region specificity"	"Detected in all"								"Secreted to blood"	3300000	3300000				"prognostic favourable (1.90e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (1.56e-8)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	0.2	0.1	0.1	0.1	0.1	27.6	2.1	0.1	0.2	5.5	0.2	0.1	0.0	1.3	1.5	0.0	4.6	0.2	26.7	1.1	0.1	0.1	0.7	0.4	1.8	0.0	0.2	0.0	0.2	3.8	0.1	0.4	0.2	0.1	0.4	0.0	0.1	172.4	0.3	0.2	0.3	0.2	0.1	0.2	1.0	12.7	0.2	0.0	0.3	0.2	28.4	10.0	3.8	1.9	0.0	0.0	152.9	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.0	0.0	9.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	9.5	0.0	2.3	0.0	3.5	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell line enriched"	"Detected in some"	7	"A549: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA077996			Uncertain	Nucleoli,Centrosome				Centrosome	Centrosome	"HPA077996: AB_2686873"																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	9.9	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935868-70965431	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 37.9;placenta: 29.0;salivary gland: 106.9"	"Group enriched"	"Detected in some"	9	"BEWO: 13.5;HaCaT: 12.4;SK-BR-3: 30.6"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	12	"monocytes: 1.4;T-cells: 1.0"	"Not detected"	"Not detected"							"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	0.6	0.0	0.1	0.1	0.1	0.0	4.4	0.8	0.2	12.2	0.1	0.1	6.9	0.1	0.5	0.4	0.5	5.0	0.1	0.3	0.1	0.0	37.9	0.1	2.1	0.1	0.1	0.1	2.0	1.1	0.0	1.7	29.0	0.1	0.6	0.0	7.4	106.9	1.1	0.1	11.8	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.3	0.1	1.6	1.1	0.1	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.2	0.2	0.3	0.8	1.6	1.9	13.5	0.2	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.7	12.4	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.3	0.9	0.4	30.6	0.0	0.3	0.0	0.2	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.0	0.1	0.1	0.1	0.1
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory beta subunit"	Q8WZ55	1	54998193-55011784	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 3.9;kidney: 12.3;salivary gland: 4.2"	"Cell line enriched"	"Detected in single"	20	"RPMI-8226: 12.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"					"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced									"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.0		4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.4	0.2	3.9	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.3	0.2	0.5	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.9	0.1	0.4	0.2	0.1	0.1										
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in some"	6	"BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	52.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.4	20.7	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	2.3	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.2	0.0	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2
CRACR2B	"EFCAB4A, MGC45840"	ENSG00000177685	"Calcium release activated channel regulator 2B"	Q8N4Y2	11	826144-831991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pancreas: 71.2;salivary gland: 149.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.8;NB-4: 14.1;SK-BR-3: 49.8;U-266/70: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.3"	"Group enriched"	"Detected in many"	4	"B-cells: 8.3;granulocytes: 6.6;NK-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046217	Approved									"HPA046217: AB_10960833"	"unprognostic (8.87e-2)"	"unprognostic (4.89e-2)"	"prognostic unfavourable (1.81e-5)"	"unprognostic (4.47e-3)"	"unprognostic (8.20e-3)"	"unprognostic (5.27e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.49e-3)"	"unprognostic (9.25e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-1)"	"unprognostic (5.15e-3)"	1.8	1.5	0.7	4.9	0.8	3.7	15.6	0.7	0.8	2.8	7.2	0.9	10.0	6.3	1.2	2.1	2.1	1.2	9.6	3.5	0.9	0.0	3.1	0.9	4.8	1.3	0.6	0.6	0.7	71.2	3.1	5.1	0.8	1.4	9.5	4.4	1.1	149.6	21.4	1.1	4.5	9.7	1.3	0.8	2.8	15.7	1.2	0.6	0.7	1.1	4.7	9.3	7.4	2.6	8.3	1.0	6.6	1.3	3.0	0.6	0.5	1.8	1.2	0.2	0.5	0.2	0.1	5.4	0.1	0.0	0.0	0.0	1.6	6.0	0.0	2.3	0.0	1.2	0.9	0.1	0.0	12.8	0.5	6.4	1.4	3.9	0.0	4.6	0.1	0.1	0.2	0.0	0.0	0.2	7.8	4.5	0.0	3.0	0.1	14.1	0.3	0.1	1.1	0.2	11.2	4.1	1.2	1.1	0.7	0.1	49.8	0.0	7.8	4.2	0.1	0.6	0.2	0.1	0.1	12.6	1.1	1.7	2.2	6.3	0.0	4.8	1.3	6.6	0.4	0.0	0.0	8.3	0.0	0.6	0.0	2.9	0.0	0.0	0.3	3.0	0.5	1.0	0.0	0.5	0.7	0.8	0.7	0.8	0.9	0.0	0.6	0.6	1.4	0.6
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.9;HEK 293: 37.9;RPTEC TERT1: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.2	0.8	0.2	38.9	1.8	2.0	1.2	3.6	4.3	2.3	1.8	2.7	1.5	0.0	4.2	2.1	8.2	3.7	2.7	1.9	2.2	37.9	1.5	2.2	1.3	1.2	0.5	2.5	6.8	3.7	3.1	3.6	3.3	1.0	0.0	0.9	1.5	0.0	0.8	0.1	3.1	0.0	1.6	0.2	15.2	5.5	1.4	3.4	4.5	0.0	2.6	1.1	0.6	0.8	4.9	3.0	2.5	3.8	0.1	0.3	0.0	1.4	1.8	4.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6
IGSF22	"FLJ37794, IGFN2"	ENSG00000179057	"Immunoglobulin superfamily member 22"	Q8N9C0	11	18704305-18726230	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"salivary gland: 22.7"	"Cell line enhanced"	"Detected in single"		"RH-30: 2.9"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											CAB026459	Uncertain									"CAB026459: "	"unprognostic (4.05e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.99e-4)"	"unprognostic (9.35e-2)"	"unprognostic (3.72e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.94e-3)"	0.3	0.1	0.7	0.2	3.9	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.1	0.7	0.3	0.4	1.5	0.2	0.2	0.2	0.3	0.3	0.2	1.2	0.5	0.0	0.5	0.2	0.2	0.2	0.0	0.2	22.7	0.2	0.5	4.6	0.4	0.2	0.2	0.2	0.0	2.2	0.2	0.2	0.2	1.3	0.3	0.5	0.2	0.2	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.7	3.9	0.2	1.1	0.4	1.5	0.3	0.2	0.2	0.2
MDFIC2		ENSG00000242120	"MyoD family inhibitor domain containing 2"	A0A1B0GVS7	3	70196894-70312726	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.5;salivary gland: 1.1"	"Cell line enriched"	"Detected in single"	5	"HeLa: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Cell line enriched"	"Detected in single"	7	"RH-30: 5.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"					"Low region specificity"	"Detected in all"			HPA055697	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 21.0;salivary gland: 20.9;testis: 37.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.2;HEL: 11.3;HeLa: 29.2;K-562: 13.4;U-698: 41.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 10.5;eosinophil: 21.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	27	"basal ganglia: 6.7"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.8	0.0	0.2	0.2	0.2	5.5	1.0	0.4	0.4	1.4	0.4	0.2	1.4	0.2	0.3	0.2	0.8	2.2	2.1	0.2	0.2	0.0	0.2	0.2	2.1	3.3	0.2	0.2	0.3	0.9	1.7	0.2	0.3	0.4	1.8	0.2	0.2	20.9	0.2	0.5	0.4	0.4	0.2	0.2	0.9	0.4	37.5	0.2	0.9	0.2	1.2	1.1	0.3	0.6	0.8	1.4	21.0	2.3	1.0	3.3	1.3	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	11.3	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	10.5	2.3	21.0	2.2	1.6	3.3	0.8	1.1	1.8	0.6	0.6	1.5	2.2	0.2	1.0	0.3	1.4	0.5	1.3	0.2	0.2	0.4	0.4	0.2	0.0	0.2	0.2	0.4	0.2
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590103-180591540	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 6.2;T-47d: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 25.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8000000	8000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	0.2	0.1	0.1	0.1	0.3	0.1	23.5	0.1	0.2	56.1	0.1	0.1	0.1	0.1	2.3	1.6	12.1	5.7	113.1	0.3	0.1	0.6	0.1	0.5	176.2	0.1	0.1	0.1	1.5	2.9	0.0	1.6	0.1	0.2	4.5	0.0	0.3	196.6	0.6	0.2	0.4	0.1	0.1	0.1	1.6	9.6	0.3	0.1	0.2	0.2	8.4	19.9	3.9	0.1	0.7	5.3	10.3	25.1	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.4	2.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.3	1.5	8.2	7.2	0.7	1.9	2.5	5.3	0.0	3.3	2.6	0.0	0.0	25.1	0.1	2.2	1.2	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530016-38605930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;salivary gland: 11.7;skin 1: 6.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.1;SCLC-21H: 16.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favourable (1.76e-4)"	1.3	2.6	7.9	0.5	9.5	0.6	1.7	16.3	21.2	1.3	0.8	18.4	0.0	1.2	1.0	1.3	0.5	2.1	0.4	0.6	7.0		0.5	1.8	0.8	0.6	9.0	10.5	0.4	1.6	2.2	0.0	0.6	10.2	0.8	0.7	0.5	11.7	1.7	0.9	6.1	0.9	0.5	5.5	0.6	0.9	0.8	10.7	0.0	0.8	0.0	0.4	0.9	0.0	0.3	0.3	1.3	0.2	0.2	0.2	0.0	0.5	0.5	1.2	3.4	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.6	1.0	1.1	0.0	1.2	1.5	0.2	0.1	1.2	1.4	0.0	0.5	1.4	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.1	5.1	0.0	3.1	0.0	0.0	1.6	0.1	0.1	0.0	0.1	0.5	2.5	16.1	2.3	0.0	1.4	0.9	2.5	0.5	0.0	0.0	1.6	0.0	0.0	1.1	0.2	0.1	0.1	0.7	0.7	1.3	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.2	0.6	0.2	0.0	0.3	0.0	0.0										
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285207	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;HEL: 9.2;hTCEpi: 10.6;RPTEC TERT1: 26.2;RT4: 18.9;SCLC-21H: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 7.0"	"Cell type enriched"	"Detected in single"	7	"gdTCR: 2.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favourable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.0	0.2	0.6	4.0	1.1	0.0	12.9	0.6	0.9	8.7	8.5	1.2	6.3	0.2	0.8	8.2	6.0	1.5	8.7	0.1	0.6	0.1	52.2	0.1	12.3	1.5	0.4	0.0	0.6	2.8	0.4	1.5	4.7	7.0	6.1	10.5	0.8	93.5	2.9	2.4	13.1	1.3	0.4	0.4	0.9	6.2	0.8	0.3	0.4	37.3	7.2	6.3	1.4	4.1	0.0	0.1	0.1	0.1	0.4	2.9	0.0	0.0	1.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.4	0.0	0.2	2.7	2.6	0.0	0.0	1.9	9.2	0.0	0.0	0.0	0.0	0.3	0.0	10.6	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	26.2	18.9	8.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.9	0.6	0.1	0.4	0.0	7.0	0.3
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687546-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;CAPAN-2: 7.1;WM-115: 5.8"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA010992: "	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	2.1	1.7	10.8	1.0	24.0	3.2	2.2	2.1	14.8	1.2	1.0	21.6	0.0	1.0	1.2	0.9	1.8	1.1	2.2	1.2	11.5	5.7	0.9	0.9	0.9	1.1	11.6	12.7	1.4	1.2	0.6	1.5	1.2	16.5	1.2	1.3	0.9	15.0	1.4	6.0	2.7	0.7	1.2	16.9	1.1	2.4	2.3	8.8	0.0	1.1	0.4	1.3	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	4.4	2.5	0.5	0.4	0.6	1.2	0.5	0.6	0.9	2.5	7.1	0.3	3.2	0.5	0.8	0.4	0.4	0.3	0.5	1.3	1.0	0.6	0.0	0.3	1.0	0.8	0.6	0.6	0.6	1.2	0.8	0.8	0.5	0.9	0.0	0.8	1.2	0.5	0.2	0.9	0.5	0.0	0.7	0.4	0.6	1.0	0.5	0.1	3.5	0.5	0.6	0.5	0.9	1.7	0.6	0.7	0.5	0.2	0.1	0.4	0.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.0	2.1	12.3	11.5	5.7	11.6	12.7	16.5	8.8
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 7.0;T-47d: 12.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.1	9.8	0.1	0.0	2.0	0.1	0.6	0.0	70.9	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	72.9	2.6	0.2	4.9	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	37.6	52.2	0.1	10.8	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.4	0.1	0.6	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.4	1.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.8	0.8	0.2	0.2	7.0	0.0	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.6	2.0	0.0	0.6	0.0	0.1	0.9	0.7	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	12.8	0.0	0.1	0.0	0.2	1.1	0.0	1.7	1.1	0.1	0.8	0.2	0.4	0.0	0.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ZAR1	Z3CXXC6	ENSG00000182223	"Zygote arrest 1"	Q86SH2	4	48490252-48494389	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.2;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	7	"basal ganglia: 1.7;hypothalamus: 1.1;midbrain: 2.7;pons and medulla: 0.5"													"unprognostic (9.71e-2)"	"unprognostic (2.58e-1)"		"unprognostic (4.59e-3)"	"unprognostic (2.47e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-1)"				"unprognostic (1.08e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.32e-5)"	"unprognostic (4.51e-1)"	0.0	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.7		0.4	0.0	0.0	0.5	0.0		0.0	0.0		1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.2			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.1	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC011479.1		ENSG00000267748			19	38289151-38304910	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	4	"blood: 14.9;pancreas: 6.4;salivary gland: 15.1"	"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 3.7;SK-BR-3: 8.6;U-266/84: 4.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.48e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.31e-1)"		"unprognostic (7.07e-2)"		"unprognostic (1.36e-1)"		"unprognostic (4.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.56e-1)"	0.0	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.9	1.4			2.5	0.2	1.7	1.9	0.0	0.1	0.0	0.0	0.0	2.8	0.0	1.0	0.1	0.0		2.5	6.4	0.0	2.1	1.2		2.1	0.5		15.1	0.9	0.0	2.2	1.1	0.0	0.0	0.3	1.9	0.6			2.9		0.0	0.6	1.2	4.6	14.9	14.5	2.9	0.3	2.9	5.2	4.4	2.0	0.0	0.3	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.3	0.0	1.4	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	1.2	1.3	0.6	3.1	0.0	0.0	0.9	1.5	0.0	0.0	0.7	8.6	0.0	1.4	2.6	1.2	0.0	0.0	0.0	0.0	1.0	4.7	0.2	0.0	0.0	0.6	11.1	2.9	14.5	0.1	1.7	0.2	3.3	1.4	0.5	11.7	4.6	2.9	2.5	1.6	0.3	1.6	14.9	0.4	5.2										
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Group enriched"	"Detected in some"	5	"A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.8	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.6	0.0	63.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	4.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.8	0.2	4.1	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515131	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"salivary gland: 39.2;smooth muscle: 10.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 42.4;hTEC/SVTERT24-B: 15.0;HUVEC TERT2: 15.2;TIME: 29.8;U-87 MG: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA067015: AB_2685764"	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.5	0.6	0.2	0.6	0.2	0.0	5.2	0.6	0.1	3.3	1.2	0.1	0.0	0.1	2.4	0.2	0.8	0.0	2.1	5.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.1	3.6	0.7	3.2	39.2	1.7	0.6	0.9	0.8	10.9	0.3	0.0	0.6	0.1	0.0	0.0	0.1	1.0	0.6	6.1	5.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	9.0	0.0	0.9	0.6	0.0	2.7	0.0	0.0	42.4	0.4	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.2	0.0	15.0	0.2	15.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	6.4	0.4	0.0	8.3	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274790-193378843	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 17.5;salivary gland: 28.9"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.7;SK-BR-3: 5.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Region enriched"	"Detected in many"	10	"pons and medulla: 15.2"	"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031774"	Uncertain									"HPA031771: AB_2674038, HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.1	0.0	1.4	0.1	1.5	0.1	17.5	0.3	0.9	0.1	0.1	2.8	0.1	0.0	0.3	0.9	0.9	0.0	0.1	0.1	1.0	0.7	0.1	0.1	0.4	0.1	0.9	0.1	0.2	0.1	0.1	0.2	0.1	15.2	0.3	0.0	0.4	28.9	0.1	1.3	5.1	0.1	0.1	0.3	0.1	1.4	0.3	0.1	0.4	1.4	1.3	0.7	0.1	0.1	0.4	0.4	4.1	0.3	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.7	1.7	0.3	1.0	0.0	0.0	0.4	0.6	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.9	0.0	0.3	0.4	0.3	0.4	0.3	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	4.1	0.3	0.0	0.4	0.1	0.1	1.4	1.5	0.3	0.9	1.0	0.7	0.9	0.1	15.2	0.1
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB033311: AB_781574, HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
CHADL	SLRR4B	ENSG00000100399	"Chondroadherin like"	Q6NUI6	22	41229510-41240934	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 45.8;salivary gland: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.8;Hep G2: 4.3;hTCEpi: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005696, HPA024654"	Uncertain				"Secreted to extracellular matrix"					"HPA005696: AB_1079724, HPA024654: AB_1846615"	"unprognostic (6.14e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.20e-2)"	"prognostic favourable (1.56e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-8)"	"unprognostic (8.36e-3)"	"unprognostic (4.10e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.09e-2)"	3.2	6.3	8.6	0.7	20.3	1.2	2.4	2.7	22.4	2.8	4.1	45.8	0.4	2.0	1.5	2.1	4.3	3.1	3.4	6.9	12.7	9.8	1.3	1.7	2.8	1.0	18.6	10.1	2.8	4.5	0.5	1.7	0.9	17.2	4.6	0.5	7.3	14.2	5.3	2.6	7.0	1.8	1.2	39.8	1.0	3.3	2.0	20.3	0.0	4.0	0.2	0.6	1.8	1.3	0.3	4.2	1.6	1.4	0.0	1.6	1.2	0.8	0.3	0.3	0.4	0.2	0.1	15.8	0.6	0.0	0.0	0.3	0.2	0.1	0.2	0.1	0.8	0.7	0.0	0.8	0.0	0.2	0.3	0.0	0.4	4.3	0.5	0.2	0.1	1.4	4.5	0.4	0.0	0.5	0.0	0.6	0.0	0.4	0.2	0.7	0.4	0.6	0.2	0.7	0.2	0.3	0.4	1.0	0.2	1.7	0.3	0.2	0.1	1.6	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.1	2.1	0.0	0.6	1.6	0.7	1.4	0.9	0.0	0.6	1.0	0.5	0.3	1.6	0.7	0.7	0.0	0.2	4.2	0.1	1.2	8.6	20.3	2.7	15.2	12.7	9.8	18.6	10.1	17.2	20.3
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165564-30166756	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0"	"Group enriched"	"Detected in some"	15	"HaCaT: 2.2;hTCEpi: 2.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced									"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	24.4	2.8	0.0	9.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN22	CLDN21	ENSG00000177300	"Claudin 22"	Q8N7P3	4	183318194-183320774	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"fallopian tube: 4.2;salivary gland: 7.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.0;RT4: 1.2;SCLC-21H: 1.4;THP-1: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																																							0.0	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.5	0.1	0.1			0.0	1.0	0.0	0.9	4.2	0.0	0.0	0.5	0.2	1.1	1.3	0.1	0.0	0.1		0.0	0.2	0.1	0.4	0.0		0.4	0.0		7.2	0.1	0.5	0.4	0.0	0.1	0.2	0.2	0.0	0.1			0.5		0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"				"Plasma membrane, Centrosome"	"Plasma membrane, Centrosome"	"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favourable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	4.9	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.6	0.7	2.8	0.3	3.5	3.3	1.2	11.6	2.7	3.1	4.2	3.7	0.7	1.1	9.8	10.6	3.2	2.1	9.7	4.2	1.4	4.3	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.7	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"					"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favourable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.2	0.5	27.2	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3
FAM240A		ENSG00000283473	"Family with sequence similarity 240 member A"	A0A1B0GVK7	3	46612435-46626543	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"breast: 1.9;salivary gland: 3.3"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Low region specificity"	"Detected in single"																															0.6	0.0		0.0		0.0	1.9		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.3	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		3.3	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.1			0.3		0.0	0.0		0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.5	0.4	0.8	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
GPR12	"GPCR21, PPP1R84"	ENSG00000132975	"G protein-coupled receptor 12"	P47775	13	26755200-26760785	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 29.4;salivary gland: 7.7"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 17.7"	"Group enriched"	"Detected in some"	7	"breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050972	Uncertain									"HPA050972: AB_2681295"	"unprognostic (2.37e-2)"				"unprognostic (9.64e-3)"			"unprognostic (3.75e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.40e-1)"	1.1	0.7	4.9	0.5	29.4	0.9	4.6	17.7	14.6	1.4	0.7	1.6	0.0	0.7	0.6	0.5	0.8	2.5	0.7	0.7	5.6	2.6	0.6	0.5	0.7	0.6	2.2	4.8	0.6	0.5	0.5	0.7	1.6	1.1	0.6	0.7	1.9	7.7	0.6	0.9	4.4	0.9	0.9	0.7	0.8	0.7	0.8	6.6	0.0	0.6	0.0	0.6	0.6	0.0	0.3	0.2	2.4	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.1	4.9	29.4	17.7	8.4	5.6	2.6	2.2	4.8	1.1	6.6
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell line enhanced"	"Detected in many"		"AF22: 15.2;BEWO: 10.9;Hep G2: 13.2;HSkMC: 15.1;U-251 MG: 13.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"									HPA064126			Approved	Vesicles				Vesicles	Vesicles	"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.2	0.0	4.6	5.2	10.9	4.3	6.3	3.9	4.1	0.0	0.1	0.0	0.0	5.9	0.0	0.4	2.4	2.0	1.2	3.1	0.3	2.0	13.2	6.0	0.5	2.3	15.1	0.8	1.3	3.6	0.0	4.5	0.0	3.1	0.8	0.7	0.6	0.5	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	3.8	0.0	0.0	13.9	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0
INSM2	"IA-6, Mlt1"	ENSG00000168348	"INSM transcriptional repressor 2"	Q96T92	14	35534042-35537054	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9"	"Cell line enriched"	"Detected in single"	134	"SH-SY5Y: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	"Low region specificity"	"Detected in some"			"HPA044885, HPA051925"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044885: AB_10794779, HPA051925: AB_2681664"	"unprognostic (9.88e-2)"	"unprognostic (8.74e-2)"			"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"		"unprognostic (3.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-3)"		"unprognostic (7.51e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.36e-3)"	"unprognostic (5.00e-1)"	0.3	2.3	1.0	0.5	2.8	0.2	0.3	0.5	5.2	0.2	0.2	1.0	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.8	5.0	0.2	0.2	0.3	0.2	1.9	1.2	0.2	0.2	0.2	0.1	0.2	2.7	0.2	0.2	0.7	1.6	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.2	2.9	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	49.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.5	4.6	0.8	5.0	1.9	1.2	2.7	0.2
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 173.1"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 51.5"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	408	"plasmacytoid DC: 40.8"	"Lineage enriched"	"Detected in single"	408	"dendritic cells: 40.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favourable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.0	1.3	0.0	0.0	2.1	0.7	0.1	0.3	6.8	0.0	11.2	1.2	0.3	0.1	0.7	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.4	0.4	0.0	173.1	20.0	0.0	1.3	4.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	10.3	4.6	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	8.5	0.0	51.5	0.0	0.0	0.4	0.1	0.2	2.5	0.0	1.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029816	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 65.7"	"Cell line enhanced"	"Detected in many"		"A-431: 46.1;SK-MEL-30: 57.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.1;T-cells: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA004880	Approved				"Intracellular and membrane"	230000000	230000000			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	6.0	1.6	1.9	3.5	2.0	1.8	7.5	2.7	2.8	4.4	5.1	3.3	3.5	2.1	4.9	4.8	2.4	6.4	2.5	3.3	1.8	1.1	5.1	1.4	1.6	1.7	1.0	1.0	1.3	4.3	15.9	1.8	4.4	2.9	3.7	1.9	2.9	65.7	4.7	1.4	10.5	8.7	3.1	1.1	1.0	1.1	2.6	0.9	3.6	2.0	1.3	2.4	2.0	5.4	0.2	1.9	0.2	2.1	0.5	3.3	0.6	46.1	10.1	0.1	0.3	1.4	1.9	1.2	0.8	0.4	1.5	1.9	2.8	6.9	1.3	10.0	1.6	14.4	0.5	0.0	0.7	2.1	3.2	1.6	2.2	1.2	9.4	0.2	9.2	10.1	1.2	1.3	0.1	0.2	1.2	9.1	0.9	2.8	2.6	0.0	1.0	6.6	3.8	1.6	0.5	0.2	0.4	0.9	3.4	9.5	0.8	57.0	2.8	1.4	0.3	0.3	8.1	1.6	5.7	1.5	12.8	1.2	1.1	2.7	0.0	0.1	0.3	0.0	1.2	1.0	3.3	0.2	1.0	1.0	1.9	0.2	0.3	0.1	0.2	0.5	2.1	0.0	0.1	0.6	1.9	2.0	2.7	2.8	1.8	1.1	1.0	1.0	2.9	0.9
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	35	"AN3-CA: 21.3;CAPAN-2: 17.8;SK-MEL-30: 62.1;WM-115: 58.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"									HPA042369	Approved				"Secreted to blood"					"HPA042369: AB_10794420"	"prognostic favourable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	62.1	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	58.8	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Group enriched"	"Detected in some"	17	"BJ: 98.9;BJ hTERT+: 269.1;fHDF/TERT166: 116.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	170000	170000	Vesicles	Vesicles	"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	269.1	1.7	0.5	0.0	0.0	0.0	0.0	116.5	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.2	0.8	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CAPAN-2: 5.5;HaCaT: 5.3;HeLa: 26.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"					"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.4	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC19	FLJ35746	ENSG00000205592	"Mucin 19, oligomeric"		12	40393395-40570832	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	4	"salivary gland: 22.6"	"Cell line enriched"	"Detected in some"	4	"U-937: 8.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"						"unprognostic (7.80e-3)"	"unprognostic (2.84e-1)"		"unprognostic (1.69e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.25e-3)"		"unprognostic (8.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.35e-3)"	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NXPE2	"FAM55B, FLJ25224"	ENSG00000204361	"Neurexophilin and PC-esterase domain family member 2"	Q96DL1	11	114678386-114706933	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"epididymis: 22.9;salivary gland: 44.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.9;U-87 MG: 2.6"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA039744, HPA039876"	Enhanced									"HPA039744: AB_2676660, HPA039876: AB_2676721"	"unprognostic (2.85e-1)"		"prognostic favourable (9.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.46e-2)"		"unprognostic (9.35e-2)"		"unprognostic (1.27e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-4)"	"unprognostic (9.00e-2)"		"unprognostic (9.22e-2)"		0.2	0.1	0.2	3.0	0.2	0.0	0.2	0.1	0.2	0.3	7.4	0.0	0.8	0.3	0.5	22.9	0.4	0.2	0.0	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.5	7.1	0.0	44.1	0.0	0.2	0.2	1.8	0.5	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.7	4.8	0.2	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	2.9	0.1	0.8	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76033932	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 142.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 43.3;RPTEC TERT1: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1"	"Group enriched"	"Detected in many"	7	"monocytes: 2.5;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028"	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	13.2	15.9	9.4	8.4	12.1	9.0	13.5	6.4	15.7	11.5	4.5	11.1	4.8	3.4	7.1	3.1	33.3	5.1	20.0	9.6	8.2	7.9	13.8	33.2	14.2	3.0	8.4	5.6	10.8	8.8	2.6	6.0	7.1	10.0	4.8	5.5	24.9	142.4	6.5	3.3	6.3	7.0	7.6	9.7	14.6	10.8	2.3	10.1	2.5	18.0	13.2	19.9	17.0	17.8	0.3	0.1	0.4	2.5	0.3	4.1	0.6	13.5	16.3	12.8	7.0	6.0	12.4	0.9	11.5	31.1	5.2	7.3	9.0	16.6	0.0	3.5	4.8	7.0	0.3	19.3	11.3	2.0	0.2	0.3	0.8	15.2	8.7	0.3	3.5	3.8	14.2	21.8	43.3	12.5	1.1	0.4	26.8	1.7	0.0	1.7	4.6	25.2	0.0	3.3	0.4	54.9	30.8	0.9	2.4	2.0	0.1	37.4	8.2	0.1	11.6	17.9	1.7	20.8	11.3	0.2	0.0	0.0	30.2	0.2	22.3	0.3	0.1	0.2	2.4	0.2	3.9	0.3	2.5	2.5	0.0	0.2	0.5	0.6	0.4	0.3	2.5	0.1	4.1	0.6	9.4	12.1	6.4	7.7	8.2	7.9	8.4	5.6	10.0	10.1
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139746	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 1246.7;seminal vesicle: 651.3"	"Cell line enriched"	"Detected in single"	330	"T-47d: 123.4"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.5;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 2.6"									"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	89000000	89000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	144.4	0.2	0.1	0.2	0.1	0.0	219.3	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1246.7	651.3	0.2	7.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	49.3	1.1	1.8	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	123.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.0
PYCR1	P5C	ENSG00000183010	"Pyrroline-5-carboxylate reductase 1"	P32322	17	81932384-81942412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 56.1;salivary gland: 53.3;stomach 1: 16.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 7.7"	"Group enriched"	"Detected in many"	7	"B-cells: 7.7;dendritic cells: 3.3;T-cells: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047660	Approved									"HPA047660: AB_2680115"	"unprognostic (1.12e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (2.80e-1)"	"unprognostic (9.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.02e-3)"	"unprognostic (7.12e-2)"	"prognostic unfavourable (7.33e-12)"	"unprognostic (7.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.92e-2)"	2.1	1.3	4.3	5.0	5.0	4.0	6.9	2.1	4.3	10.4	9.1	2.3	10.1	5.6	4.2	2.2	6.4	3.5	5.7	3.5	3.5	3.6	2.4	3.1	4.9	2.3	6.0	2.0	7.6	56.1	0.0	7.6	8.3	6.4	10.4	5.6	1.5	53.3	4.7	3.4	1.8	4.8	4.6	2.9	2.4	16.6	8.7	4.0	1.7	3.3	4.5	6.4	4.9	4.0	7.7	3.3	0.0	0.4	0.6	3.0	2.2	19.1	20.5	11.7	43.3	7.0	13.3	22.4	32.2	15.9	10.4	14.0	23.4	21.6	29.4	7.2	34.4	8.4	27.5	12.2	6.2	7.6	3.4	17.3	10.6	63.2	41.5	11.5	13.4	11.3	24.5	12.7	33.6	17.6	55.7	27.4	6.5	67.9	12.1	9.2	9.8	31.9	0.1	19.7	37.1	9.3	7.0	45.0	31.7	6.7	38.0	41.0	39.1	21.3	12.9	10.1	38.9	17.0	11.9	34.6	24.0	27.3	10.8	0.1	33.2	0.0	0.3	0.0	0.5	0.4	0.7	7.7	1.3	0.4	2.3	3.5	3.0	2.3	0.0	0.6	0.0	3.3	0.5	2.2	4.3	5.0	2.1	3.6	3.5	3.6	6.0	2.0	6.4	4.0
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555181-6579757	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"salivary gland: 10.9;testis: 8.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;HDLM-2: 4.6;Hep G2: 4.5;LHCN-M2: 3.6;U-698: 2.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034579, HPA034580"	Approved									"HPA034579: AB_2674232, HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.4	0.8	0.7	0.1	0.8	1.5	0.4	0.6	1.2	0.7	0.9	0.1	0.1	0.4	0.1	0.1	0.4	0.4	1.0	0.1	1.2	0.2	0.1	0.1	0.6	0.2	0.2	0.1	0.9	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.7	10.9	2.1	0.6	1.4	0.5	0.1	0.1	1.3	0.5	8.7	0.1	0.1	0.1	2.2	0.5	0.4	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.5	0.1	0.3	0.1	2.7	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.1	4.5	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.7	0.8	0.6	1.2	1.2	0.2	0.2	0.1	0.5	0.1
TAS1R3	T1R3	ENSG00000169962	"Taste 1 receptor member 3"	Q7RTX0	1	1331314-1335306	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.2;salivary gland: 17.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.9"	"Cell type enriched"	"Detected in single"	37	"memory B-cell: 5.2"	"Lineage enriched"	"Detected in single"	37	"B-cells: 5.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA053439	Uncertain									"HPA053439: AB_2682150"	"unprognostic (1.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.59e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-1)"	0.4	0.4	0.4	1.5	0.4	0.5	0.4	1.9	0.4	0.6	1.4	0.4	1.0	2.0	0.5	35.2	1.9	0.6	0.7	1.4	0.4	0.1	0.5	1.6	0.9	1.6	0.4	0.4	0.4	0.4	0.1	2.6	1.9	0.4	0.4	0.1	0.4	17.9	0.4	1.4	0.2	3.2	0.4	0.4	6.4	0.9	1.6	0.4	0.4	0.8	1.5	2.5	1.0	0.9	5.2	0.1	0.0	0.0	0.0	0.1	0.2	1.4	1.3	0.3	0.5	0.0	0.0	0.7	0.7	0.2	0.2	0.1	0.9	2.9	1.7	0.3	0.0	0.6	0.0	0.0	0.0	3.6	1.0	0.2	2.5	0.9	0.3	0.0	0.5	0.1	0.2	0.1	0.0	0.0	0.4	5.9	0.0	0.8	0.3	0.6	0.8	3.4	0.9	0.7	0.8	0.0	0.2	2.2	0.4	0.4	2.3	1.9	2.0	0.4	0.3	0.5	0.2	1.8	0.8	3.7	3.4	0.8	0.2	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	1.9	0.4	0.4	0.1	0.4	0.4	0.4	0.4
TMEM211	bA9F11.1	ENSG00000206069	"Transmembrane protein 211"	Q6ICI0	22	24934954-24946695	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 5.3;salivary gland: 6.6;stomach 1: 5.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HEK 293: 1.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.8;endometrial cancer: 3.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066784	Uncertain									"HPA066784: AB_2685722"	"unprognostic (7.89e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.09e-2)"		"unprognostic (5.97e-3)"		"unprognostic (5.88e-2)"		"unprognostic (1.31e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.4	0.4	0.0	0.8	0.4	0.1	5.3	0.4			0.0	1.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.2	0.0	0.2	0.0		0.1	0.1		6.6	0.0	0.0	1.4	0.1	0.0	0.0	0.0	5.8	0.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Group enriched"	"Detected in some"	9	"A-431: 26.2;CAPAN-2: 49.1;EFO-21: 41.0;HaCaT: 35.8;RPTEC TERT1: 38.1"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"					"Group enriched"	"Detected in many"	13	"basal ganglia: 10.7;hypothalamus: 32.7;midbrain: 14.3;pons and medulla: 12.8;thalamus: 8.5"	HPA042302	Enhanced				"Secreted in other tissues"	1300000	1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	49.1	0.0	41.0	0.0	35.8	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.6	4.3	0.0	0.0	0.0	0.0	38.1	0.3	1.2	0.2	2.4	0.0	0.2	0.7	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523007-62587709	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 99.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	12.6	5.0	6.8	7.0	7.5	22.8	16.0	8.0	6.8	7.5	8.5	6.0	5.3	6.8	6.9	7.1	6.5	7.4	9.0	8.5	5.3	5.7	5.8	23.0	10.1	7.6	8.1	5.7	8.8	6.3	7.8	8.5	8.2	5.5	8.1	5.8	4.5	99.1	5.9	16.8	11.3	7.5	7.6	5.6	8.9	6.5	13.4	8.9	10.8	7.8	4.3	6.4	11.0	19.3	1.6	1.0	4.9	1.6	0.6	2.0	0.4	5.8	5.1	4.4	8.7	13.5	5.8	8.4	3.4	5.1	8.1	8.1	2.7	3.6	16.6	4.5	5.6	10.0	14.2	7.5	3.4	11.4	6.7	4.4	11.8	18.6	4.6	8.3	6.4	5.7	9.7	5.1	9.6	15.2	4.6	5.6	2.6	4.8	5.4	3.5	2.8	5.1	7.2	4.7	0.1	5.6	6.0	5.6	3.5	5.7	12.8	5.0	4.5	6.6	6.4	8.0	5.5	3.1	4.8	2.2	4.2	7.1	6.0	3.5	2.9	0.0	1.0	2.4	1.7	1.6	1.2	0.5	1.1	1.5	0.3	1.6	2.0	1.3	4.9	0.6	0.3	1.0	1.2	0.4	6.8	7.5	8.0	6.8	5.3	5.7	8.1	5.7	5.5	8.9
AC025165.3		ENSG00000257921			12	57773028-57787046	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pancreas: 14.2;salivary gland: 16.5"	"Group enriched"	"Detected in some"	27	"ASC diff: 3.6;fHDF/TERT166: 1.6;HMC-1: 1.9;Karpas-707: 1.7;RH-30: 4.6"	"Cancer enriched"	"Detected in single"	6	"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.74e-2)"	"unprognostic (6.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.74e-2)"	3.0	1.2	1.4	0.8	1.3	0.8	3.4	1.4	1.5	2.4	1.3	0.0	2.8	0.8	3.3	2.3	1.7	0.8	2.5	0.8	0.9	1.0	3.7	1.7	2.1	3.3	1.2	0.1	3.6	14.2	0.8	0.8	0.9	0.4	2.3	2.0	1.6	16.5	5.3	0.8	0.8	0.8	2.0	2.5	0.8	1.0	1.0	0.0	0.0	2.4	1.1	1.7	2.3	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.4	1.5	0.9	1.0	1.2	0.1	0.4	0.0
AC106782.1		ENSG00000258130			16	30204316-30209071	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 12.2;testis: 12.1"	"Group enriched"	"Detected in some"	6	"A549: 6.6;CAPAN-2: 24.3;SK-BR-3: 20.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA053608	Uncertain									"HPA053608: AB_2682205"	"unprognostic (4.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.14e-2)"	2.1	0.2	0.8	1.9	0.1	0.7	1.7	0.4	1.8	2.1	0.7			3.2	1.0	0.0	0.0	2.9	2.1	0.7	0.4	2.1	2.8	0.0	0.9	2.0	0.4		0.4	0.0	0.3	4.6	0.2		0.9	0.1		12.2	0.5	0.8	0.7	2.5	0.4	0.1	1.6	1.5	12.1			0.8		1.4	1.5	0.7	1.0	4.2	0.4	4.6	0.4	2.5	1.1	1.6	6.6	0.3	0.1	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	24.3	0.2	1.6	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.3	0.4	0.0	20.5	0.0	0.6	0.1	0.6	0.3	0.4	0.2	0.1	0.2	1.3	0.1	1.8	0.2	0.0	0.3	4.2	0.0	1.4	4.6	0.7	1.0	2.5	1.4	4.2	0.1	0.4	2.1	0.4	0.4	1.0	0.2	2.1	1.1										
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597237-132618967	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 35.6;salivary gland: 29.0"	"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 86.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"cerebellum: 5.3;pons and medulla: 1.6"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"	"Vesicles, Mitochondria"	"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	13.9	1.9	0.3	2.9	0.4	0.5	10.9	0.4	0.4	3.7	8.7	0.2	4.5	16.2	5.6	7.1	5.7	2.6	9.8	7.1	0.6	0.6	6.6	2.0	10.0	2.7	0.6	0.2	2.1	3.0	0.0	8.2	0.7	0.6	5.2	1.2	1.3	29.0	2.0	3.1	10.7	35.6	5.0	0.4	1.5	10.5	3.4	0.1	0.8	1.8	12.8	1.5	8.2	4.5	0.2	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	3.4	0.0	14.2	86.6	0.8	2.4	0.0	0.1	0.9	0.0	8.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1
ADM2	"AM2, FLJ21135"	ENSG00000128165	"Adrenomedullin 2"	Q7Z4H4	22	50481556-50486440	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 30.2;salivary gland: 32.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 21.7;hTCEpi: 13.6;Karpas-707: 21.6;SK-MEL-30: 14.2;U-266/70: 15.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (1.30e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.26e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.41e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (1.06e-2)"	0.5	0.5	0.4	2.9	0.4	0.1	0.7	0.4	0.4	0.8	1.2	0.0	1.3	3.7	0.5	2.9	2.2	0.6	5.6	0.4	0.4	0.4	11.4	6.6	0.8	4.1	0.4	0.0	0.4	30.2	0.0	0.6	0.7	0.2	2.6	0.4	0.1	32.2	2.2	0.4	0.5	5.2	0.0	0.5	2.0	4.3	0.6	0.0	1.6	11.7	1.7	4.0	0.5	0.6	0.9	0.5	2.0	0.5	0.4	1.4	0.2	1.0	0.2	0.3	1.1	0.7	1.2	4.0	5.1	0.4	0.7	1.7	2.1	0.8	0.0	0.7	4.3	0.8	1.1	0.6	0.2	9.7	0.0	0.0	0.2	1.5	21.7	2.0	1.4	4.3	13.6	2.3	4.9	0.0	1.3	21.6	0.1	3.1	0.2	0.4	0.7	3.2	0.0	0.0	8.1	0.9	0.1	0.5	2.3	0.0	3.1	14.2	4.3	6.7	0.0	0.0	4.8	0.0	0.0	15.8	2.2	2.8	0.4	0.0	1.2	0.7	0.5	0.4	0.6	0.2	0.3	0.6	0.5	0.6	0.0	0.9	1.4	1.1	2.0	0.4	0.5	0.5	0.3	0.2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.2	0.0
AL032819.3		ENSG00000284395			16	1431035-1433397	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"intestine: 4.1;prostate: 5.2;salivary gland: 2.5;stomach 1: 4.5"	"Cell line enriched"	"Detected in single"	30	"SCLC-21H: 27.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.2	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.2	0.0	0.4	2.5	0.0	0.2	0.3	2.1	1.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	27.1	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
AL929554.1		ENSG00000261793			9	137168854-137171984	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"salivary gland: 31.6;testis: 18.3"	"Group enriched"	"Detected in some"	5	"REH: 9.8;RPMI-8226: 16.3;SK-BR-3: 11.0;T-47d: 6.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	33	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 6.5"																																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	31.6	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.2	0.1	0.0	9.8	0.0	16.3	0.0	1.3	0.4	0.1	0.0	11.0	0.0	6.3	0.5	0.0	0.0	0.4	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0										
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Supported	Mitochondria		23000	23000	Mitochondria	Mitochondria	"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.2	17.3	16.6	43.6	22.4	21.7	17.9	21.3	32.1	21.7	27.3	34.6	14.6	62.1	20.0	33.5	24.2	33.3	21.9	24.7	17.6	26.2	19.7	12.3	49.1	14.7	34.3	22.0	22.7	13.5	17.7	34.7	22.7	18.3	13.1	16.2	26.2	31.0	22.1	19.6	17.3	29.2	19.1	21.3	25.3	13.9	16.6	16.5	16.9	13.5	15.7	20.1	16.0	18.8	9.0	14.4	23.2	24.4	15.1	11.2	38.0	17.6	39.8	11.5	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Cell line enriched"	"Detected in single"	4	"THP-1: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	68000000	68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161921-138344663	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2;parathyroid gland: 24.5;salivary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"MCF7: 11.2;RH-30: 10.6;RT4: 15.0;SK-BR-3: 17.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain									"HPA036350: AB_10672084"	"prognostic unfavourable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.6	5.5	15.1	1.5	15.7	1.1	11.0	26.2	19.7	7.3	5.7	17.1	2.1	3.2	1.5	1.8	1.0	3.4	2.7	1.7	10.9	10.2	3.5	0.7	8.4	0.9	13.9	13.6	0.7	11.2	24.5	9.3	2.4	11.7	15.8	6.6	0.7	26.6	1.9	0.9	1.7	2.9	1.5	12.4	1.1	13.1	1.3	14.5	0.0	2.9	0.0	1.1	4.2	0.9	0.2	0.1	1.0	0.0	0.6	0.1	0.0	6.0	2.4	0.0	0.4	0.0	0.0	3.7	0.3	0.2	0.1	0.0	0.1	0.3	0.0	2.5	0.2	2.0	2.9	1.5	0.0	0.0	3.8	0.0	1.2	0.7	0.0	2.3	0.0	0.0	0.7	0.0	0.7	3.2	0.0	3.8	0.0	11.2	0.0	0.0	2.1	2.6	0.5	10.6	2.0	2.0	15.0	5.5	0.0	6.1	17.5	0.7	3.5	0.0	0.3	0.2	1.8	0.0	6.0	1.3	4.9	0.0	2.6	1.4	0.4	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	15.1	15.7	26.2	19.7	10.9	10.2	13.9	13.6	11.7	14.5
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 57.9;Karpas-707: 25.3;MOLT-4: 51.8;SK-BR-3: 42.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved					100000000	100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favourable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.1	2.4	0.1	0.1	0.6	0.0	0.0	4.8	0.4	20.4	1.2	0.0	0.3	22.2	57.9	0.0	0.0	0.1	0.0	0.0	4.1	25.3	0.0	24.3	51.8	23.9	0.2	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.1	0.0	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;MCF7: 16.3;RT4: 12.9;SK-BR-3: 22.7;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	"Plasma membrane, Focal adhesion sites"	"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favourable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	4.1	0.3	0.5	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	12.9	3.3	0.0	0.0	22.7	0.2	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Group enriched"	"Detected in some"	8	"BEWO: 39.7;SK-BR-3: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.2	1.4	0.0	0.0	39.7	0.5	0.0	0.0	0.0	0.7	1.0	1.0	0.8	0.0	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	0.4	1.9	0.0	1.2	0.3	1.5	1.0	0.4	0.8	0.7	3.2	0.0	0.9	1.0	1.3	0.3	14.2	0.4	1.4	2.1	0.2	0.5	1.0	0.5	0.5	3.4	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 19.8;Karpas-707: 11.3;RPMI-8226: 45.9;SK-BR-3: 9.3;T-47d: 15.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, CAB016087, CAB032276"	Enhanced				"Secreted to blood"	160000000000	160000000000			"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226"	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.4	5.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	1.9	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	45.9	0.0	0.0	0.0	0.7	0.3	9.3	4.5	15.4	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.3	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell line enhanced"	"Detected in some"		"A-431: 19.7;CAPAN-2: 12.7;MCF7: 29.4;RPMI-8226: 15.4;SK-BR-3: 14.8;T-47d: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	19.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	4.1	12.7	0.0	0.2	0.0	1.8	0.2	0.0	0.0	2.1	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.3	0.0	0.5	0.0	0.4	0.0	15.4	1.9	4.3	6.8	0.0	0.0	14.8	0.0	14.9	2.1	0.0	0.0	0.0	0.0	0.0	4.8	6.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8
C10orf113	bA165O3.1	ENSG00000204683	"Chromosome 10 open reading frame 113"	Q5VZT2	10	21125763-21146559	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"salivary gland: 1.2;testis: 4.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;hTCEpi: 1.2;RT4: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA037013	Uncertain									"HPA037013: AB_10672106"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-2)"												"unprognostic (4.18e-1)"		"unprognostic (5.00e-1)"	"unprognostic (3.11e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.7	0.0			0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0	0.4	0.0		0.0	0.0		1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.8			0.2		0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	20.4	0.2	2.7	1.3	0.0	5.6	0.0	0.3	1.5	0.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408548-55418764	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA067189: AB_2685800"	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	3.4	3.1	6.5	0.9	7.4	0.8	5.4	2.4	6.7	7.7	5.2	3.7	5.4	2.9	3.7	11.2	3.4	13.7	5.3	7.0	6.0	7.6	11.2	1.9	3.8	2.2	5.2	6.8	4.6	11.0	6.2	17.2	1.2	12.0	5.8	6.2	2.8	27.6	5.3	8.7	2.4	2.5	3.7	3.4	1.9	7.8	11.3	4.6	1.7	7.1	0.6	1.8	3.6	1.5	2.3	0.6	6.5	1.6	0.0	0.7	0.4	0.8	1.7	2.9	1.8	4.5	6.6	0.5	1.6	2.2	1.4	2.8	0.0	1.5	1.3	4.4	5.1	1.3	0.0	2.7	0.5	2.4	2.0	1.2	10.0	0.4	8.7	2.8	1.6	2.8	14.7	4.1	1.2	2.6	2.3	4.3	6.1	2.2	0.1	9.2	0.9	3.3	0.5	0.0	11.1	7.6	0.0	7.8	4.7	2.0	3.3	12.7	6.8	2.7	1.9	2.4	0.9	2.5	0.9	1.9	4.9	1.2	6.1	7.2	1.1	6.5	1.1	3.9	0.5	1.6	0.0	1.9	0.1	0.7	0.6	2.3	0.1	0.0	2.1	0.0	0.8	0.2	0.0	0.4	6.5	7.4	2.4	6.7	6.0	7.6	5.2	6.8	12.0	4.6
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902932	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.7;salivary gland: 26.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.4;HMC-1: 7.2;hTCEpi: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Not detected"	"Not detected"							HPA069713	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA069713: AB_2686181"	"prognostic favourable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.4	3.7	5.0	2.3	5.1	4.2	3.0	7.7	8.7	3.9	1.4	0.2	5.9	2.1	1.9	5.9	1.3	1.8	3.3	15.3	3.8	4.3	2.2	8.8	2.9	1.0	1.6	4.2	6.4	7.7	6.2	25.7	1.5	1.7	4.5	0.9	2.1	26.0	6.4	0.6	3.3	1.6	1.2	2.2	2.1	4.6	4.7	0.6	0.1	1.9	0.6	2.7	3.3	1.9	0.0	0.0	6.7	0.2	0.0	0.9	0.1	0.6	0.8	1.0	0.3	2.1	1.7	1.5	3.8	0.5	0.2	0.5	0.7	0.7	0.4	0.6	5.4	1.4	0.1	0.5	0.3	0.1	0.8	2.0	0.6	0.7	3.0	0.0	7.2	1.7	6.5	0.1	0.4	0.2	0.0	0.1	0.1	0.7	0.1	0.6	0.3	0.7	0.3	0.2	2.8	0.3	0.3	0.1	0.5	0.6	2.3	0.3	0.6	1.0	0.5	0.3	0.7	0.6	0.5	0.6	0.6	0.1	0.4	0.1	0.3	0.0	0.2	0.8	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.7	0.0	0.1	0.0	0.0	0.1	5.0	5.1	7.7	8.7	3.8	4.3	1.6	4.2	1.7	0.6
C2CD4D	FAM148D	ENSG00000225556	"C2 calcium dependent domain containing 4D"	B7Z1M9	1	151837819-151840557	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 4.1;skin 1: 4.9"	"Cell line enriched"	"Detected in some"	9	"HDLM-2: 20.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0;T-reg: 2.2"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.17e-3)"	"unprognostic (5.08e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (9.03e-4)"	"unprognostic (2.69e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.28e-2)"	0.4	0.8	0.9	0.7	0.6	0.0	0.4	1.9	2.3	0.1	1.0			0.5	0.0	0.0	0.6	0.5	0.7	0.4	1.6	0.8	0.9	0.2	0.8	0.8	1.4		0.0	2.6	0.0	1.2	0.0		1.0	0.1		4.1	0.6	0.4	4.9	0.6	0.0	3.3	0.5	1.9	0.5			0.3		0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	20.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.1	1.5	1.1	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1										
C5orf38	"CEI, IRX2NB"	ENSG00000186493	"Chromosome 5 open reading frame 38"	Q86SI9	5	2752131-2755397	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"salivary gland: 34.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.4;HaCaT: 12.8;hTCEpi: 20.5;MCF7: 10.9;SiHa: 15.7;SK-BR-3: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073667			Approved	"Golgi apparatus,Vesicles"	"Secreted - unknown location"			"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA073667: AB_2686624"	"unprognostic (5.00e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-5)"	"unprognostic (4.08e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.67e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.84e-7)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.60e-2)"	8.3	0.5	4.5	0.6	7.6	0.5	16.3	10.4	3.0	0.6	1.1	1.5	9.8	0.7	0.7	6.8	4.1	0.6	0.6	2.4	6.0	7.0	6.6	0.5	19.4	1.1	10.5	2.0	0.5	3.8	5.0	2.6	4.3	14.8	5.9	0.7	3.4	34.9	3.9	0.9	10.6	0.5	0.5	12.2	0.7	11.2	1.5	4.7	0.0	5.0	1.6	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	6.7	0.0	2.9	2.1	37.4	4.8	3.8	3.2	2.8	1.9	0.0	0.0	0.0	0.9	12.8	0.7	3.7	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	20.5	0.8	2.6	0.0	0.0	0.0	0.8	10.9	0.0	0.1	1.0	0.0	0.0	1.3	0.0	4.2	0.0	1.0	0.0	15.7	14.7	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.6	10.4	0.3	6.0	7.0	10.5	2.0	14.8	4.7
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Group enriched"	"Detected in some"	6	"SK-BR-3: 9.7;T-47d: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050769	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.7	0.0	18.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.9;salivary gland: 27.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.8;U-87 MG: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol				Cytosol	Cytosol	"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4.0	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1.0	4.0	2.5	5.5	16.0	6.0	7.5	5.0	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5.0	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0.0	1.0	1.1	4.8	8.4	0.9	4.2	3.0	5.4	0.3	3.4	3.7	3.2	1.5	3.0	1.5	2.9	3.6	6.4	14.5	2.3	4.1	2.0	0.1	7.7	3.3	17.8	1.1	3.1	0.5	2.6	4.1	3.5	6.1	2.1	1.4	2.6	0.1	1.6	1.3	4.0	1.9	0.9	7.9	2.1	3.7	3.4	3.5	3.1	4.9	2.7	1.3	10.0	2.2	3.8	1.1	2.0	5.6	7.6	7.1	2.7	0.4	0.2	0.1	20.5	2.8	0.7	0.0	1.8	3.6	0.6	3.9	1.0	0.0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0.0	4.1	0.8	0.0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16.0	11.2	5.0
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.2	0.8	2.5	0.3	0.0	0.0	0.4	0.5	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.4	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.6	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1
CCDC129	FLJ38344	ENSG00000180347	"Coiled-coil domain containing 129"	Q6ZRS4	7	31514071-31658720	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.2;salivary gland: 10.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.6;U-2 OS: 5.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA024103	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA024103: AB_1846132"	"unprognostic (1.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.78e-5)"	"unprognostic (9.72e-3)"	"unprognostic (1.78e-1)"		"unprognostic (3.89e-2)"	"unprognostic (6.42e-3)"		"unprognostic (1.01e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"		0.1	0.0	0.1	0.6	2.0	0.1	3.3	7.9	0.3	3.7	0.9	1.2	0.0	2.1	1.1	0.2	0.1	0.1	0.1	0.0	0.4	1.4	0.1	0.0	0.4	0.0	5.0	0.0	0.0	0.2	0.0	0.4	0.9	17.2	0.1	0.2	0.0	10.9	0.0	0.0	4.5	0.9	1.1	0.2	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.8	1.1	0.0	0.1	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.1	2.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	5.4	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.2	0.1	0.1	0.8	1.0	0.4	1.1	0.1	0.0	0.8	0.0	0.1	0.1	2.0	7.9	0.3	0.4	1.4	5.0	0.0	17.2	0.0
CCDC140	FLJ32447	ENSG00000163081	"Coiled-coil domain containing 140"	Q96MF4	2	222298147-222305217	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;NB-4: 3.7;RH-30: 2.1;SK-MEL-30: 3.9;WM-115: 2.3"	"Cancer enriched"	"Detected in single"	9	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042500, HPA048166"	Uncertain									"HPA042500: AB_2678028, HPA048166: AB_2680295"					"unprognostic (2.50e-2)"	"unprognostic (3.54e-1)"			"unprognostic (5.25e-2)"									0.3	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.2	0.0	3.1	1.8	0.0	0.0	1.6	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.1	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	2.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCDC160		ENSG00000203952	"Coiled-coil domain containing 160"	A6NGH7	X	134237047-134246207	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.9"	"Group enriched"	"Detected in some"	5	"AF22: 25.1;RPTEC TERT1: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044684	Uncertain									"HPA044684: AB_10806506"	"unprognostic (7.45e-3)"	"unprognostic (2.79e-2)"		"prognostic favourable (2.31e-4)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-4)"		"unprognostic (4.22e-2)"	"unprognostic (2.07e-2)"	"prognostic favourable (7.62e-6)"	"unprognostic (3.32e-2)"	"unprognostic (4.51e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.44e-3)"	0.5	0.3	4.2	0.5	3.5	0.5	6.0	2.8	3.6	4.6	0.5	2.5	7.1	0.4	1.3	4.2	0.8	5.0	1.9	0.4	5.1	5.2	9.6	0.3	3.1	0.8	7.7	3.0	2.2	2.0	8.0	1.2	0.5	7.5	3.5	0.4	0.9	21.9	11.7	1.5	0.6	0.3	0.4	5.8	0.8	1.6	3.0	6.5	0.0	0.6	0.5	0.4	1.4	0.6	0.3	0.2	0.2	0.1	0.1	0.5	0.0	0.0	0.0	25.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	7.0	2.0	0.0	0.1	0.0	0.3	0.3	3.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.4	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	4.2	3.5	2.8	3.6	5.1	5.2	7.7	3.0	7.5	6.5
CEP41	"DKFZp762H1311, FLJ22445, JBTS15, TSGA14"	ENSG00000106477	"Centrosomal protein 41"	Q9BYV8	7	130393771-130442433	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 34.2;testis: 35.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024090	Uncertain									"HPA024090: AB_10966276"	"unprognostic (3.87e-2)"	"unprognostic (5.96e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (1.17e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-7)"	"unprognostic (1.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.45e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.57e-1)"	3.4	6.0	4.8	3.7	11.7	3.8	4.6	3.5	11.4	3.9	3.0	10.5	3.0	2.5	4.8	3.6	2.6	9.2	3.8	2.9	5.6	7.0	3.3	2.5	3.3	4.5	5.8	6.5	5.2	3.5	7.0	11.4	4.9	8.0	3.2	4.5	5.2	34.2	4.1	1.8	2.4	2.4	5.2	6.5	5.0	2.7	35.3	5.0	12.2	3.9	3.3	4.2	3.6	2.5	3.3	6.0	5.9	5.1	8.3	17.1	5.6	7.8	8.9	10.4	12.7	3.7	5.5	2.9	8.5	6.1	8.2	8.0	4.4	9.5	13.0	5.6	6.8	8.6	11.4	7.3	12.4	3.9	3.5	4.6	4.2	2.5	5.8	7.7	4.1	6.5	5.0	11.1	4.1	12.3	2.2	2.9	12.3	5.4	22.5	7.7	9.1	7.7	19.4	13.7	0.4	4.7	5.6	20.2	14.8	7.1	14.0	8.7	3.9	7.1	6.0	11.9	3.4	9.1	12.5	7.7	20.3	14.4	11.6	8.5	17.5	5.9	3.4	3.6	7.5	5.1	4.7	2.8	5.3	5.0	6.0	3.3	8.7	17.1	0.6	8.3	2.5	2.9	4.6	5.6	4.8	11.7	3.5	11.4	5.6	7.0	5.8	6.5	8.0	5.0
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956519	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.7;HHSteC: 26.5;hTCEpi: 42.0;SK-MEL-30: 29.6;U-266/70: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 1.8;monocytes: 1.1;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	6.0	1.0	2.6	1.5	2.1	1.7	1.0	1.7	5.6	1.1	1.9	0.3	1.1	1.9	1.1	1.8	18.6	1.5	5.7	2.2	2.6	4.8	3.1	14.1	1.5	1.1	2.6	2.2	11.3	53.0	0.9	1.3	1.1	6.2	1.5	1.1	0.2	39.9	1.3	52.4	1.3	1.5	1.1	5.3	1.1	11.2	0.9	1.0	0.0	1.7	4.7	4.6	2.7	2.7	1.8	0.1	0.2	1.1	0.0	1.3	0.2	2.8	1.9	0.5	8.7	1.4	1.0	3.5	16.8	34.7	1.8	5.0	4.6	0.7	0.8	1.3	1.5	1.8	3.8	1.3	1.3	3.2	0.7	0.7	0.5	0.0	26.5	2.2	0.0	11.8	42.0	5.5	7.6	1.7	2.3	4.0	1.5	1.6	1.6	0.0	1.6	6.5	1.4	0.0	3.8	0.9	1.0	1.7	2.5	0.5	3.0	29.6	1.1	15.9	0.5	0.3	5.2	0.4	3.0	26.0	5.5	3.3	1.6	3.1	3.9	0.0	0.4	0.0	1.3	0.4	0.0	1.8	0.2	0.8	0.1	0.0	0.0	1.0	0.2	0.0	1.1	0.0	0.0	0.2	2.6	2.1	1.7	5.6	2.6	4.8	2.6	2.2	6.2	1.0
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.7;salivary gland: 47.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.5;MOLT-4: 83.0;U-698: 18.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.0"	"Group enriched"	"Detected in many"	4	"B-cells: 16.8;T-cells: 36.0"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"	480000	480000			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (9.10e-5)"	"prognostic favourable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	8.3	0.9	3.9	38.7	11.9	0.9	13.4	0.3	11.9	0.7	2.5	5.9	0.3	0.4	0.6	3.7	2.2	0.7	4.4	20.8	8.3	8.3	3.0	0.3	21.0	19.1	5.6	1.2	1.4	0.3	0.1	1.6	5.8	7.3	3.9	1.0	4.2	47.2	0.3	3.0	3.2	2.6	1.2	28.4	18.4	2.5	4.4	2.1	86.7	4.2	4.2	39.4	19.3	1.7	16.8	0.5	0.9	1.2	6.4	36.0	10.1	0.0	0.0	0.1	0.1	23.5	4.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	6.8	0.0	0.0	0.1	0.3	0.3	0.0	0.4	5.6	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	83.0	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.1	1.3	0.1	18.5	5.8	0.1	0.5	0.3	1.2	0.1	8.7	0.3	2.2	14.3	6.1	14.3	0.3	16.8	36.0	13.6	0.9	6.4	0.2	0.5	3.6	10.1	3.9	11.9	0.3	5.4	8.3	8.3	5.6	1.2	7.3	2.1
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Cell line enriched"	"Detected in some"	8	"U-87 MG: 18.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in many"														"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185317	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;Hep G2: 9.3;RPTEC TERT1: 29.3;SCLC-21H: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"					"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.3	0.4	1.7	0.3	2.4	0.2	3.7	1.0	2.6	4.0	2.1	4.5	0.7	0.4	0.3	0.9	2.2	13.6	4.5	3.4	3.7	2.7	2.4	12.1	8.6	0.1	2.6	0.8	1.2	11.9	0.1	4.3	0.1	4.9	4.8	0.4	5.3	23.4	2.7	0.4	0.4	0.7	0.3	5.3	7.1	1.0	8.5	4.2	0.0	0.3	3.9	7.0	2.6	10.5	0.5	0.1	0.8	0.1	0.3	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.3	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.3	0.5	0.3	0.0	0.1	0.1	0.0	1.7	2.4	1.0	2.6	3.7	2.7	2.6	0.8	4.9	4.2
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 58.4;salivary gland: 25.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057717	Approved									"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.1	0.5	0.2	0.1	0.2	0.0	0.1	2.8	0.2	0.7	0.1	0.1	2.2	0.0	0.5	0.5	0.1	0.1	0.4	1.2	0.1	0.1	58.4	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.9	0.8	0.4	0.3	0.5	0.0	1.2	25.7	0.7	0.1	0.0	0.2	0.3	0.5	0.1	0.1	0.7	0.1	0.1	11.5	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.8	0.0	2.2	0.0	5.1	0.7	0.1	1.7	0.0	0.3	0.0	0.0	0.0	3.1	0.1	0.6	0.0	0.3	0.0	0.2	0.3	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.4	0.8	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.8	0.2	0.1	0.1	0.1	0.1	0.3	0.1
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HEL: 5.4;HUVEC TERT2: 8.2;NTERA-2: 16.2;RPTEC TERT1: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.8"	"Low region specificity"	"Detected in all"							"CAB012969, HPA042348"	Enhanced									"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (4.75e-3)"	0.8	0.5	28.3	0.5	17.1	1.9	2.6	5.9	17.7	26.0	0.6	4.3	0.0	1.4	8.1	15.4	2.6	16.0	23.1	0.6	18.1	6.2	50.5	1.7	0.8	0.5	10.8	12.0	1.1	97.3	0.8	1.1	0.7	5.7	1.4	0.6	3.4	70.0	0.6	0.5	4.5	0.5	0.7	2.8	0.7	1.0	0.9	6.3	0.0	0.5	2.1	49.4	0.6	0.2	1.2	0.6	7.8	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	0.0	0.0	33.4	0.0	0.2	0.2	0.0	0.0	0.0	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.6	0.0	0.1	28.3	17.1	5.9	17.7	18.1	6.2	10.8	12.0	5.7	6.3
CLDN24	CLDN21	ENSG00000185758	"Claudin 24"	A6NM45	4	183321764-183322426	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"kidney: 4.6;salivary gland: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.8;fHDF/TERT166: 3.5;HSkMC: 1.4;SCLC-21H: 1.4;SK-BR-3: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.49e-1)"				"unprognostic (9.27e-2)"		"unprognostic (1.89e-1)"					"unprognostic (4.93e-3)"					0.1	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.1	0.1			0.0	0.1	0.0	1.0	0.1	0.0	0.2	0.0	0.0	4.6	0.4	0.6	0.0	0.0		0.2	0.3	0.5	0.1	0.0		0.1	0.0		2.1	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.2			0.2		0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.3	1.8	0.7	0.0	0.3	0.0	0.4	3.5	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	1.4	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLLU1OS		ENSG00000205057	"Chronic lymphocytic leukemia up-regulated 1 opposite strand"	Q5K130	12	92420094-92428148	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 2.9;salivary gland: 4.0"	"Cell line enriched"	"Detected in some"	8	"U-698: 11.7"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	31	"memory B-cell: 4.0;naive B-cell: 3.8;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	27	"B-cells: 4.0;dendritic cells: 1.3"																				"unprognostic (9.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.41e-1)"		"unprognostic (1.75e-2)"		"unprognostic (2.58e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.88e-1)"		"unprognostic (2.51e-1)"	0.4	0.0	0.0	0.7	0.0	1.4	0.5	0.0	0.0	0.1	0.2			0.1	0.0	0.0	1.1	0.0	0.3	0.5	0.0	0.0	0.4	0.2	0.5	2.8	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.1		4.0	0.0	0.3	0.2	0.6	0.0	0.1	2.9	0.2	0.1			0.0		2.9	2.4	0.3	4.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.5	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2										
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 1.2;salivary gland: 1.1;testis: 1.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042407	Uncertain									"HPA042407: AB_10806237"																		0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.6	0.3	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.1	0.4	0.0	0.4		0.0	0.0	0.0	0.2	0.0		0.1	0.0		1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739812	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0"	"Cell line enriched"	"Detected in single"	137	"NTERA-2: 32.4"	"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010510	Uncertain				"Secreted to extracellular matrix"					"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.3	0.3	3.1	0.3	11.1	0.3	0.4	0.9	2.5	0.3	0.5	4.3	0.0	0.3	0.3	0.3	0.6	0.4	0.3	0.4	3.0	2.6	0.3	0.3	3.9	0.3	3.7	0.9	0.4	1.1	0.3	2.5	0.5	3.1	1.6	0.5	6.1	15.1	0.4	0.5	0.5	0.4	0.3	4.4	1.0	0.4	4.2	4.1	0.0	8.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	3.1	11.1	0.9	2.3	3.0	2.6	3.7	0.9	3.1	4.1
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020953-100358885	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;pituitary gland: 12.0;salivary gland: 28.4"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.2;TIME: 2.1;U-138 MG: 1.0;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	100000	100000			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.3	0.5	6.5	0.3	4.0	0.2	0.2	0.6	10.9	0.7	0.4	0.5	0.0	0.3	0.6	0.3	0.3	3.8	0.3	0.4	5.0	3.4	1.4	0.5	0.7	0.3	1.4	2.0	0.4	0.9	0.2	12.0	7.4	3.9	0.5	0.3	0.0	28.4	1.1	0.2	0.2	0.3	0.4	0.5	0.2	0.5	0.8	0.3	0.0	5.9	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.8	0.2	2.1	1.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.0	0.6	10.9	5.0	3.4	1.4	2.0	3.9	0.3
CRACR2A	"EFCAB4B, MGC4266"	ENSG00000130038	"Calcium release activated channel regulator 2A"	Q9BSW2	12	3606633-3764819	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 37.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"basophil: 12.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038686	Enhanced									"HPA038686: AB_10671748"	"unprognostic (6.78e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.96e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.11e-2)"	"prognostic favourable (2.85e-6)"	"unprognostic (4.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.04e-2)"	1.4	0.7	0.7	6.3	1.2	10.3	3.1	0.6	0.7	1.3	5.9	0.5	1.6	2.8	0.9	1.8	0.8	0.9	2.5	2.1	0.8	0.7	0.9	1.4	1.9	4.2	0.9	0.1	1.1	10.1	0.0	0.8	0.3	0.4	6.3	9.3	0.6	37.6	0.8	0.8	2.0	5.5	2.0	0.7	4.9	2.2	1.4	0.4	13.8	1.3	2.5	8.3	1.7	1.2	2.7	0.9	12.3	1.3	3.8	6.0	2.0	7.8	2.7	0.5	0.1	1.1	3.3	6.3	0.9	0.7	2.3	3.2	5.4	1.6	11.8	0.3	3.1	0.0	9.1	0.0	3.3	17.6	2.0	10.3	0.0	0.0	1.8	14.2	0.2	2.5	0.9	7.2	0.0	6.6	7.1	5.2	3.0	6.4	13.0	7.0	3.3	0.0	7.0	7.5	2.3	0.0	10.1	6.0	1.4	1.8	2.0	0.0	0.3	8.1	9.6	0.0	9.7	7.9	0.0	0.0	0.0	15.2	0.0	6.7	0.0	12.3	1.1	2.6	6.0	1.3	5.9	2.7	3.2	4.8	0.9	1.2	1.8	3.1	1.2	3.8	0.3	0.3	1.2	2.0	0.7	1.2	0.6	0.7	0.8	0.7	0.9	0.1	0.4	0.4
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	65	"HEL: 14.2;RT4: 4.8;SK-BR-3: 10.8;T-47d: 5.3"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"					"Low region specificity"	"Detected in many"			HPA054392	Supported				"Secreted in other tissues"	390000000	390000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	10.8	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Cell line enhanced"	"Detected in some"		"A549: 33.7;EFO-21: 28.4;HSkMC: 20.5;hTEC/SVTERT24-B: 14.7;RPTEC TERT1: 108.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"									HPA065474	Approved				"Secreted to blood"					"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	33.7	0.1	0.0	0.0	1.2	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	28.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.5	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.8;RPMI-8226: 53.0;RPTEC TERT1: 43.9;U-698: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.3	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	29.8	0.7	0.3	0.1	1.6	0.0	0.1	0.6	0.8	4.0	0.2	0.1	3.8	0.8	6.9	1.7	2.8	0.2	0.1	0.0	0.0	4.9	0.1	2.0	0.0	0.7	0.4	1.0	0.1	1.4	53.0	43.9	1.2	0.9	0.2	0.5	3.2	0.9	2.8	0.1	0.0	0.1	0.2	6.3	0.1	13.2	3.1	15.6	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446841-22455740	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.2;salivary gland: 16.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.1;LHCN-M2: 4.7;RPTEC TERT1: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 2.5"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favourable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	2.1	0.2	0.7	1.4	0.7	0.0	5.6	0.8	0.7	2.4	1.0	0.7	1.1	0.7	1.2	1.8	5.5	0.3	1.2	0.6	0.6	0.5	5.5	12.2	1.1	1.4	0.8	0.4	0.6	2.7	6.1	2.9	0.0	0.9	2.4	0.4	1.9	16.3	0.5	0.9	0.5	0.8	0.7	0.7	0.4	2.8	0.6	0.0	1.1	5.0	0.6	2.0	0.9	1.7	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.6	0.1	0.0	0.4	0.1	0.2	0.0	10.1	0.3	0.4	0.1	0.1	0.0	2.2	0.0	0.3	2.0	2.7	0.3	0.0	0.7	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.7	0.0	3.7	4.7	1.0	0.0	0.0	2.0	3.4	0.0	0.2	1.4	4.8	0.0	0.2	0.0	1.3	0.8	2.2	0.0	0.0	3.4	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.9	0.0
DNASE1L2	DNAS1L2	ENSG00000167968	"Deoxyribonuclease 1 like 2"	Q92874	16	2235816-2238711	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 11.7;skin 1: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.4;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044714			Approved	Mitochondria	"Secreted in other tissues"			Mitochondria	Mitochondria	"HPA044714: AB_10962870"	"unprognostic (9.88e-2)"	"unprognostic (1.11e-3)"	"unprognostic (6.80e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.67e-4)"	"unprognostic (1.40e-4)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.94e-4)"	0.6	1.3	1.3	0.6	2.1	0.8	2.1	8.8	2.8	0.6	0.6	0.6	0.6	0.8	1.2	3.5	0.6	0.4	0.6	0.6	1.6	2.1	0.9	1.6	0.6	0.6	1.5	0.6	0.7	1.9	0.2	2.1	1.3	1.3	0.8	0.2	0.6	11.7	0.6	0.7	20.6	0.8	0.6	1.3	1.0	0.9	1.9	0.6	2.4	2.7	7.1	3.4	0.6	0.6	0.0	0.0	1.6	0.0	0.0	0.2	0.0	1.9	3.9	1.7	1.7	1.4	0.7	6.8	0.6	0.5	1.6	0.8	4.3	4.1	2.6	2.1	0.2	0.6	0.6	0.2	0.1	5.0	3.7	1.1	6.2	1.0	0.2	1.2	4.1	0.9	1.4	1.2	0.3	0.3	3.5	3.8	0.6	4.5	3.5	7.4	1.6	2.6	6.6	2.0	3.5	0.9	0.8	3.5	1.8	0.9	1.5	2.7	6.1	2.7	0.1	3.3	4.4	1.9	1.3	9.3	4.5	2.3	1.1	2.4	1.7	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	2.1	8.8	2.8	1.6	2.1	1.5	0.6	1.3	0.6
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 49.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA061357	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA061357: AB_2684489"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	3.6	3.5	19.1	5.2	21.3	4.7	13.9	14.5	24.6	7.7	2.7	9.5	13.6	2.2	4.7	14.0	4.6	7.3	5.9	3.4	20.6	12.6	6.3	5.1	6.6	4.6	12.4	11.7	7.2	10.3	12.2	9.6	5.4	13.2	10.5	2.4	4.2	49.4	13.9	2.7	4.6	2.3	3.1	13.1	4.4	7.7	9.0	7.3	6.3	15.7	1.0	5.4	5.2	4.3	7.4	1.1	7.2	2.2	5.1	7.4	2.8	8.8	7.5	6.2	6.8	3.6	4.5	0.2	2.7	3.7	3.4	4.8	2.9	2.3	4.7	1.1	2.2	3.2	4.3	11.6	1.9	7.1	9.9	3.7	2.3	8.8	2.5	4.7	3.6	3.6	9.9	3.6	6.2	4.6	0.3	7.2	2.5	8.9	7.6	3.9	7.0	5.1	6.1	9.9	8.8	6.4	8.3	8.1	11.8	8.8	15.6	10.8	8.2	2.7	1.9	1.3	6.4	2.0	4.8	12.6	5.5	8.4	4.0	8.5	5.0	0.5	2.2	7.2	5.8	1.1	6.6	5.7	7.4	5.2	0.7	7.4	7.3	5.0	4.3	5.1	0.6	1.1	6.4	2.8	19.1	21.3	14.5	24.6	20.6	12.6	12.4	11.7	13.2	7.3
EDN3	ET3	ENSG00000124205	"Endothelin 3"	P14138	20	59300427-59325992	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8"	"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory CD4 T-cell: 2.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"												"Secreted to blood"						"unprognostic (4.64e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.73e-4)"	"unprognostic (1.58e-1)"		"unprognostic (1.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.08e-2)"	"unprognostic (4.48e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.40e-2)"		0.0	1.2	1.1	0.7	2.5	0.0	3.7	0.8	3.3	22.7	21.7	2.1	0.2	20.7	2.6	3.2	9.2	0.0	1.3	0.0	2.3	1.6	0.2	0.0	0.2	0.0	1.8	1.7	0.6	5.1	0.0	20.8	0.2	3.2	3.2	8.9	86.8	37.0	0.4	0.6	0.8	35.8	1.3	1.7	3.6	0.8	1.1	0.4	0.1	33.2	1.3	0.6	0.2	37.8	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	1.1	2.5	0.8	3.3	2.3	1.6	1.8	1.7	3.2	0.4
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"salivary gland: 39.7"	"Cell line enriched"	"Detected in many"	7	"RH-30: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Centrosome	"HPA043020: AB_2678274, HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	9.3	6.1	3.1	3.8	3.0	1.6	10.1	3.7	3.8	8.9	5.4	2.5	8.7	2.8	10.1	8.1	6.4	7.2	8.3	3.9	2.5	1.6	10.8	6.1	7.2	5.5	2.1	2.7	10.7	34.4	6.0	3.6	4.5	3.5	7.7	3.7	6.1	39.7	14.6	2.8	6.2	3.3	7.0	2.9	3.8	6.0	4.3	1.4	1.5	8.4	5.1	6.2	7.7	6.9	0.7	3.9	1.2	5.4	1.8	10.6	2.6	1.9	3.4	1.8	2.1	5.2	4.9	1.5	2.1	4.3	3.6	3.6	2.0	3.2	1.1	2.4	2.9	1.9	1.3	1.3	3.6	1.1	2.0	5.5	1.9	3.5	4.6	1.3	2.4	5.2	3.4	3.7	3.9	3.8	3.3	8.7	2.1	1.4	1.6	3.9	1.3	3.2	3.2	58.0	3.7	2.4	2.2	1.7	2.3	3.8	2.8	2.3	4.6	3.6	3.6	5.4	3.0	2.2	2.2	1.9	0.8	1.4	4.1	5.8	3.6	0.5	3.9	0.1	2.5	1.5	10.6	0.7	4.9	2.9	3.9	0.7	2.5	1.9	1.2	1.8	5.4	2.0	3.0	2.6	3.1	3.0	3.7	3.8	2.5	1.6	2.1	2.7	3.5	1.4
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.7;HaCaT: 23.9;HBEC3-KT: 26.3;RT4: 53.1;T-47d: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.7	0.0	4.4	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	4.7	53.1	0.0	0.0	0.1	3.6	0.0	53.8	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030341-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7;salivary gland: 109.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	17.7	3.4	2.5	4.9	3.6	9.2	21.7	1.8	3.2	5.5	15.4	2.0	7.7	6.2	5.3	2.1	22.2	5.0	7.0	9.4	2.2	1.8	6.0	39.6	6.9	7.4	4.3	1.4	9.3	94.7	1.7	2.2	8.7	2.8	7.4	4.6	2.8	109.8	8.0	38.4	4.9	9.0	7.1	4.2	9.3	10.6	3.0	2.7	2.7	3.7	12.6	9.2	11.3	11.1	16.3	41.3	31.3	53.5	4.0	7.6	28.0	20.4	10.6	3.1	18.4	4.0	3.5	13.6	22.7	10.6	12.3	19.7	7.0	5.3	8.0	15.9	11.3	10.9	10.3	18.5	7.3	6.1	33.5	46.8	4.7	9.6	41.8	15.1	7.5	9.8	30.2	13.6	25.5	19.7	25.5	21.4	5.1	12.8	13.2	36.8	22.9	42.7	11.6	13.0	28.2	4.6	2.0	43.2	32.8	4.6	7.5	53.4	10.0	17.8	18.5	7.4	24.3	21.9	17.2	30.8	16.7	9.2	17.3	26.8	16.0	5.1	53.5	31.3	3.9	41.2	3.5	16.3	4.5	4.0	41.3	13.5	3.6	3.6	4.7	4.0	31.4	31.3	7.6	28.0	2.5	3.6	1.8	3.2	2.2	1.8	4.3	1.4	2.8	2.7
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.9;EFO-21: 10.2;HaCaT: 10.1;HeLa: 16.9;MCF7: 14.6;SK-BR-3: 7.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	5.4	0.4	0.0	10.2	0.0	10.1	1.0	0.1	0.0	0.0	2.6	0.0	16.9	3.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.6	1.7	0.0	1.6	7.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0										
ETV1	ER81	ENSG00000006468	"ETS variant 1"	P50549	7	13891228-13991425	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 90.0;salivary gland: 45.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.2;SCLC-21H: 26.3;U-87 MG: 51.9;WM-115: 25.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 90.0"	"Cell type enriched"	"Detected in single"	5	"T-reg: 3.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 418.9"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	2.5	12.4	8.1	1.1	11.7	0.2	4.4	90.0	35.2	1.4	2.4	3.1	0.1	1.2	2.4	1.3	1.5	1.1	9.2	18.0	7.0	4.5	2.1	2.0	14.9	0.7	4.5	6.9	1.0	1.6	11.4	7.4	1.9	8.3	3.1	2.4	0.9	45.8	7.1	0.9	1.5	1.9	2.0	3.5	4.5	1.7	4.5	2.9	0.3	6.5	0.9	4.7	1.8	1.3	0.0	0.0	0.0	0.6	0.0	3.1	0.2	0.0	1.6	11.7	22.2	4.1	12.2	0.0	1.0	3.9	0.6	2.6	0.0	5.3	0.0	1.2	1.8	0.1	0.4	1.2	1.4	0.3	0.5	0.6	1.0	0.0	2.4	3.8	1.5	3.6	0.0	7.6	0.6	5.0	3.4	0.1	4.7	0.0	0.0	0.0	17.5	11.8	0.0	7.1	0.9	7.9	0.1	26.3	5.1	0.0	0.4	6.3	0.4	0.1	2.7	2.3	0.7	4.5	4.3	4.0	1.2	0.0	51.9	0.2	25.6	0.0	0.2	0.0	0.1	0.6	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	8.1	11.7	90.0	10.9	7.0	4.5	4.5	6.9	8.3	2.9
FAM196B	C5orf57	ENSG00000204767	"Family with sequence similarity 196 member B"	A6NMK8	5	169864264-169980740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.5;breast: 14.4;salivary gland: 10.6"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 19.8;HUVEC TERT2: 12.6;U-138 MG: 32.9;U-251 MG: 11.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047227	Uncertain									"HPA047227: AB_2679992"	"unprognostic (5.30e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (1.26e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.73e-3)"	1.4	1.5	3.8	1.3	8.8	1.1	14.4	2.3	10.4	0.6	0.6	13.5	0.0	0.5	0.8	0.5	0.6	0.6	1.1	0.8	4.9	3.6	1.4	0.7	0.7	0.6	6.7	3.5	4.6	0.6	0.5	3.3	0.6	5.2	2.1	0.6	6.7	10.6	0.6	0.5	1.0	0.5	1.1	7.9	3.0	0.5	0.7	5.9	0.0	2.3	0.0	0.5	0.8	0.4	0.3	0.1	0.9	0.4	0.0	0.4	0.0	0.1	0.2	0.7	0.0	5.2	1.9	0.0	3.5	1.8	3.0	2.3	0.0	0.0	0.0	7.9	19.8	0.0	0.1	6.1	5.8	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.7	0.0	4.1	3.7	12.6	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	32.9	0.3	0.9	11.1	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.4	0.9	0.0	0.2	0.0	0.0	0.0	3.8	8.8	2.3	8.3	4.9	3.6	6.7	3.5	5.2	5.9
FAM20A	DKFZp434F2322	ENSG00000108950	"FAM20A, golgi associated secretory pathway pseudokinase"	Q96MK3	17	68535113-68601389	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.2;salivary gland: 50.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.5;BJ hTERT+: 26.7;HSkMC: 22.3;U-2197: 7.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.8"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.0;granulocytes: 1.8;monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048964	Supported				"Secreted in other tissues"	10000000	10000000			"HPA048964: AB_2680575"	"unprognostic (3.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (9.16e-10)"	"unprognostic (1.25e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.39e-2)"	4.9	1.1	0.2	4.7	0.4	1.0	3.7	0.2	1.5	12.1	3.2	0.7	0.7	1.4	7.6	9.9	2.2	4.1	2.3	6.5	0.3	0.4	19.6	59.2	17.6	14.7	0.3	0.8	6.8	1.0	0.6	4.8	4.2	3.8	3.5	1.0	8.7	50.4	1.7	2.8	1.5	1.2	4.7	2.4	7.3	9.5	9.1	0.2	0.9	8.2	4.0	2.5	3.7	3.4	0.2	1.0	1.8	2.1	0.1	0.3	0.0	0.0	0.1	0.0	0.1	1.3	11.5	0.0	0.5	26.7	0.0	0.0	0.0	0.0	0.0	2.3	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	22.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.9	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.1	1.8	0.1	2.1	1.0	0.0	0.0	0.2	0.4	0.2	1.5	0.3	0.4	0.3	0.8	3.8	0.2
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 52.0;U-87 MG: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	160000000	160000000	"Golgi apparatus"	"Golgi apparatus"	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.8	6.7	0.2	9.6	12.3	20.4	0.0	12.3	20.9	6.7	5.4	0.8	8.5	0.0	6.8	18.4	12.0	1.0	0.6	1.7	2.9	0.6	0.0	3.2	3.7	9.3	0.0	0.9	52.0	1.5	0.2	0.7	4.6	0.0	0.1	1.7	1.8	0.0	0.7	6.5	0.4	1.5	0.4	0.0	5.0	0.0	3.2	0.1	12.8	0.0	1.9	9.1	6.3	12.9	8.4	4.2	7.1	3.7	0.0	0.0	0.0	32.0	0.8	23.8	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"Family with sequence similarity 3 member B"	P58499	21	41304212-41357431	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;pancreas: 120.3;salivary gland: 67.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 5.9;Hep G2: 15.2;RPMI-8226: 42.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777"	Approved		Approved	Vesicles	"Secreted to blood"	57000	57000	Vesicles	Vesicles	"HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	0.6	0.2	0.2	4.5	0.4	0.0	4.3	0.2	0.3	1.8	38.5	0.4	29.9	38.2	0.2	8.8	17.4	4.5	6.9	0.4	0.2	0.2	5.2	0.6	2.0	0.7	0.3	0.2	0.7	120.3	0.0	1.9	7.9	0.4	10.0	0.0	0.2	67.9	36.0	0.2	0.9	83.8	2.0	0.3	0.5	30.8	2.0	0.2	2.3	3.9	7.4	17.6	17.5	4.7	0.2	1.3	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	42.1	0.0	2.8	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	6.9	0.0	0.6	1.3	0.0	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.2
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.4;RT4: 2.8;T-47d: 2.3;U-266/70: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"	8200	8200			"HPA013844: AB_2668897"	"prognostic favourable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	3.4	0.3	0.0	0.0	1.3	0.3	1.4	0.7	0.0	0.3	0.5	1.0	0.1	2.8	0.2	1.3	0.0	0.0	0.0	2.3	0.0	0.5	0.1	0.7	0.9	0.6	1.8	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48600810-48614854	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.5;intestine: 17.8;salivary gland: 15.6;stomach 1: 23.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;NTERA-2: 3.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049305	Uncertain									"HPA049305: AB_2680705"	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.4	0.0	0.4	8.2	0.4	0.0	0.7	0.4	0.5	5.0	15.3	0.5	1.2	17.0	1.9	0.4	4.3	2.7	29.5	0.4	0.4	0.0	0.5	0.4	5.3	0.4	0.4	0.4	0.7	2.1	0.0	0.4	0.8	0.6	1.8	5.6	0.5	15.6	1.2	0.4	0.9	17.8	0.4	0.4	0.4	23.9	1.0	0.4	0.4	0.4	2.6	2.9	1.2	1.9	2.2	0.1	2.1	0.7	0.1	1.3	0.1	0.8	0.6	0.2	1.7	0.2	0.3	1.4	0.3	0.0	0.1	0.2	0.7	8.1	1.7	0.6	0.6	0.7	0.4	0.2	0.0	1.2	0.6	0.3	0.6	0.2	0.1	0.3	0.9	0.4	0.4	0.0	0.2	0.1	0.2	0.6	0.0	1.5	0.1	2.0	3.1	1.9	0.7	0.3	0.8	0.0	0.5	1.3	0.7	0.1	0.5	0.4	0.5	0.2	0.2	0.0	1.4	0.4	0.0	0.7	1.2	0.1	0.5	0.5	0.1	0.3	0.2	0.0	0.3	0.4	0.6	2.2	0.3	0.8	0.1	0.4	0.3	1.3	2.1	0.1	0.7	0.1	0.4	0.1	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
FBN3		ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149846	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 5.2;salivary gland: 7.5"	"Group enriched"	"Detected in some"	4	"NTERA-2: 12.4;REH: 17.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA049482	Uncertain				"Secreted to extracellular matrix"					"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	1.0	0.2	1.2	0.0	0.5	0.2	2.4	0.2	0.2	2.8	0.2	0.0	0.7	0.2	0.5	1.8	0.2	0.2	1.0	1.1	3.6	0.5	5.2	0.2	2.4	0.2	0.8	0.2	0.0	1.9	0.2	2.1	1.7	0.3	0.2	7.5	0.2	0.9	0.6	0.3	0.3	2.0	0.2	0.1	1.1	1.7	0.8	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.4	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.2	2.4	1.0	1.1	2.4	0.2	2.1	1.7
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552520	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4"	"Group enriched"	"Detected in some"	5	"U-266/70: 5.6;U-698: 12.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 11.4;naive B-cell: 13.3"	"Lineage enriched"	"Detected in single"	19	"B-cells: 13.3"														"Secreted to blood"	36000000	36000000				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.7	0.4	0.3	33.9	0.3	1.1	1.3	0.3	0.3	1.6	7.4	0.1	0.0	3.6	0.5	0.1	4.6	0.8	0.8	0.4	0.3	0.3	1.6	0.8	1.6	17.4	0.3	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.5	2.7	1.0	12.4	0.8	0.3	0.3	6.4	0.1	0.3	29.5	2.5	0.9	0.0	3.1	1.1	0.7	39.1	5.3	0.6	13.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;Karpas-707: 42.0;RPMI-8226: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.1	2.8	0.5	0.7	12.6	19.1	1.0	16.6	23.9	18.4	21.8	10.7	12.0	32.4	0.5	27.2	8.9	5.8	7.3	9.6	6.8	1.2	1.2	3.0	0.1	46.2	0.6	0.9	21.3	14.2	14.1	26.3	10.4	0.4	42.0	6.7	6.0	4.8	1.1	1.4	5.3	13.3	0.8	42.0	2.3	0.4	6.9	2.0	5.5	8.3	3.7	0.5	1.0	8.3	3.6	0.7	0.3	0.3	24.6	20.3	16.4	2.2	0.7	5.9	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Group enriched"	"Detected in some"	7	"HeLa: 81.7;RPTEC TERT1: 86.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	81000	81000	"Nuclear membrane"	"Nuclear membrane"	"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	7.6	7.7	0.0	7.9	0.1	0.1	0.4	0.3	0.0	0.0	0.2	0.1	81.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.6	0.0	86.8	0.0	0.0	0.5	0.2	1.2	0.0	11.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles				"Nucleoli, Vesicles"	"Nucleoli, Vesicles"	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 40.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	1.1	1.0	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.8	40.9	0.3	0.3	0.0	7.2	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.9	0.3	0.3	0.3	0.1	1.8	0.0	0.3	2.2	0.3	0.1	0.3	0.0	6.1	0.0	0.1	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.2	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 14.6;RPMI-8226: 5.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favourable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.2	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	5.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in some"	29	"MOLT-4: 137.7;RPTEC TERT1: 315.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"midbrain: 2.6"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		26000	26000	Mitochondria	Mitochondria	"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.2	315.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 160.2;salivary gland: 141.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 88.3;hTCEpi: 160.7;RT4: 83.9;SK-BR-3: 82.6;WM-115: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.2"									HPA010856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	0.4	0.1	1.6	29.5	2.3	0.0	20.4	1.7	2.1	30.0	133.2	1.1	2.3	8.6	3.9	2.9	82.1	9.0	56.6	0.8	1.4	0.3	2.1	0.5	35.8	0.3	2.1	0.8	1.9	28.9	0.0	3.7	41.9	2.2	58.4	160.2	15.8	141.7	3.5	0.5	64.2	36.4	7.5	1.8	0.4	50.6	0.7	1.0	2.5	0.5	93.2	49.8	48.7	42.5	0.3	3.2	0.6	0.1	0.0	0.2	0.5	15.9	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.5	23.2	0.0	0.0	0.0	88.3	0.0	33.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	160.7	0.0	0.0	0.0	0.0	0.1	0.0	29.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	83.9	19.7	0.2	0.1	82.6	6.1	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	59.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	3.2	0.0	0.5	1.6	2.3	1.7	2.1	1.4	0.3	2.1	0.8	2.2	1.0
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4"	"Cell line enriched"	"Detected in some"	5	"A549: 55.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 29.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.3	0.5	0.3	8.8	0.4	0.0	0.3	0.3	0.3	5.3	37.6	0.3	0.3	25.4	1.3	0.4	8.7	0.7	29.6	0.3	0.3	0.2	9.9	0.4	0.7	0.3	0.3	0.3	1.1	1.7	0.0	0.4	1.0	0.5	1.0	33.4	0.3	27.4	0.3	0.3	0.2	103.3	0.9	0.3	0.3	6.5	1.7	0.3	0.5	0.7	5.2	15.5	0.7	14.0	1.2	1.4	3.4	0.8	1.1	0.7	0.1	0.0	55.8	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.0	0.0	2.3	2.3	0.2	9.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.2	0.0	0.1	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.2	3.5	0.1	0.0	2.6	0.8	0.6	0.7	0.4	0.4	0.6	0.5	0.3	0.2	1.2	0.4	0.6	3.4	1.1	0.4	1.4	0.5	0.1	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.5	0.3
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"salivary gland: 16.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.9;BJ hTERT+: 5.0;fHDF/TERT166: 4.0;HHSteC: 5.5;HSkMC: 13.7;U-87 MG: 6.4"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA015648	Uncertain				"Secreted to blood"					"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	1.3	0.2	0.6	0.2	1.9	0.2	0.9	0.2	1.3	0.7	2.3	0.1	1.0	0.1	0.9	0.2	0.2	0.2	0.5	0.9	0.3	0.1	0.8	0.1	3.3	0.1	0.7	0.0	0.4	0.1	0.1	4.1	0.2	0.6	1.6	0.2	0.5	16.4	2.4	0.2	0.2	0.1	1.1	1.0	0.1	0.3	0.7	0.0	1.0	0.5	1.1	0.1	0.5	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	16.9	0.1	2.6	5.0	0.4	0.9	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	13.7	0.1	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.2	0.0	0.1	0.6	1.9	0.2	1.3	0.3	0.1	0.7	0.0	0.6	0.0
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;HeLa: 4.5;Karpas-707: 2.0;U-2197: 13.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles				Vesicles	Vesicles	"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	13.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3										
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Group enriched"	"Detected in some"	8	"RT4: 29.8;SK-BR-3: 10.2;T-47d: 31.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					33000	33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favourable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favourable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	29.8	0.1	0.1	0.0	10.2	0.0	31.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 4.2;salivary gland: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;HDLM-2: 1.4;RH-30: 1.4;SH-SY5Y: 1.3;U-2 OS: 1.6;U-2197: 4.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534"	Uncertain									"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.9	0.0	4.2	0.0			0.0	0.9	0.0		0.0		0.0	0.0		3.0	0.0	0.0	0.0	1.2	0.0		0.0	0.7	1.5			0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.6	0.0	0.0	1.4	0.3	0.0	0.9	0.8	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.6	4.3	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923269-99929620	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.1;pancreas: 12.1;salivary gland: 9.0"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 5.7;U-2197: 4.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain									"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.0	0.5	0.1	0.0	0.3	0.0	9.1	0.0	0.5	0.0	0.1			0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	1.1	2.8	0.1	0.1	0.6		0.3	12.1	0.0	0.1	1.2		4.3	0.0		9.0	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.8	1.6			0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.6	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	1.2	2.6	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.3	0.9	0.2	2.3	0.0	0.4	0.3	0.4	0.0	0.1	0.6	1.1	1.4	1.7	0.3	1.3	0.5	1.2	3.0	0.2	0.0	1.2	0.8	0.0	1.1	0.5	0.6	0.3	1.0	5.7	1.8	0.2	0.8	0.2	1.0	4.9	0.3	0.4	1.4	0.1	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.1	0.4										
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.8;BJ hTERT+ SV40 Large T+ RasG12V: 4.1;HAP1: 6.5;SK-BR-3: 15.5;U-2197: 7.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favourable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.0	0.0	1.9	5.8	2.5	4.1	0.0	0.0	0.2	0.0	1.6	0.5	6.5	0.0	2.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.5	0.0	0.0	0.0	0.0	2.1	0.1	7.5	2.2	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favourable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	3.6	6.3	12.1	8.3	0.7	8.1	2.6	5.1	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3
H2AFB2		ENSG00000277858	"H2A histone family member B2"	P0C5Z0	X	155380787-155381134	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.3;pancreas: 2.4;salivary gland: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;CAPAN-2: 3.2;HeLa: 4.2;NB-4: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.3		0.0		0.0	0.0		0.1	0.0	0.3			2.3	0.0	0.0	0.5	0.0	0.0	1.3			0.1	0.0	0.0	0.2			0.2	2.4	0.0		0.1		0.0	0.1		2.8	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.4			0.0		0.0	0.0		0.4	0.6	0.0	0.3	0.0	0.4	1.2	2.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.7	1.1	0.0	0.0	0.2	1.5	0.0	4.2	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.1	2.6	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.2	0.4	0.9	0.0	2.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.2										
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120590-8124092	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;salivary gland: 10.5"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;Daudi: 7.0;HAP1: 9.0;HDLM-2: 7.1;HeLa: 13.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.4	0.4	1.0	0.3	1.0	0.2	0.5	9.3	2.4	1.4	0.3	0.6	0.2	0.0	2.0	0.2	0.7	0.6	0.6	1.3	1.5	0.5	1.1	0.2	0.9	0.6	1.0	0.2	1.5	0.5	0.0	0.4	3.6	2.1	0.6	0.2	0.9	10.5	2.5	1.1	0.6	0.3	0.4	1.5	0.3	0.2	2.3	0.2	0.2	0.8	0.2	0.5	1.3	0.9	0.2	0.1	0.0	0.1	0.3	0.2	0.1	6.6	0.5	0.5	2.2	0.2	0.3	0.3	0.3	0.5	0.8	2.4	0.1	0.4	7.0	0.1	0.0	0.7	9.0	0.6	0.0	7.1	4.3	0.3	13.4	0.1	0.8	0.7	0.9	0.2	1.2	1.9	5.1	0.1	0.2	3.2	0.1	0.1	0.1	0.3	0.2	1.7	0.7	0.4	1.2	0.2	0.0	0.3	3.2	0.4	0.0	0.4	0.1	0.0	0.6	0.0	1.5	1.5	2.3	4.4	0.9	0.4	0.7	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	1.0	1.0	9.3	2.4	1.5	0.5	1.0	0.2	2.1	0.2
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 9.7;RPMI-8226: 11.5;RT4: 11.6;SCLC-21H: 12.8;SK-BR-3: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.9	0.4	1.2	0.1	1.5	3.1	0.0	0.0	0.1	0.1	5.1	1.1	0.0	2.3	0.1	6.5	4.3	0.4	0.0	0.0	1.5	0.0	0.5	5.4	0.5	0.6	0.0	1.5	2.6	0.2	0.1	0.0	0.3	0.0	0.0	3.1	0.1	0.1	9.7	0.8	0.0	0.1	11.5	0.4	11.6	12.8	0.8	0.7	11.5	0.5	5.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 11.1;lymphoid tissue: 12.0;salivary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;Daudi: 5.9;NTERA-2: 3.7;SCLC-21H: 19.6"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"memory B-cell: 4.1;naive B-cell: 9.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	104	"B-cells: 9.7;dendritic cells: 11.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"amygdala: 3.3;cerebral cortex: 4.0;hippocampal formation: 4.2"	HPA069442	Supported									"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.3	0.5	2.2	4.4	3.9	0.0	0.3	0.3	0.9	0.3	2.5	0.3	0.3	1.0	0.3	0.3	0.8	0.0	0.3	0.3	2.1	0.0	0.3	0.3	0.3	9.7	0.3	0.3	0.3	3.7	0.0	0.3	0.3	0.3	0.3	0.6	0.3	8.6	0.3	0.3	0.6	2.0	1.0	0.3	3.0	0.9	0.3	0.3	0.7	0.3	0.3	12.0	0.3	0.3	9.7	11.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.6	9.7	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.2	2.2	3.9	0.3	0.9	2.1	0.0	0.3	0.3	0.3	0.3
IFNA4	"IFN-alpha4a, MGC142200"	ENSG00000236637	"Interferon alpha 4"	P05014	9	21186694-21187671	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNL3	"IL-28B, IL28B, IL28C"	ENSG00000197110	"Interferon lambda 3"	Q8IZI9	19	39243553-39245129	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5"	"Group enriched"	"Detected in some"	5	"AN3-CA: 1.1;CACO-2: 3.5;HDLM-2: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (2.67e-1)"	"unprognostic (9.19e-2)"				"unprognostic (4.17e-1)"				"unprognostic (6.86e-2)"				"unprognostic (1.89e-2)"	"unprognostic (1.66e-1)"			0.1	0.0	0.5	0.0	0.3	0.2	0.0	1.1	0.7	0.1	0.0			0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.1		0.0	0.2	0.0	0.0	0.2		0.0	0.0		1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	1.5			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0										
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3596054-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1;breast: 36.0;salivary gland: 20.9"	"Group enriched"	"Detected in some"	4	"AF22: 7.0;REH: 28.3;U-251 MG: 11.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		5.3	0.4	2.6	0.4	2.1	1.4	36.0	6.6	1.5	0.4	0.4	2.0	6.0	0.4	0.4	1.7	0.8	0.4	0.4	1.0	3.1	3.2	13.9	0.4	8.0	0.6	4.2	1.0	0.4	0.7	0.4	0.7	0.4	16.1	0.5	0.4	2.8	20.9	1.5	0.4	6.8	0.4	0.4	5.1	0.4	0.4	0.5	1.6	3.0	0.5	0.5	0.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	28.3	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	6.6	0.2	3.1	3.2	4.2	1.0	16.1	1.6
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	39.8	0.0	2.2	1.5	23.9	2.3	1.3	2.0	1.5	4.7	0.0	0.0	0.0	4.4	13.5	0.0	9.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.2	0.9	8.1	0.0	0.0	0.0	1.4	7.7	0.0	0.0	4.4	0.0	0.0	2.5	0.0	8.9	0.0	1.5	0.0	7.8	16.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2
ISG15	"G1P2, IFI15, UCRP"	ENSG00000187608	"ISG15 ubiquitin-like modifier"	P05161	1	1001138-1014541	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 103.3;salivary gland: 116.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 137.4;BJ hTERT+ SV40 Large T+ RasG12V: 138.7;HeLa: 44.8;SK-MEL-30: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004627	Approved				"Secreted to blood"					"HPA004627: AB_1079152"	"unprognostic (3.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (5.11e-10)"	"unprognostic (4.55e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.46e-2)"	25.0	5.5	22.6	14.5	14.8	48.5	8.5	2.3	22.7	15.2	11.3	6.2	5.5	17.4	12.8	20.4	7.9	4.3	12.7	12.0	13.2	16.4	29.8	28.9	18.3	13.0	12.0	8.6	6.5	8.2	2.6	10.7	50.1	13.4	9.9	3.5	7.6	116.2	9.0	7.1	3.4	16.8	7.8	17.8	26.9	11.2	4.9	6.4	28.7	16.7	6.2	9.4	9.3	9.1	30.4	22.0	103.3	50.6	31.4	61.3	27.7	5.3	0.7	0.4	3.6	0.5	1.1	3.2	3.7	8.9	137.4	138.7	8.6	8.6	4.7	27.1	3.0	3.4	0.4	1.5	2.1	5.2	2.3	2.2	44.8	5.7	5.2	1.4	9.1	2.3	0.5	8.7	0.1	4.2	1.2	2.6	1.1	25.3	4.5	23.0	0.4	29.2	7.9	1.0	2.3	1.7	1.6	0.1	0.1	7.2	1.2	43.6	0.2	2.7	2.4	2.7	2.6	1.2	0.8	3.4	1.7	3.5	2.6	5.4	0.2	55.8	35.9	103.3	30.3	50.6	39.3	30.4	35.1	33.5	22.0	23.5	22.7	26.2	83.7	31.4	42.9	7.3	61.3	27.7	22.6	14.8	2.3	22.7	13.2	16.4	12.0	8.6	13.4	6.4
ISL2	FLJ10160	ENSG00000159556	"ISL LIM homeobox 2"	Q96A47	15	76336724-76342476	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.3;pituitary gland: 12.6;salivary gland: 11.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"neutrophil: 11.3;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.3;monocytes: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075192			Approved	"Rods & Rings"				"Rods & Rings"	"Rods & Rings"	"HPA075192: AB_2686738"	"unprognostic (7.30e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.55e-15)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-1)"	0.9	0.2	0.0	0.8	1.1	0.3	0.3	0.0	0.9	2.8	3.8	2.0	0.0	2.9	0.2	0.2	1.2	0.2	1.9	0.7	0.3	0.0	0.2	0.2	0.4	0.9	0.7	0.0	0.2	0.2	0.2	12.6	0.3	1.0	4.1	0.5	1.9	11.8	0.3	0.2	1.1	2.0	0.4	1.8	1.0	3.2	2.7	1.9	0.0	0.2	4.0	1.2	0.2	6.4	1.2	0.2	11.3	3.9	0.0	0.6	0.5	1.4	1.7	0.0	1.6	0.1	0.1	1.4	4.3	2.0	1.1	1.5	3.4	0.7	3.3	2.1	0.0	1.8	6.2	0.1	0.2	3.0	15.5	1.5	3.6	3.9	1.4	3.3	4.1	0.0	0.9	0.0	0.0	0.0	4.7	2.4	0.3	0.1	4.1	8.0	0.0	2.9	2.7	2.0	4.0	0.0	0.6	4.8	5.2	2.8	0.0	0.0	0.3	7.5	0.0	1.4	3.1	0.6	4.1	3.7	3.9	1.9	1.0	2.4	0.0	0.0	1.0	0.0	0.2	1.0	0.0	1.0	0.0	0.6	0.2	1.2	0.2	0.1	11.3	0.0	3.9	0.0	0.0	0.5	0.0	1.1	0.0	0.9	0.3	0.0	0.7	0.0	1.0	1.9
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748899-54798240	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0"	"Cell line enriched"	"Detected in some"	19	"WM-115: 33.3"	"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000506	Uncertain				"Secreted to blood"					"HPA000506: AB_2666007"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 158.7;Karpas-707: 84.7;RPMI-8226: 168.2;U-266/70: 358.1;U-266/84: 139.0;U-698: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	4200000000	4200000000			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favourable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	158.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	84.7	0.0	0.0	0.2	0.5	0.1	0.0	0.2	0.1	168.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.2	358.1	139.0	206.4	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 45.7;salivary gland: 82.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.8;SK-BR-3: 27.5;WM-115: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 2.3"	"Low region specificity"	"Detected in some"			"HPA053841, HPA059622"	Approved									"HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavourable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavourable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.75e-4)"	3.0	0.1	0.5	12.2	2.5	6.5	5.6	0.4	0.5	8.0	5.7	0.7	6.4	2.0	0.9	2.9	2.6	2.6	8.8	0.6	1.4	0.5	0.8	0.3	2.6	5.7	1.7	0.6	1.3	0.3	0.0	0.3	45.7	1.5	11.0	3.8	0.8	82.3	6.8	0.7	10.8	10.0	2.0	1.1	8.4	13.6	0.9	1.0	9.1	0.7	3.6	17.3	10.3	2.4	18.7	14.4	1.9	15.8	0.0	6.9	5.2	5.1	9.5	0.0	0.0	0.0	0.8	13.5	0.2	0.7	0.5	0.1	0.1	27.8	1.4	2.2	0.2	4.1	0.0	9.8	1.4	9.3	0.0	6.8	12.5	0.2	0.0	0.0	0.1	0.0	1.2	0.6	4.4	0.0	1.5	0.8	0.1	5.0	1.4	5.2	0.0	10.3	4.6	0.1	5.1	8.5	14.4	0.0	0.0	13.8	27.5	8.1	0.0	5.5	0.3	3.8	19.7	0.1	11.1	0.0	0.3	0.6	13.1	1.2	70.6	1.9	10.2	0.0	0.3	15.8	0.4	18.7	5.1	2.6	14.4	9.4	3.4	3.2	0.5	0.0	8.6	0.4	6.9	5.2	0.5	2.5	0.4	0.5	1.4	0.5	1.7	0.6	1.5	1.0
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.96e-5)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.0	0.3	0.3	0.8	0.4	2.1	1.1	0.9	2.0	5.0	7.8	5.1	0.0	5.6	0.6	0.6	0.3	15.1	5.3	0.2	7.7	0.0	1.8	16.5	3.0	0.1	0.0	2.4	0.4	8.2	6.5	0.5	0.1	0.0	0.8	0.1	0.2	0.4	3.8	0.3	0.2	0.0	0.0	26.8	2.0	1.3	0.1	0.0	0.1	2.5	0.8	0.6	0.4	0.1	12.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468062-38483447	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 48.5;salivary gland: 57.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.8;BJ: 36.3;BJ hTERT+: 37.4;fHDF/TERT166: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	10.5	4.0	1.3	3.4	1.4	0.2	11.6	0.9	1.3	15.7	7.7	1.8	5.3	6.6	6.2	14.8	5.5	5.7	20.9	14.2	1.5	1.1	10.9	44.5	8.6	5.8	1.0	1.2	7.2	48.5	9.3	12.4	11.6	1.8	9.2	10.3	5.5	57.2	7.1	2.1	3.6	15.1	6.6	2.2	3.0	15.5	4.1	0.9	1.1	6.7	6.5	16.9	6.8	6.5	1.2	4.3	0.9	0.1	0.3	2.4	0.3	6.9	2.2	1.8	7.7	30.6	57.8	1.3	36.3	37.4	8.9	22.3	3.9	9.2	0.0	7.7	59.0	1.0	1.8	2.2	10.8	0.0	4.1	0.5	1.9	11.0	13.5	0.0	4.9	21.3	1.7	11.2	1.2	10.7	1.7	0.0	14.7	11.4	0.0	0.2	0.4	6.3	0.0	0.5	2.3	10.8	0.9	0.1	0.9	9.3	0.5	4.6	2.7	0.4	8.2	9.6	6.0	33.0	3.6	0.3	0.1	0.0	15.5	0.0	13.3	0.0	0.1	0.0	0.8	0.1	2.4	1.2	0.8	0.2	0.2	0.4	0.8	0.8	0.9	0.3	0.1	4.3	0.7	0.3	1.3	1.4	0.9	1.3	1.5	1.1	1.0	1.2	1.8	0.9
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.1;SCLC-21H: 9.1;SK-BR-3: 11.0;T-47d: 37.8;U-87 MG: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favourable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	14.1	0.1	0.1	0.2	0.0	0.0	0.1	0.5	0.2	0.0	9.1	0.2	0.0	11.0	0.0	37.8	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1
KIR3DL2	"CD158K, cl-5, nkat4, nkat4a, nkat4b"	ENSG00000240403	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2"	P43630	19	54850443-54867207	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.0;lymphoid tissue: 5.3;salivary gland: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"																				"unprognostic (6.99e-2)"	"unprognostic (1.83e-1)"		"unprognostic (3.64e-1)"		"unprognostic (4.56e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.39e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.62e-2)"	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 9.4;HaCaT: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	320000	320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	9.4	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2
KLK15	"ACO, HSRNASPH, prostinogen"	ENSG00000174562	"Kallikrein related peptidase 15"	Q9H2R5	19	50825289-50837213	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 5.7;salivary gland: 9.7"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 7.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA019802	Uncertain				"Secreted to blood"					"HPA019802: AB_1852601"		"unprognostic (6.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.13e-2)"		"unprognostic (2.90e-1)"				"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"		0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		1.4	2.1		9.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	2.1			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KLRG2	"CLEC15B, FLJ44186"	ENSG00000188883	"Killer cell lectin like receptor G2"	A4D1S0	7	139452690-139483712	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 9.7;thyroid gland: 22.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.0;HAP1: 11.5;NTERA-2: 6.1;SCLC-21H: 5.5;SK-BR-3: 23.5"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 42.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018199	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018199: AB_2133260"	"unprognostic (2.50e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.38e-8)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.13e-2)"	"prognostic favourable (8.61e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.34e-2)"	0.2	0.1	0.0	0.0	0.3	0.0	2.4	0.0	0.8	1.0	0.0	0.2	0.0	0.0	0.2	0.7	7.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	6.2	0.0	0.1	0.0	0.0	0.2	6.5	0.9	0.7	0.3	0.2	0.1	0.3	9.7	0.3	0.1	4.7	0.0	1.5	1.4	0.0	0.2	2.3	0.0	0.9	22.1	2.6	2.3	0.8	2.4	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.2	0.0	1.6	11.5	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	0.0	6.1	0.1	0.0	0.0	0.0	0.4	0.1	5.5	0.3	1.7	23.5	0.0	5.2	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.3	0.0
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922696-40937634	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.3;salivary gland: 99.8;skin 1: 48.2"	"Group enriched"	"Detected in some"	9	"HBEC3-KT: 20.7;Hep G2: 12.8;T-47d: 35.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	12	"neutrophil: 30.1"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"		170000	170000	"Intermediate filaments"	"Intermediate filaments"	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (8.26e-4)"	0.3	0.0	0.2	0.5	0.2	0.5	10.0	0.3	0.3	9.8	0.2	0.2	2.1	0.0	1.1	1.2	2.5	1.5	4.5	0.2	0.2	0.0	0.3	0.6	1.1	0.6	0.2	0.2	0.6	1.2	0.0	0.9	128.3	0.2	6.9	0.0	0.3	99.8	2.8	0.3	48.2	0.2	0.3	0.2	1.0	0.0	9.1	0.2	2.0	0.3	11.7	9.5	2.3	3.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.3	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2	0.2
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 117.7;HBEC3-KT: 262.1;RT4: 312.5;SiHa: 246.4;SK-BR-3: 143.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments"		350000000	350000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (9.42e-5)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	99.7	0.0	0.0	0.1	0.0	117.7	21.4	0.0	11.2	1.0	0.3	71.2	0.0	0.0	7.3	78.5	0.0	262.1	0.5	0.1	0.0	0.0	53.5	0.3	2.5	0.0	0.0	0.0	16.3	0.0	105.7	11.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.2	1.5	64.7	312.5	0.1	0.1	246.4	143.9	0.0	5.5	0.0	85.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 271.0;EFO-21: 111.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	870000000	870000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favourable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.5	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.0	0.0	111.0	0.0	17.7	0.0	0.5	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	4.9	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;NTERA-2: 2.5;REH: 1.5;SK-MEL-30: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 6.1"	HPA003029	Uncertain									"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.2	0.6	3.1	0.4	13.7	0.1	2.0	0.1	3.8	1.5	0.3	0.6	0.9	0.3	0.6	0.9	0.5	1.3	0.2	2.2	2.8	2.5	0.6	0.2	0.2	0.4	4.5	1.5	1.1	0.1	0.3	15.9	0.5	3.8	1.2	0.4	0.0	8.2	3.3	0.5	0.3	0.5	0.3	0.5	0.4	0.2	0.4	1.6	0.3	6.1	0.1	0.5	0.5	0.2	0.7	0.0	0.0	0.0	0.8	2.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.5	0.0	1.5	0.3	0.9	0.1	0.4	0.2	0.2	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.7	1.0	2.6	0.0	0.6	0.2	0.8	0.0	0.8	0.0	0.0	0.1	0.4	3.1	13.7	0.1	2.7	2.8	2.5	4.5	1.5	3.8	1.6
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.3;U-266/70: 7.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	7.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126614443-126701032	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5;salivary gland: 35.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.7;MCF7: 17.7;T-47d: 10.9"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.9"	HPA073716			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA073716: AB_2686630"	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	1.3	0.1	0.0	0.1	0.0	0.1	7.5	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	1.9	0.1	0.2	1.4	0.0	0.1	0.0	0.6	0.0	0.1	0.8	0.0	0.6	0.0	2.9	0.1	0.0	16.5	35.3	0.0	0.4	1.5	0.2	0.0	2.4	0.0	0.1	3.1	0.0	0.0	0.9	0.1	0.0	0.2	0.1	0.6	0.4	1.2	0.3	0.9	0.5	0.0	2.5	1.2	0.4	3.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.3	1.3	0.0	0.5	0.0	1.2	3.9	0.0	0.0	0.0	4.7	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.5	0.0	2.1	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.3	0.0	1.6	0.4	0.1	0.4	10.9	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.5	0.4	1.2	0.9	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	2.9	0.0
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839179-169869930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.3;salivary gland: 7.0;stomach 1: 7.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;HAP1: 3.6;RPTEC TERT1: 5.6;T-47d: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.3	0.0	0.3	1.2	0.3	0.0	0.3	0.3	0.3	0.9	14.2	0.3	0.3	6.4	0.3	0.3	0.3	0.0	1.0	0.3	0.3	0.0	0.3	3.9	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.5	17.3	0.3	7.0	0.3	0.3	0.0	10.5	0.3	0.3	0.3	7.6	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	5.6	0.1	0.1	0.0	0.0	0.6	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1"	"Group enriched"	"Detected in some"	10	"RPMI-8226: 29.1;TIME: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	27	"neutrophil: 4.0;non-classical monocyte: 13.5"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 13.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted in other tissues"	600000000	600000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	1.0	0.3	0.4	8.8	0.5	277.8	23.0	0.3	0.3	53.1	0.3	3.2	108.0	0.0	0.7	39.3	3.8	0.9	2.2	2.5	0.6	0.6	20.8	0.6	10.8	1.3	0.6	0.0	0.3	2.7	0.0	1.2	0.8	1.5	13.0	0.0	0.2	181.9	177.1	0.4	1.2	0.9	0.1	0.7	9.1	22.6	2.8	0.1	4.0	1.6	13.4	30.7	2.3	1.0	0.0	0.3	4.0	13.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.5	29.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.8	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	13.5	0.3	0.0	14.7	0.4	0.5	0.3	0.3	0.6	0.6	0.6	0.0	1.5	0.1
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Group enriched"	"Detected in some"	6	"Hep G2: 126.5;THP-1: 65.3;U-937: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	2600000000	2600000000	"Golgi apparatus, Actin filaments"	"Golgi apparatus, Actin filaments"	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: "	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	0.1	126.5	0.0	14.8	7.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	14.4	0.3	0.0	0.2	0.2	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.3	0.3	0.1	0.3	0.1	0.1	0.0	70.7	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5
LZTS3	"KIAA0552, ProSAPiP1"	ENSG00000088899	"Leucine zipper tumor suppressor family member 3"	O60299	20	3162617-3173592	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.9;salivary gland: 36.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031008, HPA031009"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA031008: AB_10601610, HPA031009: AB_10670162"	"unprognostic (4.09e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.98e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.69e-3)"	"prognostic favourable (5.92e-8)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.38e-1)"	2.4	5.3	17.6	1.4	31.1	1.7	3.5	51.9	45.7	11.5	2.4	4.2	2.1	8.6	4.6	3.7	1.7	6.4	6.8	5.4	16.4	10.7	11.9	2.7	5.6	1.2	7.1	17.4	9.0	17.0	11.8	4.1	2.2	10.5	5.0	2.2	7.4	36.2	7.9	5.1	1.4	6.5	2.7	4.5	1.7	7.7	1.9	6.0	0.0	7.1	0.4	1.0	2.6	1.5	0.2	0.8	0.0	0.0	0.0	0.9	0.0	2.7	2.6	3.7	4.1	5.2	1.5	2.6	2.8	6.0	4.7	7.0	15.0	7.9	4.7	1.5	5.4	1.3	2.0	2.9	3.6	0.1	2.7	0.2	0.5	12.3	11.8	0.2	1.3	1.9	6.5	6.6	2.5	0.7	2.7	1.5	2.3	1.2	0.3	0.6	8.4	2.6	1.2	1.2	5.0	5.9	1.0	14.8	4.5	2.3	3.2	2.2	7.6	0.1	4.2	5.1	9.6	2.0	0.8	3.0	0.4	1.4	2.5	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.8	0.5	0.0	17.6	31.1	51.9	45.7	16.4	10.7	7.1	17.4	10.5	6.0
MLPH	"exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a"	ENSG00000115648	Melanophilin	Q9BV36	2	237485428-237555318	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 79.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.2;LHCN-M2: 30.6;MCF7: 52.8;SK-BR-3: 50.4;SK-MEL-30: 37.2;U-87 MG: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA014685	Approved									"HPA014685: AB_1853997"	"unprognostic (3.32e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (5.14e-6)"	"unprognostic (2.26e-4)"	"unprognostic (1.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.74e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (2.34e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-3)"	5.9	0.3	0.2	4.4	0.8	0.0	22.1	0.5	0.6	19.3	8.0	0.5	40.0	3.0	9.1	7.4	2.3	6.3	54.1	21.8	0.3	0.3	1.0	15.5	27.8	0.1	1.2	0.4	3.6	10.5	2.3	0.8	5.8	1.2	39.4	7.8	36.4	79.5	41.7	3.1	3.4	7.2	4.3	1.8	0.1	35.3	2.1	0.1	0.2	35.0	7.3	9.4	10.1	15.8	1.0	0.7	1.2	0.5	0.6	1.0	0.0	0.0	28.2	0.0	0.0	13.0	8.8	0.0	5.6	6.7	3.2	4.0	0.2	21.5	0.0	0.0	10.4	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	10.7	3.1	9.4	12.3	0.0	0.0	0.0	30.6	52.8	0.0	0.1	0.0	16.3	0.1	0.0	0.0	0.1	0.6	0.3	0.0	0.0	50.4	37.2	13.2	0.3	5.6	17.5	0.5	0.2	7.9	0.0	0.0	0.0	51.7	0.0	13.4	0.8	0.5	0.4	0.5	0.2	0.6	0.4	0.6	0.5	0.2	1.0	1.0	0.5	1.2	0.6	0.4	0.7	0.3	0.0	0.2	0.8	0.5	0.6	0.3	0.3	1.2	0.4	1.2	0.1
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell line enhanced"	"Detected in some"		"A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavourable (2.53e-4)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	126.5	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2
MRGPRX3	MRGX3	ENSG00000179826	"MAS related GPR family member X3"	Q96LB0	11	18120955-18138480	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.3;salivary gland: 7.9;tongue: 4.4"	"Cell line enriched"	"Detected in some"	10	"HBEC3-KT: 17.8"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"																				"unprognostic (1.54e-3)"	"unprognostic (5.07e-2)"			"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"		"unprognostic (7.65e-2)"	"unprognostic (1.74e-1)"					"unprognostic (4.75e-2)"	"unprognostic (2.09e-1)"			0.1	0.0	0.1	0.8	0.1	0.4	10.3	0.1	0.3	0.3	0.1	0.1	0.1	0.3	0.1	0.1	3.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	7.9	0.1	0.4	0.4	0.2	0.1	0.1	0.6	0.1	0.9	0.1	0.1	0.1	4.4	1.4	0.1	0.5	0.1	0.2	1.6	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.4	0.0	17.8	0.0	0.1	0.3	0.0	0.1	0.6	0.0	0.1	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.2	0.3	0.3	0.2	0.1	0.2	0.1	0.2	0.0	0.7	0.1	0.0	0.8	0.2	0.2	0.4	0.2	0.1	1.8	1.1	0.4	0.2	0.7	0.2	0.1	0.2	0.3	0.4	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8"	"Cell line enriched"	"Detected in some"	7	"PC-3: 51.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	590000	590000	Vesicles	Vesicles	"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.1	0.1	0.7	0.1	0.0	0.2	0.1	0.1	67.4	8.4	0.0	0.0	0.0	1.9	0.0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2.0	0.0	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.1	4.6	0.0	192.8	0.0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.1	31.6	155.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 61.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA037381, HPA039262"	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	9.9	11.4	14.5	10.1	12.7	8.5	12.6	13.4	14.6	6.1	10.9	14.7	14.6	18.0	7.1	19.5	10.6	7.1	8.0	4.9	13.9	11.4	9.7	11.3	7.8	19.5	10.8	10.0	7.5	15.4	13.2	7.7	5.3	10.5	9.8	11.8	10.0	61.5	10.7	18.6	16.2	15.4	10.1	9.3	8.8	7.3	15.5	3.9	7.5	7.5	24.2	9.9	6.5	6.9	11.0	12.6	8.2	9.5	15.4	6.5	4.5	2.2	3.6	13.3	7.0	33.2	22.9	6.4	5.3	7.2	5.5	5.0	4.4	9.3	2.5	2.6	8.7	3.2	2.1	3.7	1.6	4.7	2.6	3.8	5.0	4.1	11.6	5.8	3.5	17.2	3.5	4.3	4.6	3.3	3.9	3.5	6.7	4.1	3.1	4.0	2.8	5.5	2.8	2.8	1.5	9.0	10.4	6.1	3.4	1.8	4.5	3.6	7.3	5.3	5.4	4.7	0.9	4.0	3.1	13.3	2.6	1.5	5.2	5.2	2.4	8.2	7.4	1.1	3.1	4.7	3.9	7.9	5.1	1.8	6.6	11.0	6.5	6.3	5.0	15.4	9.5	12.6	2.3	4.5	14.5	12.7	13.4	14.6	13.9	11.4	10.8	10.0	10.5	3.9
NCALD		ENSG00000104490	"Neurocalcin delta"	P61601	8	101686543-102124907	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;salivary gland: 48.5"	"Group enriched"	"Detected in some"	4	"AF22: 43.5;HDLM-2: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 32.8"	"Group enriched"	"Detected in many"	13	"NK-cells: 32.8;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Approved									"HPA043245: AB_2678385"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (5.30e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.00e-2)"	9.6	3.4	21.2	5.6	26.8	0.7	21.2	2.7	57.2	6.9	8.8	7.3	1.3	2.7	3.7	2.0	6.1	18.6	5.8	5.1	25.1	16.4	7.0	7.0	9.4	5.6	7.2	18.4	18.2	4.3	0.6	6.6	4.6	7.8	5.9	4.2	20.8	48.5	7.4	6.4	7.3	4.6	5.7	4.4	3.6	5.7	3.4	2.8	0.3	2.6	3.1	4.9	5.4	2.1	0.3	1.9	0.5	0.1	32.8	17.1	4.6	2.1	3.1	43.5	0.2	0.3	7.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	2.7	0.9	3.2	0.0	0.3	0.0	0.0	53.7	0.3	0.2	0.0	0.1	0.0	1.8	0.3	1.4	0.0	0.1	0.0	0.0	0.0	6.3	0.2	0.0	0.3	0.7	0.5	0.0	1.0	0.0	0.0	7.1	0.1	0.2	4.2	0.0	1.0	1.8	0.3	1.5	0.0	0.6	0.1	0.0	0.1	11.8	1.7	0.0	0.1	0.0	0.7	0.1	0.1	0.1	17.1	0.1	15.4	0.3	6.6	10.1	1.9	0.2	1.6	8.5	0.5	32.8	0.1	0.1	6.5	4.6	21.2	26.8	2.7	57.2	25.1	16.4	7.2	18.4	7.8	2.8
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 310.5;skeletal muscle: 253.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9;HMC-1: 20.0"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"myeloid DC: 54.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		150000	150000	"Centriolar satellite"	"Centriolar satellite"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favourable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	19.3	45.3	140.2	4.8	135.1	1.4	50.3	93.5	110.0	35.5	21.0	89.6	23.8	12.2	30.7	44.4	37.3	29.5	21.5	45.2	103.6	86.1	24.3	84.8	13.7	7.7	128.9	73.5	79.7	15.5	35.6	6.0	8.1	95.4	23.7	18.8	8.9	310.5	37.3	253.0	18.9	12.0	22.0	73.0	21.1	11.2	5.2	71.2	0.4	13.6	53.4	16.1	13.9	19.3	1.8	54.5	0.4	1.8	0.7	5.4	4.0	5.3	1.1	3.4	6.4	0.5	0.0	0.5	0.1	2.2	2.0	1.1	7.4	10.0	0.3	2.0	0.1	8.8	15.4	3.1	2.7	0.0	5.5	6.9	1.2	27.9	0.7	0.6	20.0	6.1	6.7	0.4	0.9	0.0	13.9	0.6	0.3	4.6	2.4	1.9	9.1	0.4	7.1	0.3	1.6	3.8	13.6	0.0	9.9	1.5	1.7	7.0	13.5	4.0	0.0	0.6	10.9	0.2	0.2	3.1	2.2	0.1	0.9	0.1	2.3	0.0	1.8	0.2	2.4	0.4	3.2	1.8	3.6	3.3	54.5	1.3	5.4	4.0	0.4	0.7	0.0	1.9	2.4	4.0	140.2	135.1	93.5	110.0	103.6	86.1	128.9	73.5	95.4	71.2
NEURL3	"Lincr, LOC93082, RNF132"	ENSG00000163121	"Neuralized E3 ubiquitin protein ligase 3"	Q96EH8	2	96497643-96508109	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 16.6;RPMI-8226: 10.5;RT4: 5.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"														"unprognostic (4.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.57e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.9	0.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0		5.3	0.6	1.8	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.0	0.2	1.4	0.1	0.0	22.4	10.8	0.4	0.0	1.2	0.0	0.2	0.0	0.1	0.2	0.0	6.4	0.0	0.5	0.1	0.4	0.0	0.3	0.2	0.7	0.1	0.1	0.1	3.0	1.0	0.5	0.0	0.3	0.0	0.0	4.1	0.0	0.4	0.3	0.2	2.4	16.6	0.0	1.3	0.0	2.5	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	2.2	5.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.1	3.0										
NKX2-6	"CSX2, NKX4-2"	ENSG00000180053	"NK2 homeobox 6"	A6NCS4	8	23702451-23706598	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.4;heart muscle: 2.7;lymphoid tissue: 3.0;salivary gland: 4.3"	"Group enriched"	"Detected in some"	8	"hTEC/SVTERT24-B: 8.9;LHCN-M2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (1.86e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 51.2"	"Group enriched"	"Detected in some"	4	"BEWO: 6.8;HEL: 26.1;K-562: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol				Cytosol	Cytosol	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	27.1	11.6	4.4	7.6	5.6	0.2	17.4	2.7	6.0	20.5	11.0	2.3	10.3	10.4	11.9	12.1	7.8	9.0	20.5	9.8	4.8	4.1	27.9	7.8	19.6	3.5	5.8	3.7	11.2	14.8	2.3	4.2	18.5	7.9	9.4	12.5	2.8	51.2	13.6	7.6	4.2	22.3	9.7	5.1	5.6	16.5	11.2	3.9	0.7	8.5	8.6	2.6	7.6	12.8	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	4.0	4.3	0.0	2.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	26.1	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	2.2	0.9	0.0	0.1	0.1	1.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	4.4	5.6	2.7	6.0	4.8	4.1	5.8	3.7	7.9	3.9
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"		11	17208153-17349980	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"salivary gland: 160.3"	"Cell line enhanced"	"Detected in all"		"HL-60: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA008395, CAB015931, CAB079781"	Approved	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favourable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	10.2	13.9	9.5	7.5	13.1	66.4	17.9	13.5	7.5	18.3	7.8	3.8	79.5	6.6	11.4	59.6	29.7	13.7	7.3	25.0	7.5	10.9	10.8	51.1	12.5	13.5	8.5	7.6	15.4	92.8	58.9	69.7	35.8	10.3	13.4	8.3	5.8	160.3	104.9	7.2	4.2	6.8	11.3	9.4	9.8	11.4	18.7	6.1	86.1	22.7	17.7	10.4	12.1	11.0	3.7	71.7	28.8	7.6	45.2	49.5	20.1	12.1	5.1	5.6	17.1	12.8	17.6	6.9	27.2	39.6	12.2	21.7	5.0	2.8	18.7	6.8	25.8	5.2	3.5	6.9	19.1	12.9	8.0	13.8	6.4	8.6	37.0	187.4	25.4	7.6	9.2	8.8	21.5	14.9	11.9	38.0	12.0	10.7	66.0	67.8	1.3	5.3	24.4	13.8	1.5	5.4	3.8	6.7	3.8	11.9	12.0	6.0	9.8	51.0	13.3	13.0	12.0	39.2	11.5	7.5	4.0	10.4	15.0	66.2	11.1	28.8	7.6	27.6	17.1	5.0	22.3	3.7	16.3	31.5	6.9	2.4	46.0	49.5	7.0	45.2	4.0	71.7	7.0	20.1	9.5	13.1	13.5	7.5	7.5	10.9	8.5	7.6	10.3	6.1
OOEP	"C6orf156, Em:AC019205.2, KHDC2"	ENSG00000203907	"Oocyte expressed protein"	A6NGQ2	6	73368555-73395133	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 8.7;testis: 18.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 12.7;MCF7: 4.1;U-2 OS: 2.8"	"Cancer enriched"	"Detected in single"	26	"testis cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.0;granulocytes: 1.6;T-cells: 2.7"									HPA055165	Approved									"HPA055165: AB_2682722"	"unprognostic (7.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.98e-2)"	0.4	0.3	0.1	0.2	0.6	0.1	0.5	0.2	0.2	0.2	0.4	0.2	0.0	0.3	0.3	0.0	0.4	0.2	2.6	0.8	0.1	0.2	0.3	0.5	1.1	0.8	0.4	0.0	0.9	1.6	0.0	0.3	5.2	0.6	0.5	0.1	0.6	8.7	1.5	0.1	1.7	0.6	1.3	0.3	0.4	0.8	18.5	0.0	0.2	2.0	0.3	1.6	0.8	0.2	2.0	0.2	1.6	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.3	0.0	0.2	0.3	0.0	12.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	1.4	2.0	1.1	0.8	0.0	0.7	0.0	1.6	0.3	0.0	0.3	0.2	0.8	0.1	0.1	0.6	0.2	0.2	0.1	0.2	0.4	0.0	0.6	0.0
OR1A1	OR17-7	ENSG00000172146	"Olfactory receptor family 1 subfamily A member 1"	Q9P1Q5	17	3207539-3218896	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.1;bone marrow: 3.2;salivary gland: 4.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 7.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																																							0.3	0.3	0.4	0.6	0.5	3.2	0.3	0.4	0.6	1.2	0.4			0.8	0.3	0.9	0.4	0.3	0.1	0.5	0.4	0.3	0.4	0.4	0.3	0.5	0.3		0.4	0.5	0.0	0.3	0.0		0.3	0.0		4.2	0.0	0.5	1.5	0.3	0.0	0.4	0.5	0.4	1.2			0.3		0.1	0.6	0.4	2.2	1.4	4.1	1.3	1.5	1.6	0.3	1.5	0.9	0.8	1.4	0.4	0.3	1.6	0.8	0.3	0.2	0.3	0.6	1.1	1.8	1.5	0.4	0.9	0.1	0.2	0.3	2.1	0.6	1.2	2.8	0.7	0.1	1.4	4.2	0.4	0.3	0.3	0.4	0.3	0.8	7.7	0.0	0.9	1.6	1.5	1.9	1.0	2.0	1.3	2.3	0.2	1.8	1.5	1.1	0.6	1.0	0.9	1.6	1.5	0.8	1.4	2.6	1.4	1.5	3.2	2.0	1.4	1.0	1.5	1.2	4.1	1.2	1.0	1.4	1.2	1.2	1.3	1.2	1.0	0.8	2.2	1.6	1.5	2.0	1.5	1.3	1.4	0.9	0.3										
OR2T3		ENSG00000196539	"Olfactory receptor family 2 subfamily T member 3"	Q8NH03	1	248473351-248474307	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.1		1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0			0.0		0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
OR2T5		ENSG00000203661	"Olfactory receptor family 2 subfamily T member 5"	Q6IEZ7	1	248488589-248491113	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.7	0.0		1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2Y1		ENSG00000174339	"Olfactory receptor family 2 subfamily Y member 1"	Q8NGV0	5	180739042-180740099	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.2		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5M10		ENSG00000254834	"Olfactory receptor family 5 subfamily M member 10"	Q6IEU7	11	56576736-56577787	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3"	"Cell line enriched"	"Detected in many"	9	"THP-1: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	113	"neutrophil: 11.3"	"Lineage enriched"	"Detected in single"	113	"granulocytes: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012341, HPA052122"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"CAB012341: AB_2157155, HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.5	0.4	8.2	0.4	4.3	0.4	1.1	0.2	7.2	0.4	0.4	5.8	0.0	0.6	0.4	0.4	1.4	0.5	0.5	0.4	9.0	1.4	0.4	0.5	0.8	0.4	2.0	3.4	0.6	0.6	0.4	0.1	0.4	0.1	2.3	0.4	18.9	19.6	0.4	0.4	14.3	0.4	0.4	0.1	0.6	1.0	0.9	4.4	0.0	0.4	4.4	5.6	0.6	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.4	0.8	2.7	1.6	0.0	0.1	3.8	0.0	0.2	0.2	0.2	2.8	1.4	0.1	0.5	0.0	1.9	1.8	1.2	0.3	0.6	1.6	1.7	1.4	3.1	0.0	1.2	1.3	0.0	0.5	0.0	0.5	0.0	1.5	0.0	0.1	1.3	1.6	2.9	0.0	1.0	1.4	2.3	0.4	0.7	0.5	0.3	0.3	1.1	0.1	0.9	0.6	33.9	0.1	0.6	1.1	0.0	0.5	1.0	0.7	2.5	0.2	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	8.2	4.3	0.2	7.2	9.0	1.4	2.0	3.4	0.1	4.4
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928518-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1"	"Cell line enriched"	"Detected in some"	5	"EFO-21: 28.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Intracellular and membrane"	1900000000	1900000000			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favourable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favourable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	0.3	0.3	0.3	74.2	0.3	0.0	6.9	0.3	0.3	35.1	232.8	0.6	0.4	158.9	2.6	0.5	2.6	0.7	139.0	0.3	0.3	0.3	52.5	5.0	25.1	0.3	0.3	0.3	0.6	4.2	0.0	0.9	0.4	0.3	3.0	75.6	0.4	398.1	0.6	0.4	0.4	320.1	2.0	0.3	0.4	25.3	0.6	0.3	0.4	0.4	23.9	22.5	4.9	0.6	3.4	1.1	1.4	0.5	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.4	0.2	0.0	0.2	0.0	4.9	0.1	1.3	0.6	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.2	0.3	1.0	0.0	0.1	0.0	1.4	0.5	0.3	0.4	0.2	0.5	3.4	0.3	0.3	1.1	3.4	0.5	0.5	1.4	0.5	0.3	0.9	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.1	2.5	0.0	0.0	5.1	0.0	0.2	13.4	0.8	3.7	0.0	0.4	0.0	10.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	17.4	0.2	0.3	51.7	1.2	5.6	0.0	0.0	1.0	0.6	0.0	0.0	0.3	0.0	26.4	0.0	0.0	0.8	0.0	0.2	0.2	0.0	32.9	0.0	27.1	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 12.7;BJ hTERT+: 10.1;TIME: 29.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	99000	99000	Cytosol	Cytosol	"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.4	0.0	9.4	12.7	0.0	4.2	10.1	0.8	1.1	0.0	2.1	0.0	0.2	4.4	2.0	0.0	3.0	0.9	0.0	0.0	0.0	7.1	0.0	0.7	0.0	0.0	5.1	3.4	1.2	1.3	5.8	0.0	0.0	1.4	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.3	1.4	0.0	1.6	0.1	29.2	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.0;hTERT-HME1: 18.6;LHCN-M2: 30.6;RPTEC TERT1: 39.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules				Microtubules	Microtubules	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.0	0.0	0.0	0.1	0.0	13.3	3.8	4.0	2.5	1.1	0.9	0.0	0.2	38.0	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.5	0.0	0.0	0.9	1.2	5.1	18.6	0.0	1.5	0.1	30.6	1.9	0.0	0.0	3.2	3.8	0.0	0.0	0.2	39.1	2.8	10.2	7.0	0.0	9.2	5.6	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome				Centrosome	Centrosome	"HPA037583: "	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.3	0.2	9.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	4.3	0.1	1.4	16.9	0.1	0.2	0.1	1.4	0.1	5.8	0.0	0.0	0.3	0.1	0.0	0.3	3.4	0.1	0.0	0.0	0.0	2.0	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 14.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077050			Supported	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"	"Vesicles, Lipid droplets"	"HPA077050: "	"prognostic favourable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favourable (2.16e-4)"	20.9	1.7	8.0	2.9	5.2	3.9	6.5	4.2	5.8	1.8	3.3	2.0	10.5	1.6	1.6	5.5	1.9	3.1	1.9	12.0	7.8	1.4	5.8	44.6	2.8	1.5	3.4	2.6	25.8	30.1	0.5	6.2	0.6	3.7	4.5	0.9	3.4	40.3	4.6	40.8	1.7	1.3	1.5	1.7	1.8	11.5	1.4	4.2	0.0	2.2	6.0	1.1	3.7	5.7	0.6	0.4	14.7	0.5	0.8	0.4	0.1	0.5	0.3	1.1	3.8	2.8	0.1	5.5	0.2	0.2	0.2	0.1	0.4	1.0	0.3	1.2	0.2	0.4	0.0	0.0	0.0	0.5	0.4	0.3	1.4	1.7	0.6	0.4	0.9	0.7	0.0	0.0	0.1	0.3	1.2	0.5	0.3	0.9	0.3	0.9	0.7	0.5	0.3	0.2	3.4	0.3	5.0	0.7	4.7	0.5	0.8	0.0	10.4	0.7	1.0	0.6	0.5	0.5	0.3	0.6	0.2	0.2	0.5	1.1	0.2	1.5	0.5	0.8	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.4	14.7	0.8	0.3	0.4	0.2	0.1	8.0	5.2	4.2	5.8	7.8	1.4	3.4	2.6	3.7	4.2
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;salivary gland: 28.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048046	Enhanced					17000	17000			"HPA048046: AB_2680239"	"prognostic unfavourable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	3.7	17.4	15.5	2.9	34.9	1.5	4.5	16.1	46.3	3.5	14.8	45.8	1.8	3.3	8.1	5.3	6.4	3.8	6.1	3.1	19.9	9.4	1.3	1.3	2.1	1.4	39.7	17.3	1.3	5.6	1.1	0.6	1.4	18.4	9.0	3.2	2.8	28.9	10.7	1.4	11.3	3.4	8.9	25.6	1.3	4.4	7.2	40.2	0.0	1.3	0.2	1.2	6.8	3.8	0.1	2.7	0.0	0.0	0.7	0.0	0.7	4.8	0.5	0.6	0.4	0.6	0.4	0.3	4.5	0.9	0.6	1.6	0.0	0.1	0.0	2.9	1.2	0.5	0.0	3.8	0.5	0.1	0.0	3.0	5.4	3.4	1.3	0.0	0.3	1.0	2.8	2.8	1.8	1.8	0.2	1.7	1.2	3.9	0.0	0.7	0.1	7.5	1.4	0.5	0.0	0.7	2.2	1.3	4.1	0.2	4.2	10.1	5.6	0.0	7.9	4.7	2.4	3.7	5.6	1.6	0.4	0.1	10.2	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.7	15.5	34.9	16.1	20.8	19.9	9.4	39.7	17.3	18.4	40.2
PPP1R1B	"DARPP-32, FLJ20940"	ENSG00000131771	"Protein phosphatase 1 regulatory inhibitor subunit 1B"	Q9UD71	17	39626740-39636626	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 173.9;salivary gland: 105.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;SCLC-21H: 19.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 173.9"	"Cell type enriched"	"Detected in single"	37	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.6"	"Region enriched"	"Detected in many"	8	"basal ganglia: 1113.7"	"Region enriched"	"Detected in all"	21	"basal ganglia: 1698.9"	"CAB004026, HPA048630, HPA061142"	Approved	Approved								"CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: "	"unprognostic (2.71e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.69e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.55e-1)"	26.2	10.0	25.6	5.8	173.9	0.6	23.3	14.6	24.1	7.4	64.1	16.2	39.4	25.7	1.8	2.2	1.9	9.4	4.6	0.7	17.3	11.2	2.0	0.5	5.1	0.5	21.9	22.2	2.6	19.1	0.6	1.7	0.5	17.9	19.9	63.3	6.9	105.3	49.6	0.5	5.7	20.9	4.1	12.4	0.5	13.6	4.6	40.0	0.0	0.5	0.3	0.8	3.6	1.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.3	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.6	0.0	0.0	0.4	0.0	0.0	19.3	0.4	0.0	1.0	0.0	0.4	0.7	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	173.9	14.6	24.1	17.3	11.2	21.9	22.2	17.9	40.0
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.4;salivary gland: 71.0"	"Cell line enhanced"	"Detected in some"		"AF22: 13.5;CACO-2: 25.1;CAPAN-2: 10.7;EFO-21: 24.5;NTERA-2: 36.4;RPTEC TERT1: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA004922, CAB011525, HPA031053"	Enhanced									"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favourable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.5	0.5	2.5	11.5	2.2	1.3	11.2	1.0	2.2	20.1	13.8	2.3	1.6	5.2	4.7	3.1	1.8	1.9	12.6	2.7	3.1	2.1	30.2	1.6	3.6	0.1	2.3	0.6	1.6	10.7	0.0	1.8	12.7	2.1	1.6	7.4	52.4	71.0	2.9	0.7	1.1	13.5	1.7	1.8	0.6	10.9	5.0	0.9	0.3	1.7	3.8	10.2	3.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	10.7	0.3	24.5	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	36.4	0.0	0.9	0.0	0.0	33.7	0.0	4.2	1.4	0.0	0.8	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.5	2.2	1.0	2.2	3.1	2.1	2.3	0.6	2.1	0.9
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 57.3;CACO-2: 37.6;CAPAN-2: 25.8;hTCEpi: 37.0;SK-BR-3: 43.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"	3500000	3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	37.6	25.8	0.0	0.3	0.0	17.0	0.0	16.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.0	0.0	0.5	0.0	0.4	0.0	0.0	15.3	0.1	0.3	4.7	0.0	0.1	0.0	0.2	1.7	3.0	0.2	0.1	0.0	43.5	0.0	9.9	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843063	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favourable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	2.5	1.9	8.0	2.4	5.2	6.0	2.2	9.7	7.2	2.5	2.0	1.2	1.3	1.5	6.7	1.9	1.3	2.7	2.4	3.3	6.2	6.1	1.0	1.2	1.2	2.2	2.5	5.8	19.1	1.1	82.4	6.8	1.0	6.0	1.8	1.4	4.6	44.3	1.7	2.0	2.3	1.3	6.6	5.5	1.8	1.2	32.0	5.2	0.0	3.1	2.4	1.3	2.2	2.3	3.4	7.6	3.3	3.8	2.0	2.4	0.5	0.3	0.4	1.5	3.6	1.2	1.3	1.4	1.1	2.4	0.7	0.7	0.4	0.5	1.5	0.7	0.5	0.1	1.5	0.1	0.3	3.1	2.8	0.9	1.2	1.1	0.4	0.9	1.7	0.5	0.6	1.4	0.1	0.2	1.0	1.6	0.1	0.8	1.8	2.9	0.5	0.5	1.4	0.3	0.7	0.3	0.1	2.2	0.9	0.4	0.6	1.0	0.3	1.7	0.2	0.3	0.8	1.8	0.7	2.7	15.0	4.4	0.8	4.3	0.5	3.3	3.8	0.3	1.1	2.0	2.4	2.2	1.4	1.4	2.5	3.4	1.7	1.3	1.3	2.0	1.8	7.6	0.7	0.5	8.0	5.2	9.7	7.2	6.2	6.1	2.5	5.8	6.0	5.2
PTH2R	PTHR2	ENSG00000144407	"Parathyroid hormone 2 receptor"	P49190	2	208359714-208854503	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 8.6;brain: 8.9;salivary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.4;HEL: 16.2;HL-60: 4.0;SH-SY5Y: 6.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010655	Approved									"HPA010655: AB_2668333"	"unprognostic (4.76e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.77e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.54e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.37e-2)"	2.5	0.9	6.0	0.6	3.5	8.6	2.1	0.2	8.6	0.2	0.2	0.0	0.0	0.0	1.6	4.9	0.2	0.2	0.2	0.2	8.9	4.3	0.5	1.4	0.3	0.3	0.5	4.3	0.1	1.4	0.0	1.0	2.7	0.1	1.2	0.1	0.0	8.2	1.4	0.1	0.3	0.2	1.2	0.4	0.4	0.1	1.7	0.0	0.0	0.2	0.1	0.2	0.2	0.2	1.4	0.6	0.9	1.3	0.0	0.8	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.7	1.3	0.8	1.4	0.0	0.0	0.0	1.0	0.4	0.0	0.9	0.0	0.9	0.6	0.0	0.4	6.0	3.5	0.2	8.6	8.9	4.3	0.5	4.3	0.1	0.0
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7"	"Cell line enhanced"	"Detected in many"		"A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.6	1.0	13.6	0.4	19.9	0.5	0.9	30.5	13.5	2.0	4.1	0.5	1.5	5.7	0.4	2.3	1.2	0.9	1.1	1.2	18.0	6.2	0.7	21.9	0.6	0.6	5.6	9.1	0.6	24.6	3.1	9.2	0.3	2.5	2.2	5.4	0.7	17.7	1.6	1.1	1.2	6.0	0.4	1.9	0.6	5.3	0.6	3.2	0.0	1.2	0.0	1.1	0.9	0.0	0.8	0.2	0.0	0.1	0.0	1.1	0.7	1.1	13.6	0.0	3.5	0.2	0.1	0.1	0.6	1.1	0.5	0.9	0.4	2.7	0.2	0.9	0.8	2.2	0.7	0.2	0.0	1.5	1.4	0.5	14.9	1.2	0.6	0.0	0.4	0.5	0.1	0.1	0.2	0.3	0.3	0.0	1.6	8.9	0.0	0.6	0.8	1.2	1.1	1.1	2.3	5.2	0.9	18.9	3.7	0.3	17.1	0.6	5.6	0.2	0.6	0.0	2.5	0.2	0.2	2.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	13.6	19.9	30.5	13.5	18.0	6.2	5.6	9.1	2.5	3.2
RBBP8NL	"C20orf151, dJ908M14.3"	ENSG00000130701	"RBBP8 N-terminal like"	Q8NC74	20	62410237-62427533	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 17.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.6;CACO-2: 20.9;MCF7: 8.6;SK-BR-3: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (8.99e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.18e-1)"		"unprognostic (1.86e-2)"		"unprognostic (1.27e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.76e-1)"		"unprognostic (2.15e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.65e-3)"	"prognostic favourable (6.91e-4)"	0.2	0.0	0.2	1.7	0.2	0.0	1.4	0.2	0.5	2.2	1.9	0.2	13.9	7.6	0.6	2.9	10.7	1.2	2.3	0.2	0.2	0.0	1.7	0.2	0.8	0.2	0.2	0.2	1.1	5.5	2.9	2.6	4.4	0.2	4.4	1.0	0.2	17.4	12.2	0.2	5.3	7.9	0.2	0.2	0.2	2.6	3.1	0.2	0.5	7.7	2.0	5.6	3.5	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	20.9	2.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	9.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Group enriched"	"Detected in some"	6	"HEL: 27.6;K-562: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.1	27.6	0.6	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.1	8.5	0.7	0.0	0.1	0.2	0.2	3.1	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.2	0.4	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.4	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4, Y-linked 2"	Q8TD47	Y	20756164-20781032	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3"	"Cell line enriched"	"Detected in single"	7	"U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"					"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.7"									HPA000857	Uncertain									"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.1	0.0	10.7	0.0	0.0	0.0	0.0	0.0										
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193080-194573	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 7.0;pancreas: 5.9;salivary gland: 7.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;RPMI-8226: 1.8;SK-BR-3: 2.1;U-266/70: 1.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"basophil: 5.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.0"														"Secreted - unknown location"															"unprognostic (5.09e-3)"								0.1	0.7	0.1	0.1	0.1	2.5	0.4	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.7	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	5.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	7.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 30.7;RT4: 13.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	13.8	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139477-59158836	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 132.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 58.2;Karpas-707: 62.8;RPMI-8226: 127.1;U-266/70: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"				"Nuclear membrane"	"Nuclear membrane"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	5.9	18.4	30.1	18.6	29.7	11.3	16.0	14.9	25.2	12.2	18.7	24.4	27.8	27.5	9.1	58.0	10.7	9.2	11.1	7.2	27.7	33.9	19.0	66.8	13.0	22.0	41.8	21.3	7.0	96.8	14.6	46.6	8.1	27.1	48.8	16.4	10.0	132.6	34.1	4.3	7.9	21.1	6.6	51.3	23.6	28.4	6.4	25.3	7.3	35.9	8.6	23.4	18.9	5.9	33.6	50.0	10.6	17.6	17.3	34.4	32.6	8.6	10.4	5.7	8.8	3.5	0.6	7.3	7.9	6.7	9.7	5.9	7.3	4.7	19.9	12.4	4.7	9.3	8.9	5.9	5.6	58.2	12.2	6.4	7.3	22.4	10.6	21.0	9.7	2.0	14.1	6.0	16.2	3.2	7.3	62.8	3.4	10.2	8.6	8.4	5.7	6.4	7.9	5.6	127.1	6.3	7.3	26.6	10.5	4.7	19.1	26.6	8.6	15.5	2.5	11.8	4.9	4.1	9.4	64.0	47.1	19.5	11.7	14.3	14.4	10.6	13.1	9.4	25.9	15.5	33.1	33.6	27.3	25.2	13.5	17.4	14.3	19.5	2.0	17.3	17.6	50.0	34.4	32.6	30.1	29.7	14.9	25.2	27.7	33.9	41.8	21.3	27.1	25.3
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232799-210246631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.3"	"Cell line enhanced"	"Detected in many"		"A-431: 7.3;BEWO: 7.6;SCLC-21H: 7.6;SK-BR-3: 8.7;T-47d: 10.7;U-2 OS: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.5	1.0	2.3	0.7	7.7	0.1	12.3	2.6	4.3	6.2	6.2	1.5	4.6	1.1	6.2	3.2	15.7	3.2	2.9	4.2	1.8	2.1	2.5	0.2	3.4	0.4	2.8	0.4	2.5	0.2	1.5	1.4	11.7	3.0	3.6	3.3	1.0	36.3	11.1	0.5	5.3	1.1	6.0	2.7	0.3	2.3	0.7	2.1	1.9	3.2	14.6	7.7	1.7	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	1.6	0.0	0.8	0.8	7.6	1.8	1.8	1.4	2.5	0.3	0.9	0.0	0.2	0.4	3.6	0.3	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.3	1.7	0.0	0.0	5.3	0.3	0.0	2.5	0.0	1.2	1.3	7.6	6.6	1.2	8.7	0.1	10.7	0.0	2.3	2.1	9.1	0.1	5.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.7	2.6	4.3	1.8	2.1	2.8	0.4	3.0	2.1
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631283-79703659	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 104.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 37.8;HEL: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.4;neutrophil: 2.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		4700000	4700000	Nucleoplasm	Nucleoplasm	"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	21.0	3.9	11.6	6.5	10.7	1.1	29.3	9.7	18.3	14.6	24.7	2.6	7.9	17.3	9.1	13.0	29.8	9.3	14.2	7.4	12.3	13.8	8.2	27.6	8.0	4.1	14.6	7.8	3.5	11.6	17.9	12.6	14.4	22.4	13.8	24.1	9.6	104.4	6.4	8.3	7.1	17.3	8.2	13.9	3.8	34.1	3.7	2.4	0.4	38.3	11.1	15.0	8.7	12.6	0.0	0.2	7.4	0.3	0.0	1.2	10.8	3.9	0.7	3.6	0.7	3.2	2.8	8.6	0.2	2.6	0.9	1.9	37.8	7.7	0.0	5.5	0.2	1.8	3.3	4.3	3.2	0.0	4.8	19.2	0.8	7.2	1.4	0.7	0.5	1.5	3.5	2.7	1.6	11.2	7.6	0.0	0.3	0.6	0.0	0.0	3.1	1.3	0.0	1.0	0.1	0.9	12.7	9.8	10.7	0.2	1.1	0.2	0.2	1.6	6.3	2.5	1.6	0.0	2.2	5.7	2.7	0.0	0.4	0.0	0.8	7.4	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.2	2.7	0.0	0.0	0.2	0.0	10.8	11.6	10.7	9.7	18.3	12.3	13.8	14.6	7.8	22.4	2.4
SH3BP4		ENSG00000130147	"SH3 domain binding protein 4"	Q9P0V3	2	234951973-235055714	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 50.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 4.0;plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037533, HPA037534"	Uncertain									"HPA037533: AB_10672903, HPA037534: AB_2675528"	"unprognostic (2.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.30e-1)"	"prognostic favourable (2.07e-6)"	"unprognostic (2.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.17e-2)"	7.7	6.5	8.6	3.2	14.8	0.6	20.4	2.6	9.5	12.9	7.9	19.1	16.3	9.9	9.2	9.9	5.6	10.6	11.3	7.1	8.3	5.4	13.4	17.7	8.3	1.3	18.0	6.3	13.9	35.0	3.9	3.1	11.9	12.1	12.5	8.1	10.0	50.2	15.2	6.5	10.8	6.9	8.1	9.4	4.1	14.8	9.2	16.5	1.8	7.9	7.6	4.8	5.3	5.2	0.3	6.3	1.3	0.2	0.3	0.0	0.2	14.1	9.0	23.5	1.7	10.5	7.0	10.7	20.8	20.0	16.6	14.9	6.9	8.6	0.0	5.8	41.6	7.7	6.8	14.1	20.1	0.0	3.0	0.0	12.4	18.7	17.3	0.0	0.0	13.6	21.2	23.4	12.8	17.6	0.1	0.0	24.4	11.0	0.0	0.0	12.8	5.0	0.0	4.8	2.7	15.2	2.9	14.6	5.9	4.7	30.5	12.7	3.6	0.0	14.0	18.3	16.2	14.2	13.4	0.0	0.0	0.0	17.0	0.0	26.7	1.3	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.3	0.0	6.3	0.0	0.2	8.6	14.8	2.6	9.5	8.3	5.4	18.0	6.3	12.1	16.5
SHROOM3	"APXL3, KIAA1481, SHRM, ShrmL"	ENSG00000138771	"Shroom family member 3"	Q8TF72	4	76435100-76783253	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 47.0"	"Cell line enhanced"	"Detected in many"		"A-431: 19.4;AF22: 19.1;BJ hTERT+: 18.2;EFO-21: 20.2;fHDF/TERT166: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047784	Enhanced									"HPA047784: AB_2680155"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.64e-13)"	"unprognostic (2.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	1.0	1.5	3.3	3.0	4.5	0.0	9.0	7.4	6.4	3.9	11.3	2.3	4.9	8.5	2.5	21.2	18.2	9.1	16.7	2.6	5.6	1.1	5.9	6.2	6.3	0.3	5.5	2.5	0.8	4.6	11.1	4.4	2.1	6.8	6.3	10.0	9.4	47.0	4.7	0.3	3.0	12.1	5.3	6.6	6.8	12.7	0.6	1.2	0.6	2.8	14.6	14.8	4.7	2.4	0.2	0.1	1.0	0.0	0.1	0.1	0.0	19.4	3.8	19.1	12.5	0.0	0.3	0.7	6.1	18.2	0.4	0.8	3.3	13.0	0.3	20.2	16.9	10.0	2.5	8.7	0.3	0.0	3.3	0.0	3.7	0.0	0.1	0.0	0.0	0.1	2.2	0.7	3.4	0.3	0.0	4.7	0.4	1.7	0.3	0.0	8.0	2.3	1.7	3.2	3.0	3.0	0.4	7.5	10.0	2.5	14.0	1.0	3.4	0.1	0.0	3.3	2.8	0.1	2.6	6.0	6.2	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.0	3.3	4.5	7.4	6.4	5.6	1.1	5.5	2.5	6.8	1.2
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 52.7;RH-30: 28.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.9	0.2	11.7	6.8	8.0	0.1	2.0	4.5	2.3	2.0	0.0	3.7	0.0	1.1	0.4	2.7	3.9	3.6	0.8	0.0	9.4	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.7	1.6	0.3	0.1	2.6	0.0	52.7	1.3	0.0	0.2	0.0	4.7	0.0	28.8	0.0	2.2	6.4	1.1	0.1	2.3	0.1	2.4	1.3	0.2	6.7	3.1	3.2	3.6	2.9	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005161-45009430	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.3;skeletal muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.4;LHCN-M2: 21.5;RH-30: 14.8;SCLC-21H: 25.3;U-2197: 16.4;U-698: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA056958: AB_2683287"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	5.8	0.2	0.2	0.2	0.4	0.1	3.4	0.5	0.4	13.3	0.4	0.2	0.0	0.1	1.1	0.8	0.8	0.1	0.1	0.8	0.1	0.0	0.4	0.1	0.3	0.2	0.9	1.8	0.3	4.6	5.7	13.5	0.3	1.4	5.2	0.1	9.3	23.3	1.3	21.0	0.3	0.1	0.4	0.8	0.1	7.4	1.1	0.0	3.9	0.7	4.0	0.8	1.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	6.2	23.4	0.0	0.1	1.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	2.1	3.9	0.2	0.0	1.1	0.0	7.5	0.0	0.0	0.0	2.1	1.1	0.0	4.8	0.0	0.7	0.0	0.0	21.5	0.7	0.0	1.2	0.2	4.7	0.0	14.8	0.0	0.0	1.2	25.3	0.2	3.2	0.1	0.0	0.1	1.8	0.3	0.4	1.2	16.4	0.0	0.5	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.1	0.0	0.9	1.8	1.4	0.0
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709528-60724348	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3"	"Cell line enhanced"	"Detected in many"		"A-431: 21.0;RH-30: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA031794	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	2.0	1.5	0.9	0.6	0.9	0.3	4.8	4.3	4.5	3.3	0.7	0.1	3.3	0.4	1.6	1.3	0.5	3.5	1.1	1.5	1.0	1.0	1.4	0.5	2.1	0.2	1.0	2.2	2.9	3.3	20.4	6.3	2.1	3.6	4.0	0.3	0.8	16.4	2.7	19.3	0.5	0.5	0.9	1.8	0.3	2.0	0.7	1.1	0.8	3.9	2.4	1.4	1.7	14.3	0.2	0.1	1.0	0.1	0.3	0.2	0.0	21.0	1.6	1.3	5.6	5.0	6.3	9.9	4.8	7.2	1.4	2.1	1.0	6.7	0.0	3.2	2.4	8.0	5.7	3.9	3.3	1.7	4.6	0.6	2.1	1.4	1.6	2.1	0.2	2.9	1.8	1.3	6.7	1.2	4.1	0.0	7.3	5.2	0.0	0.2	3.6	9.1	1.3	21.3	0.0	2.5	12.1	3.4	0.3	3.0	4.8	1.3	6.5	0.1	4.1	4.4	9.8	3.0	4.3	1.4	0.0	0.0	1.5	0.0	0.8	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.9	0.9	4.3	4.5	1.0	1.0	1.0	2.2	3.6	1.1
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189688	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 50.7;salivary gland: 61.2"	"Cell line enhanced"	"Detected in all"		"A549: 31.1;AF22: 32.1"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favourable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	5.5	11.0	10.8	9.4	24.1	2.7	26.2	11.4	18.1	5.1	28.5	37.2	0.0	24.6	5.7	1.9	3.8	4.1	50.7	4.1	15.5	9.9	4.5	2.9	6.5	3.5	36.1	13.5	5.6	5.3	11.2	5.5	3.3	30.0	14.8	36.3	8.5	61.2	2.1	8.5	23.0	28.8	6.6	27.7	2.9	36.3	5.5	26.7	2.0	5.6	6.8	18.3	4.2	3.6	3.6	9.8	0.5	1.2	3.6	3.0	0.4	6.2	31.1	32.1	12.4	8.0	5.2	6.6	5.8	4.4	4.2	4.4	12.4	10.0	9.3	7.9	5.0	19.0	6.1	6.7	6.5	9.3	7.6	2.7	5.5	1.8	2.5	3.3	4.7	5.5	2.4	9.3	5.5	6.8	4.3	6.4	6.5	6.6	5.9	2.8	3.7	10.2	3.3	9.0	3.8	4.9	21.4	5.6	3.6	11.7	5.1	4.6	2.8	1.7	11.4	10.5	7.0	7.9	7.4	5.4	4.8	10.4	5.5	2.0	8.4	0.5	0.7	0.2	1.9	1.2	3.0	2.7	1.8	2.3	0.9	3.6	2.0	2.7	0.3	3.6	0.8	9.8	1.6	0.4	10.8	24.1	11.4	18.1	15.5	9.9	36.1	13.5	30.0	26.7
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 90.6"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved									"HPA026540: AB_1855408"	"prognostic unfavourable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favourable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	7.3	5.2	12.2	6.3	17.8	2.3	8.0	24.2	22.2	8.5	14.2	28.6	4.9	28.0	10.9	6.8	19.4	15.4	9.4	37.3	16.7	17.3	11.3	23.1	9.3	4.1	22.4	14.4	5.7	30.2	15.1	8.1	8.3	32.8	8.4	11.8	19.0	90.6	11.6	69.9	12.6	18.2	12.1	21.6	4.7	8.8	11.1	18.3	5.6	48.6	19.8	10.5	14.6	11.5	3.2	5.2	3.1	3.0	9.6	7.5	4.1	17.7	4.9	6.7	5.6	3.9	3.2	15.0	16.4	28.4	8.5	21.2	13.2	47.5	6.0	19.2	14.6	29.3	3.8	16.6	15.0	1.4	3.0	9.6	1.8	7.5	5.5	3.4	4.4	3.5	15.1	8.8	8.7	4.2	9.1	4.9	16.1	4.9	6.0	5.5	6.7	3.1	5.1	7.4	6.3	7.7	17.5	1.8	7.0	4.4	7.7	4.5	6.2	5.9	12.9	18.4	6.3	4.4	8.8	3.3	7.2	4.3	5.7	6.7	9.9	3.1	3.0	0.3	5.6	2.2	6.3	3.1	6.0	5.2	5.2	3.2	7.5	5.6	1.2	9.6	1.9	3.0	5.8	4.1	12.2	17.8	24.2	19.9	16.7	17.3	22.4	14.4	32.8	18.3
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221562-113264492	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.7;salivary gland: 57.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0"	"Low region specificity"	"Detected in all"							HPA013810	Approved									"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.51e-2)"	7.8	12.1	5.0	4.9	6.1	4.6	6.0	3.7	6.7	10.6	16.2	6.7	21.2	20.7	4.9	7.8	9.8	4.8	5.7	5.8	5.0	4.9	15.4	55.7	8.8	3.5	5.6	4.0	6.3	11.4	5.8	9.4	7.9	7.4	10.3	8.1	8.5	57.9	21.7	3.0	14.3	41.8	4.6	5.8	8.6	9.3	4.7	5.0	2.6	6.3	6.8	9.8	5.8	5.2	1.0	9.9	5.0	17.0	2.5	2.0	4.3	8.2	8.9	7.3	16.1	16.8	12.0	27.1	14.7	22.4	10.2	11.9	12.7	7.3	6.5	6.0	12.6	20.6	13.9	8.4	11.5	5.7	7.7	5.3	8.0	14.2	41.2	9.7	8.1	14.5	19.0	13.2	21.7	9.3	12.1	12.1	9.6	8.8	6.6	4.9	11.9	10.1	6.8	19.3	6.4	9.3	10.4	6.9	9.1	14.2	28.5	38.5	14.5	8.3	8.5	7.7	4.7	15.3	8.8	7.3	14.8	9.0	12.7	9.2	8.9	1.3	13.0	1.5	1.5	16.2	2.0	1.0	1.0	1.5	9.9	0.9	1.2	1.1	5.0	2.5	17.0	1.4	1.1	4.3	5.0	6.1	3.7	6.7	5.0	4.9	5.6	4.0	7.4	5.0
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0;hTERT-HME1: 22.6;LHCN-M2: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"				"Nuclear speckles"	"Nuclear speckles"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.4	2.4	1.3	2.0	21.7	8.9	4.7	4.1	5.3	5.0	4.8	1.8	1.6	0.3	0.8	3.4	20.2	1.9	11.7	4.7	2.7	0.8	0.3	1.2	2.8	8.3	2.1	1.2	10.0	33.0	11.7	22.6	2.6	1.5	3.0	26.1	5.2	2.1	1.2	0.7	2.3	0.4	19.7	0.3	1.7	3.3	1.2	2.1	5.6	17.5	1.6	6.2	1.9	2.4	2.7	1.9	9.0	3.5	1.8	3.8	0.2	8.7	2.9	2.7	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 43.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048185, HPA050695, HPA060150"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavourable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	3.0	2.5	2.4	7.4	2.2	1.3	2.7	2.1	2.4	7.4	8.1	1.8	3.8	8.4	2.6	4.8	5.0	6.2	5.9	2.4	3.7	2.6	5.6	2.0	4.0	7.7	2.4	2.2	3.4	3.4	0.3	2.6	9.7	1.9	10.6	9.8	5.2	43.2	2.7	2.3	8.5	7.4	1.8	4.2	2.7	2.8	3.7	2.3	1.8	3.2	6.7	6.9	3.4	3.7	9.3	5.9	0.5	0.2	2.9	11.2	1.6	8.5	5.6	0.6	7.9	4.7	6.9	8.0	2.0	1.1	5.2	6.8	24.0	8.9	14.1	20.1	5.8	17.7	11.2	18.0	10.5	11.8	10.3	7.8	5.5	9.9	7.7	18.3	3.9	4.8	10.4	17.4	37.6	27.3	20.6	5.8	3.7	5.1	7.5	17.7	6.0	54.3	15.3	7.1	18.4	28.1	7.7	13.7	5.8	6.4	14.8	3.9	10.9	3.9	20.3	9.7	16.0	0.2	20.2	15.3	17.2	15.5	6.1	5.8	6.3	0.1	0.2	0.0	2.8	0.1	7.3	9.3	4.8	4.9	5.9	6.1	1.8	2.5	0.5	2.9	0.0	0.3	11.2	1.6	2.4	2.2	2.1	2.4	3.7	2.6	2.4	2.2	1.9	2.3
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063067-125090312	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.2;salivary gland: 85.6"	"Cell line enhanced"	"Detected in some"		"A-431: 12.5;CAPAN-2: 26.6;hTCEpi: 12.0;hTERT-HME1: 28.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 3.7;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain									"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	7.1	26.4	1.0	47.2	1.4	0.0	3.4	0.4	1.0	2.5	3.6	3.5	0.5	3.7	0.7	2.0	7.2	1.0	2.4	2.3	1.3	0.7	1.0	2.7	7.2	6.4	1.5	0.3	1.8	0.7	0.0	0.6	3.2	1.5	2.0	4.6	2.4	85.6	0.6	0.4	16.3	4.6	1.3	1.7	10.2	0.8	0.7	1.2	1.4	0.6	3.3	3.1	6.6	6.5	0.1	3.7	0.6	11.9	0.0	0.0	3.1	12.5	0.0	0.2	0.0	0.2	0.4	0.0	0.4	1.2	0.3	1.2	0.1	26.6	0.0	3.8	0.1	6.6	0.2	7.1	1.8	0.3	0.2	2.8	0.2	0.6	0.0	0.0	0.1	0.3	12.0	1.2	28.6	0.7	0.1	0.1	1.2	0.0	0.0	0.6	0.3	0.2	0.0	0.9	0.2	0.3	6.4	0.0	0.1	2.3	0.0	0.8	0.0	0.5	1.4	20.4	0.0	0.2	0.5	0.3	0.4	0.0	0.7	0.7	1.6	0.0	8.0	0.0	0.0	9.9	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.0	3.1	1.0	1.4	0.4	1.0	1.3	0.7	1.5	0.3	1.5	1.2
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.6;HL-60: 32.5;Karpas-707: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved									"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favourable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favourable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.4	5.4	1.2	0.0	4.5	10.4	2.8	0.6	44.6	1.6	2.7	0.2	20.2	5.3	5.9	0.1	0.3	3.8	1.2	0.9	9.1	11.0	13.8	11.4	0.1	1.8	32.5	4.7	5.5	1.4	0.8	2.6	0.6	13.8	48.4	8.6	3.6	11.7	15.2	3.6	5.3	3.0	0.0	17.3	9.4	2.0	1.6	4.0	15.2	0.2	1.4	3.7	12.1	3.1	5.4	2.0	11.0	8.6	21.7	9.0	25.1	8.9	21.2	4.9	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 35.2;Hep G2: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favourable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.3	7.6	0.9	4.0	2.6	0.7	10.9	2.7	1.7	1.4	0.8	0.5	7.0	0.0	3.1	0.9	35.2	4.2	8.3	0.2	0.0	1.7	0.3	3.3	20.6	1.6	1.9	6.9	0.3	3.4	1.7	1.6	3.5	0.7	4.9	1.4	3.4	0.2	0.2	6.1	10.3	1.2	5.2	1.7	8.5	15.0	0.4	2.5	1.4	8.8	0.2	3.4	3.3	5.9	1.0	3.6	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.5	4.7	4.4	4.5	10.1	7.3	27.3	11.1	17.1	9.8	10.7	5.6	8.8	6.1	9.6	14.6	17.0	4.3	27.7	6.1	7.3	4.0	9.3	3.0	2.4	30.7	5.5	7.1	9.1	13.4	16.5	23.0	16.2	2.6	6.0	14.4	8.1	2.8	2.9	6.2	9.7	5.0	3.9	2.8	5.1	20.5	5.1	1.6	9.4	12.8	5.6	5.9	3.4	17.4	10.4	4.2	9.7	6.1	5.4	3.4	1.8	11.2	6.1	6.0	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.1	0.5	0.8	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.0	1.7	0.1	2.1	0.1	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.5	1.1	0.0	0.3	0.2	0.0	1.4	0.1	0.1	0.1	3.5	1.4	0.0	2.1	0.3	0.1	13.7	0.1	0.1	0.2	9.5	0.0	2.1	1.9	2.3	0.0	0.2	0.2	2.7	0.7	0.0	0.0	1.4	0.7	0.3	20.5	8.2	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 50.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 46.0;REH: 26.4;U-266/70: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.1"	"Low lineage specificity"	"Detected in many"											"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"				"Cytokinetic bridge"	"Cytokinetic bridge"	"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.0	1.0	1.1	6.4	1.7	11.8	4.8	0.5	1.0	5.2	6.5	2.6	4.8	4.0	5.6	6.0	6.5	12.4	6.1	1.8	1.3	0.7	5.1	1.7	5.2	4.8	0.9	0.5	2.7	2.0	14.3	3.2	1.2	2.0	2.4	3.1	0.9	50.6	2.0	1.4	1.5	5.7	1.8	1.5	11.3	5.7	1.5	1.1	24.8	12.7	5.4	12.9	2.0	2.0	1.4	0.4	6.5	0.5	8.1	1.9	0.5	0.0	2.5	5.0	0.0	0.1	0.5	0.0	0.6	0.1	2.4	3.9	0.0	0.0	0.0	14.4	0.4	4.2	0.5	1.7	2.8	1.3	0.8	13.1	2.2	0.0	0.2	46.0	0.3	0.1	0.2	1.3	0.0	0.8	0.0	13.4	0.0	0.0	0.3	9.9	2.5	0.0	26.4	0.1	1.3	4.2	12.1	0.0	0.0	0.0	2.3	0.1	3.5	7.4	0.1	0.0	0.7	3.7	0.2	23.3	3.2	0.0	0.0	7.4	0.3	5.0	0.4	6.5	1.9	0.5	1.5	1.4	0.9	1.0	0.4	1.3	0.8	0.6	1.4	8.1	0.2	0.1	0.7	0.5	1.1	1.7	0.5	1.0	1.3	0.7	0.9	0.5	2.0	1.1
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.8	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1										
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		9500	9500	"Plasma membrane"	"Plasma membrane"	"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.3	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	45.6	0.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8
SMCO4	"C11orf75, FN5"	ENSG00000166002	"Single-pass membrane protein with coiled-coil domains 4"	Q9NRQ5	11	93478472-93543508	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"salivary gland: 124.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041120	Uncertain									"HPA041120: AB_2677309"	"unprognostic (7.45e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.51e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (5.81e-7)"	"unprognostic (1.61e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.01e-2)"	6.1	19.0	4.3	10.0	7.3	1.6	6.2	2.5	4.5	5.0	10.6	4.5	11.5	16.1	5.4	4.6	5.5	9.4	9.3	13.4	4.5	7.9	10.9	33.5	9.0	9.1	6.2	4.0	6.4	17.9	1.1	15.7	3.5	5.7	13.1	8.0	6.0	124.3	10.3	6.2	5.5	21.2	4.8	5.0	16.7	12.2	9.9	4.5	5.4	34.3	3.1	8.6	3.7	5.1	4.2	29.7	11.4	57.3	5.6	5.4	15.7	3.4	6.5	9.6	2.8	3.6	5.7	6.4	9.3	2.6	4.4	8.0	11.5	15.1	9.4	11.6	8.6	2.0	8.8	1.2	2.6	26.4	8.0	2.3	12.2	26.5	3.7	9.0	11.7	5.5	5.2	2.1	1.7	7.2	5.5	50.6	1.5	7.2	9.1	17.9	10.2	9.6	17.7	6.0	4.7	8.1	8.6	1.5	8.1	7.8	11.3	0.7	4.5	12.6	4.0	4.7	17.3	15.4	8.4	2.0	0.2	7.3	3.4	17.7	1.7	6.8	51.3	1.2	0.8	57.3	3.5	4.2	5.4	1.5	28.8	3.0	0.7	0.6	11.4	5.6	52.1	29.7	2.0	15.7	4.3	7.3	2.5	4.5	4.5	7.9	6.2	4.0	5.7	4.5
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	330000	330000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA030561: "	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.5	1.2	0.0	0.1	0.0	0.0	22.6	0.0	0.5	0.3	1.7	5.7	17.4	0.8	4.1	0.0	2.8	1.8	1.5	0.2	0.0	11.6	3.7	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.4	0.2	0.4	0.5	0.2	0.0	9.2	0.0	0.3	13.5	2.1	0.2	0.1	14.0	12.2	4.5	11.7	0.2	0.0	22.6	0.6	16.3	0.7	0.0	0.0	3.9	0.0	0.0	0.1	5.9	0.3	0.3	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box 10"	P56693	22	37970686-37987422	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.4;salivary gland: 98.4"	"Group enriched"	"Detected in some"	705	"SK-MEL-30: 61.4;WM-115: 88.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB003171: AB_2195374, HPA068898: AB_2686054"																		3.3	4.0	21.0	3.7	33.1	1.6	18.7	3.2	32.8	3.2	8.1	64.4	0.5	2.9	1.8	2.8	2.8	1.9	3.4	3.9	26.9	15.2	1.7	1.7	1.6	1.6	41.3	13.7	2.4	2.2	1.7	0.7	1.6	24.7	2.3	3.9	22.8	98.4	7.1	1.8	15.8	3.8	3.2	46.6	1.8	2.4	3.1	42.5	0.0	1.7	0.0	1.6	2.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	33.1	3.2	24.6	26.9	15.2	41.3	13.7	24.7	42.5
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box 9"	P48436	17	72121020-72126420	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 63.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.5;Hep G2: 35.3;U-251 MG: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.6	32.2	4.3	31.6	1.1	23.4	20.3	32.4	7.4	14.6	28.4	8.1	16.6	3.5	1.9	7.7	7.4	11.7	9.5	35.5	15.7	11.7	3.9	3.4	1.9	14.6	13.7	1.2	31.9	1.2	7.0	1.4	21.3	21.7	15.7	12.9	63.4	14.4	3.0	13.1	12.9	2.1	15.6	1.3	35.2	25.2	20.2	0.0	17.8	5.3	5.0	1.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	7.1	14.8	29.5	1.5	0.4	0.0	1.8	1.5	3.1	1.7	9.9	15.3	0.0	1.1	0.4	11.6	0.0	6.9	2.9	0.0	0.9	0.0	1.5	35.3	0.1	0.0	0.0	0.2	0.6	3.6	3.4	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.5	11.0	0.0	11.9	0.1	13.3	0.7	0.7	0.7	1.5	1.7	0.0	6.3	0.1	0.0	6.1	16.5	3.2	24.3	0.0	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	31.6	20.3	26.7	35.5	15.7	14.6	13.7	21.3	20.2
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in some"	5	"MCF7: 68.4;SK-BR-3: 47.3;T-47d: 37.8"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"midbrain: 2.1"	HPA055707			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.3	0.0	37.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351344	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 27.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	3.9	3.2	4.2	5.1	4.4	13.8	13.7	2.3	5.4	5.1	5.9	6.7	2.0	3.5	6.7	4.7	16.8	3.9	3.5	3.2	4.7	6.1	3.3	2.4	16.8	7.6	4.5	2.3	6.6	4.2	4.8	4.7	12.3	5.2	7.2	6.9	4.8	27.4	2.9	1.2	3.5	4.9	5.8	5.2	5.9	3.9	3.4	3.5	11.2	5.6	6.4	11.8	4.3	8.2	1.2	1.4	3.7	2.1	6.0	1.5	0.8	16.1	4.1	9.7	7.8	2.1	3.0	7.0	8.1	3.4	4.7	5.7	2.7	16.1	0.0	3.6	3.8	5.4	12.5	5.9	8.7	6.9	3.9	20.8	5.6	2.5	0.9	17.9	16.3	1.4	2.1	7.9	4.3	5.2	6.3	20.3	10.8	5.4	5.9	9.7	10.0	6.1	8.4	20.9	4.4	3.5	4.3	0.0	5.4	14.5	4.2	1.5	9.2	8.6	2.2	9.6	10.8	15.9	5.0	4.5	5.2	10.7	5.1	14.8	5.6	1.7	1.8	3.7	1.5	2.1	0.7	1.2	0.8	0.9	1.4	1.1	0.5	1.0	0.0	6.0	1.7	0.0	0.5	0.8	4.2	4.4	2.3	5.4	4.7	6.1	4.5	2.3	5.2	3.5
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.0;Hep G2: 8.1;U-2 OS: 23.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062611	Uncertain				"Secreted - unknown location"					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (2.83e-6)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0
SSPO	"FLJ36112, KIAA0543, SCO-spondin"	ENSG00000197558	SCO-spondin		7	149776042-149833979	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 1.7;salivary gland: 1.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;RPMI-8226: 2.7;T-47d: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	13	"midbrain: 44.5"						"Secreted in brain"						"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.95e-4)"	"unprognostic (5.81e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.41e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-10)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.46e-2)"	0.6	0.0		0.3		0.2	0.1		1.7	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.1	0.0			0.2	0.0	0.0	0.0			0.1	0.3	0.0		0.0		0.2	0.0		1.7	0.1	0.1	0.3	0.0	0.0		0.4	0.2	0.2			0.2		0.0	0.0		0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.7	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	2.7	0.1	0.0	0.4	0.5	0.0	0.1	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701352	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 13.9;salivary gland: 6.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.1;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	41	"eosinophil: 4.1"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain									"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.1	0.5	0.0	1.1	0.0	1.2	0.0	0.1	0.3	0.9			0.0	0.0	0.7	0.0	2.3	0.0	0.0	1.0	0.8	2.7	0.0	0.2	0.0	0.2		0.7	0.3	13.9	1.8	0.5		0.1	0.1		6.5	0.7	0.0	0.4	0.0	0.0	0.8	0.0	0.0	1.5			1.0		0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.9	0.0	0.3	0.0	1.9	0.1	0.9	0.0	0.7	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SYT7	"IPCA-7, MGC150517, PCANAP7, SYT-VII"	ENSG00000011347	"Synaptotagmin 7"	O43581	11	61515313-61581148	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.4;prostate: 36.9;salivary gland: 37.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 15.0;hTERT-HME1: 39.3;RT4: 16.0;SCLC-21H: 12.7;SK-BR-3: 17.9;T-47d: 17.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 54.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012869	Enhanced									"HPA012869: AB_1857698"	"unprognostic (7.09e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (4.37e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.47e-1)"	2.5	3.7	16.2	1.4	22.7	0.6	6.9	22.8	46.4	2.8	4.0	3.2	0.0	2.1	2.0	1.9	1.9	1.7	1.4	11.1	11.8	7.8	4.4	28.2	1.7	0.8	4.9	23.6	1.2	11.9	2.2	22.2	12.7	8.8	36.9	4.2	2.4	37.7	1.3	2.8	1.6	3.3	1.8	1.5	1.8	3.4	2.5	3.0	0.0	3.5	0.6	0.8	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.8	0.2	0.0	0.4	6.4	4.6	0.1	15.0	0.2	0.2	1.4	3.0	0.0	0.2	0.0	3.0	0.4	0.1	0.1	0.1	0.7	0.0	0.6	0.8	0.4	0.0	0.0	0.2	3.5	1.8	39.3	0.0	0.0	0.1	0.2	9.3	0.0	0.1	1.0	6.3	0.0	0.3	0.7	0.0	16.0	12.7	2.3	0.8	17.9	0.1	17.5	0.0	0.0	3.7	1.4	4.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	22.7	22.8	37.5	11.8	7.8	4.9	23.6	8.8	3.0
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell line enhanced"	"Detected in some"		"A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	74.1	0.0	0.0	0.1	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	100.5	0.0	9.7	6.3	100.7	0.0	18.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	1.1	4.2	0.0	0.1	0.0	15.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	13.5	34.8	0.0	0.0	3.2	26.8	0.1	17.5	0.1	4.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8										
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 33.4"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavourable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	6.0	5.8	11.0	2.9	9.6	3.7	4.9	15.8	17.7	4.2	3.5	2.8	6.7	3.8	3.3	5.0	2.2	4.3	3.5	4.9	9.0	5.4	7.6	6.6	6.4	3.0	3.8	12.2	2.1	16.6	5.2	5.6	3.6	7.5	4.5	1.9	5.4	33.4	6.4	6.1	3.5	2.8	3.1	3.7	3.4	3.8	2.4	4.5	0.8	5.5	1.0	2.3	4.0	2.9	0.2	1.3	0.0	0.9	0.2	2.2	1.0	2.6	5.0	3.3	6.8	4.0	4.0	2.9	4.7	2.4	3.1	2.6	4.7	2.2	6.5	4.3	3.6	4.7	5.2	1.4	2.2	7.1	6.2	5.9	6.5	4.0	2.4	4.2	2.5	1.5	2.1	2.7	1.1	3.8	7.1	3.6	2.8	4.6	2.9	8.5	3.0	3.3	15.1	6.4	4.5	2.2	1.7	26.5	6.4	3.1	11.6	1.9	3.7	3.8	4.0	6.1	6.6	5.9	4.6	2.4	2.1	8.1	2.6	6.2	5.4	0.0	0.7	0.0	2.2	0.8	0.7	0.2	0.5	0.7	1.3	0.1	0.5	0.3	0.0	0.2	0.9	0.6	0.0	1.0	11.0	9.6	15.8	12.4	9.0	5.4	3.8	12.2	7.5	4.5
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.8;salivary gland: 92.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.5;NB-4: 103.7;U-937: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 55.8"	"Lineage enriched"	"Detected in all"	5	"monocytes: 55.8"					"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA053200: AB_2682079"	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	1.8	8.4	5.0	2.4	12.1	25.5	2.3	1.2	6.8	1.8	1.2	1.8	19.4	1.8	1.3	32.9	1.3	1.3	45.8	13.2	6.2	2.2	4.6	1.9	2.9	1.8	2.4	3.3	1.5	40.5	0.7	4.0	2.5	2.2	2.5	0.7	0.3	92.6	24.4	1.3	1.8	1.7	1.4	1.6	2.7	34.4	5.0	2.2	1.2	2.1	1.2	2.5	6.5	2.3	1.9	8.5	11.3	55.8	2.5	2.3	3.9	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	2.3	0.7	0.0	0.1	1.2	0.0	0.0	6.3	4.1	17.7	1.4	12.1	0.0	7.5	64.5	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.3	14.6	103.7	1.4	0.0	0.0	0.0	8.3	8.9	2.3	2.7	0.9	0.0	0.0	0.5	0.0	8.1	0.0	0.0	0.2	0.0	0.0	2.7	6.1	0.0	0.0	34.4	0.0	0.0	11.9	11.3	1.8	14.9	0.1	1.3	0.6	2.3	8.5	1.9	0.0	1.0	3.0	2.5	55.8	0.6	0.7	3.9	5.0	12.1	1.2	6.8	6.2	2.2	2.4	3.3	2.2	2.2
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6"	"Cell line enriched"	"Detected in some"	13	"ASC diff: 41.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Cell type enhanced"	"Detected in some"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040642	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.69e-3)"	62.0	1.6	0.0	18.3	0.0	0.0	22.7	1.0	0.0	0.0	12.2	0.0	2.8	0.0	0.1	1.2	0.1	0.3	16.5	11.7	0.0	0.0	2.1	92.5	0.0	2.9	0.1	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	45.6	2.0	9.3	7.2	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.5	0.1	0.5	0.2	1.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311062-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 182.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA049314: AB_2680708, HPA076949: AB_2686820"	"prognostic unfavourable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	6.1	7.0	5.0	6.1	5.8	7.5	16.8	9.6	8.9	15.0	12.0	6.9	32.2	6.0	10.0	34.9	31.2	9.9	18.0	11.4	6.1	10.0	11.0	4.6	7.7	12.2	5.7	7.5	8.1	68.0	6.5	23.5	24.2	8.2	15.0	13.9	7.1	182.4	34.0	2.0	25.0	6.0	9.4	7.1	9.4	16.0	13.9	4.2	7.0	18.8	20.9	23.4	11.2	17.4	28.3	40.9	34.0	33.0	21.7	29.3	32.2	14.3	37.4	7.2	13.7	50.8	39.1	15.6	34.2	46.5	23.3	28.9	31.1	26.4	6.7	26.1	52.2	27.1	21.4	21.8	12.2	13.3	33.0	22.6	33.7	22.9	29.6	24.0	45.0	28.9	32.2	13.3	19.6	27.1	10.0	0.1	22.7	30.1	6.7	21.9	10.0	21.0	8.3	10.5	33.7	21.2	10.9	22.1	10.9	18.1	34.8	32.3	30.4	17.0	22.1	18.9	17.1	0.4	23.7	14.2	16.3	9.4	24.2	38.4	22.0	21.7	26.5	34.0	23.3	31.3	24.8	28.3	23.1	25.2	40.1	23.4	29.3	28.1	2.3	21.7	33.0	40.9	26.2	32.2	5.0	5.8	9.6	8.9	6.1	10.0	5.7	7.5	8.2	4.2
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;BEWO: 11.6;CACO-2: 10.6;CAPAN-2: 25.2;SK-BR-3: 21.7;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015796			Approved	Midbody,Cytosol				"Midbody, Cytosol"	"Midbody, Cytosol"	"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favourable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.5	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.6	25.2	0.0	0.6	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	4.3	6.6	0.0	0.0	21.7	0.0	17.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8
TMEM200C	TTMA	ENSG00000206432	"Transmembrane protein 200C"	A6NKL6	18	5882072-5895955	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 5.7;NTERA-2: 4.4;PC-3: 20.3;U-2 OS: 10.4;U-251 MG: 3.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047253, HPA050490"	Uncertain		Approved	Microtubules				Microtubules	Microtubules	"HPA047253: AB_2680001, HPA050490: AB_2681144"	"unprognostic (6.57e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.82e-4)"	"unprognostic (2.48e-10)"	"unprognostic (2.94e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.38e-2)"	0.4	6.3	2.6	1.0	3.7	0.1	3.5	0.7	5.7	0.8	0.5	1.7	0.1	0.5	1.6	3.2	0.6	1.1	1.3	2.9	2.7	3.5	2.0	5.3	0.5	1.1	3.7	1.6	1.9	0.2	0.1	3.3	0.1	1.7	0.9	0.3	2.7	10.1	0.7	0.1	0.7	0.6	0.5	1.2	1.6	1.3	3.5	1.5	0.1	0.2	0.1	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	20.3	1.2	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	3.5	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	0.7	4.7	2.7	3.5	3.7	1.6	1.7	1.5
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980792-54992293	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 22.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.2;pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA030614	Uncertain									"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favourable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.2	3.9	0.4	0.7	1.0	0.0	2.7	5.2	0.5	0.9	3.7	0.2	4.9	2.4	0.2	3.8	2.9	2.0	1.7	0.0	0.5	0.6	22.1	0.0	2.4	0.0	1.1	0.7	1.1	4.2	7.8	29.1	0.5	5.2	2.4	2.3	0.5	34.1	6.7	0.4	1.8	3.5	5.3	0.8	0.4	2.2	0.2	0.1	0.1	0.6	0.8	1.8	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	22.1	2.3	0.0	1.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	5.2	0.5	0.5	0.6	1.1	0.7	5.2	0.1
TMPRSS13	"MSPL, TMPRSS11"	ENSG00000137747	"Transmembrane serine protease 13"	Q9BYE2	11	117900643-117929459	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.1;salivary gland: 16.6;skin 1: 26.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;BEWO: 17.5;MCF7: 14.7;SK-BR-3: 25.3;T-47d: 25.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.16e-6)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.44e-1)"	0.2	0.3	0.2	0.6	0.2	0.3	6.2	0.2	0.2	5.8	0.2	0.2	0.2	0.2	0.9	0.7	14.8	0.1	0.2	0.2	0.4	0.0	0.7	0.2	4.0	0.7	0.2	0.2	0.3	5.7	0.0	0.5	22.1	0.2	0.9	0.2	0.6	16.6	0.2	0.2	26.0	0.5	0.2	0.2	1.0	0.1	0.3	0.2	0.4	9.5	13.7	10.6	0.3	5.6	1.0	2.6	1.0	0.7	1.9	1.2	0.8	7.3	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	5.6	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.4	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.2	0.0	0.0	25.3	0.3	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.6	0.0	0.9	0.7	0.0	1.0	0.1	1.2	1.8	0.5	0.4	0.1	0.0	1.9	0.5	2.6	0.7	0.8	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391292	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	6.5	1.7	1.7	4.8	1.2	0.2	4.3	0.4	2.3	1.5	18.4	0.8	7.6	23.1	0.9	1.9	3.8	1.3	28.7	1.1	1.3	0.7	0.9	0.8	2.3	7.4	1.0	1.0	0.7	2.9	0.1	10.1	2.8	0.7	2.1	13.9	1.3	34.3	12.9	0.6	3.3	23.9	1.3	2.9	1.2	4.3	1.2	0.8	0.7	2.0	1.8	2.3	2.3	2.3	0.0	0.6	0.2	0.0	8.9	1.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	1.5	0.1	0.9	3.5	0.3	0.1	51.3	2.3	0.0	0.5	0.7	0.0	0.2	0.5	0.1	0.1	0.3	1.3	1.3	0.0	0.0	0.0	0.4	0.0	0.0	2.5	8.1	0.1	0.0	0.2	0.6	0.6	8.7	0.3	0.2	1.3	0.0	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	8.9	0.0	0.6	1.0	0.0	1.7	1.2	0.4	2.3	1.3	0.7	1.0	1.0	0.7	0.8
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 60.5;skin 1: 47.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.1;BJ hTERT+: 26.3;fHDF/TERT166: 20.0;Hep G2: 27.3;SK-MEL-30: 45.6;WM-115: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.9;T-reg: 4.0"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA010135: "	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favourable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favourable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.3	1.3	1.0	0.4	1.4	0.6	4.6	0.8	2.0	3.4	1.5	3.0	17.1	0.7	5.3	7.3	5.1	14.3	2.3	14.7	1.5	1.5	7.1	0.5	7.9	0.6	3.0	1.3	3.4	2.2	0.1	8.0	3.8	2.8	12.7	0.8	11.4	60.5	13.0	1.2	47.9	0.9	4.1	1.9	2.5	2.4	2.7	1.1	0.8	5.7	8.0	3.7	2.7	4.0	1.9	0.7	0.7	0.0	0.6	4.0	0.2	0.0	1.0	1.1	0.0	1.6	16.1	1.1	1.2	26.3	0.6	0.9	7.6	0.0	0.0	0.0	20.0	0.0	1.0	0.9	1.2	0.0	0.9	0.2	0.8	27.3	0.7	0.0	0.3	7.7	0.2	7.6	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.7	1.6	0.0	4.5	0.0	2.7	0.1	10.5	1.8	0.0	0.0	45.6	0.0	0.1	0.0	3.8	0.2	0.0	1.1	0.0	0.0	0.0	1.5	0.0	28.4	0.0	0.0	0.7	0.0	0.0	0.4	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.7	4.0	0.2	1.0	1.4	0.8	2.0	1.5	1.5	3.0	1.3	2.8	1.1
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 102.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.4;RPTEC TERT1: 46.5;U-937: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.5;eosinophil: 22.8;intermediate monocyte: 62.7;myeloid DC: 43.0;non-classical monocyte: 37.3;plasmacytoid DC: 19.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 43.0;granulocytes: 22.8;monocytes: 63.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	29000	29000			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	12.1	14.4	18.7	15.4	24.2	18.3	12.9	5.7	15.3	15.7	20.4	8.7	27.4	32.0	7.7	12.8	6.1	14.4	29.1	9.5	11.1	10.7	34.1	11.9	43.0	39.0	14.3	9.4	14.0	20.7	5.7	10.8	6.4	31.6	13.7	18.7	22.0	102.8	69.4	3.0	5.3	18.5	10.9	13.1	16.2	23.4	5.0	9.0	3.3	14.1	8.2	11.5	10.4	8.4	4.1	43.0	22.8	63.5	1.3	0.4	30.6	8.3	3.4	1.1	2.3	1.3	0.7	1.4	1.5	1.0	0.6	0.5	1.8	5.2	3.7	18.4	1.5	5.3	0.0	1.5	0.6	6.5	2.9	2.3	7.5	3.9	2.8	2.0	2.4	1.5	1.4	0.4	2.4	1.9	1.8	1.4	0.5	1.2	0.9	6.6	1.1	2.5	6.6	1.4	15.8	46.5	5.5	2.1	2.0	2.9	7.8	1.0	10.4	5.0	1.0	2.0	2.4	0.9	3.2	0.3	1.1	0.9	0.8	17.8	3.9	9.0	63.5	22.8	0.1	62.7	0.1	2.0	0.0	0.1	43.0	4.1	0.4	0.2	8.6	1.3	37.3	19.8	0.1	30.6	18.7	24.2	5.7	15.3	11.1	10.7	14.3	9.4	31.6	9.0
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"			"Nuclear membrane"	"Nuclear membrane"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.7	1.4	0.0	0.0	11.5	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.6	0.0	14.5	0.0	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0	0.0	0.7	0.0	1.1	0.0	6.6	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1
TNS4	CTEN	ENSG00000131746	"Tensin 4"	Q8IZW8	17	40475828-40501597	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 76.9;salivary gland: 58.8;skin 1: 60.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 23.2;HBEC3-KT: 103.4;hTCEpi: 77.0;hTERT-HME1: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (4.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.68e-4)"	"unprognostic (7.88e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.08e-2)"	0.4	0.2	0.2	0.5	0.2	0.0	10.4	0.2	0.2	12.5	1.7	0.0	18.2	0.3	1.2	10.8	35.3	0.6	2.4	0.2	0.2	0.2	2.6	0.2	1.3	0.0	0.2	0.0	0.2	0.2	0.0	1.0	76.9	0.0	17.5	3.5	0.0	58.8	38.2	0.2	60.1	0.4	2.1	0.2	0.2	0.9	1.2	0.0	0.0	8.1	28.4	27.6	7.4	23.1	0.0	0.0	0.0	0.0	0.2	1.4	0.1	1.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.1	0.0	0.6	0.0	23.2	0.0	103.4	0.0	0.0	0.0	0.0	9.2	1.5	0.0	0.0	0.0	0.0	77.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	13.3	2.5	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TP53TG3E		ENSG00000275034	"TP53 target 3 family member E"	Q9ULZ0	16	33303739-33306935	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;placenta: 1.6;salivary gland: 1.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;AN3-CA: 3.1;SH-SY5Y: 1.3;U-266/70: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.3"																																					0.0	0.0		0.6		0.2	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.1	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		1.6		0.0	0.0		1.0	0.0	0.0	0.3	0.0	0.0		0.0	0.1	0.0			0.0		0.0	0.0		0.0	0.1	1.3	0.0	0.0	0.0	1.2	0.0	1.5	0.0	3.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2										
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 51.4;hTCEpi: 45.3;MCF7: 67.2;RPTEC TERT1: 52.1;SK-BR-3: 36.3;T-47d: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"	"Plasma membrane, Cell Junctions, Cytosol"	"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favourable (3.97e-4)"	"prognostic unfavourable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	6.9	7.9	0.0	51.4	0.4	0.1	12.2	1.1	1.1	0.0	0.1	12.5	8.9	0.0	26.4	5.8	15.9	1.5	11.0	0.0	0.1	11.0	0.1	11.0	0.1	1.1	0.0	0.0	1.4	45.3	0.0	5.9	0.0	5.5	0.1	0.9	67.2	0.0	0.1	0.8	4.3	0.0	0.0	0.0	52.1	1.8	1.7	0.0	13.3	36.3	0.8	31.0	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.0;salivary gland: 47.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 87.0;hTCEpi: 53.9;hTERT-HME1: 62.7;SK-MEL-30: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015272: , HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (1.70e-4)"	"prognostic unfavourable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	4.8	8.7	1.6	2.8	1.5	9.7	6.0	3.8	4.2	2.5	1.8	1.2	3.6	1.0	2.1	3.1	9.8	1.1	2.7	3.0	1.4	2.0	3.3	39.0	8.2	7.3	1.0	2.4	4.4	13.8	2.0	10.5	6.2	1.6	3.9	1.6	3.7	47.5	5.3	1.5	6.5	2.5	1.3	0.7	7.9	4.4	2.7	0.6	6.7	27.2	4.1	7.0	2.7	5.3	15.5	4.7	3.3	4.4	6.6	11.4	5.1	10.9	5.5	0.7	1.6	1.9	2.5	4.7	3.2	8.7	3.1	6.5	11.5	5.4	4.7	3.2	2.9	8.8	3.0	14.6	2.9	1.7	2.1	3.6	1.2	18.7	87.0	9.2	1.8	10.1	53.9	5.8	62.7	6.0	12.6	21.3	0.3	10.1	0.5	11.2	1.6	18.1	2.1	0.9	10.1	3.6	4.4	2.0	3.2	0.7	26.5	79.1	7.7	24.5	3.4	1.7	2.9	0.0	5.0	7.4	9.5	8.4	1.4	8.1	6.0	2.5	4.4	1.0	10.0	3.4	7.1	15.5	9.3	11.4	4.7	10.2	10.7	7.6	3.3	6.6	1.7	2.1	6.4	5.1	1.6	1.5	3.8	4.2	1.4	2.0	1.0	2.4	1.6	0.6
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783085-109833401	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 32.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.9;BJ hTERT+: 9.1;EFO-21: 8.0;HaCaT: 14.5;HUVEC TERT2: 8.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	11	"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	7	"classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain									"HPA007150: "	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.3	0.9	0.3	0.9	0.4	0.1	3.3	0.2	0.6	2.3	0.4	3.2	0.0	0.6	0.8	3.7	9.5	5.6	5.2	1.6	1.3	0.2	11.6	7.8	2.6	1.8	0.2	0.0	0.6	7.1	0.1	4.3	11.1	15.0	6.2	0.3	12.6	32.6	1.4	0.2	6.5	0.3	0.9	0.3	3.5	0.9	0.7	0.1	0.2	0.9	2.6	8.7	2.6	1.7	0.0	0.4	0.0	3.0	0.0	0.0	0.4	2.5	0.1	0.0	0.0	1.9	1.8	8.9	4.2	9.1	1.2	0.5	0.0	6.3	0.0	8.0	5.4	14.5	1.1	0.0	0.3	0.0	2.1	0.0	0.0	3.6	0.7	0.0	0.0	3.3	2.0	3.3	0.0	8.3	0.8	0.0	0.4	5.3	0.0	0.0	1.6	0.2	0.0	0.5	0.0	0.0	5.1	0.0	0.0	0.3	0.6	2.5	1.2	0.4	5.1	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.6	1.3	0.2	0.2	0.0	15.0	0.1
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;HaCaT: 10.2;RT4: 18.3;SK-BR-3: 13.5;T-47d: 30.1"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA062864	Approved									"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.1	0.0	0.0	13.5	0.3	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627109-100639991	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 88.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 42.7;RT4: 64.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 34.2"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	"Cell Junctions, Cytosol"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	27.0	9.8	7.0	4.4	6.6	0.1	33.0	2.9	4.9	15.9	17.8	12.6	6.4	9.7	11.1	10.4	27.1	24.2	10.0	5.7	7.4	7.3	26.7	68.2	8.3	3.6	6.9	4.1	27.6	25.1	19.6	17.7	23.6	34.2	15.5	20.3	16.7	88.4	6.7	3.5	4.7	11.6	4.7	10.4	8.6	8.0	17.5	6.6	2.9	24.6	11.0	19.8	17.2	11.5	0.3	0.2	0.8	0.2	0.3	6.6	1.4	7.8	10.5	28.3	14.3	12.4	6.7	11.5	4.5	7.0	8.9	20.8	23.5	13.7	0.0	18.8	4.6	6.4	0.1	8.5	10.5	0.0	15.2	1.4	6.8	26.1	6.9	0.0	1.1	13.2	4.1	7.8	3.0	18.9	0.0	0.0	9.1	8.1	0.0	0.1	42.7	7.9	0.0	13.4	0.0	13.9	64.4	1.8	7.7	4.4	3.9	6.0	5.7	1.0	5.3	5.6	8.5	9.1	2.9	0.0	0.0	0.0	4.9	0.0	3.9	0.5	0.1	0.2	1.0	0.1	3.5	0.3	2.4	0.8	0.0	0.2	6.6	3.8	0.8	0.3	0.2	0.2	0.1	1.4	7.0	6.6	2.9	4.9	7.4	7.3	6.9	4.1	34.2	6.6
VWA2	"AMACO, CCSP-2, FLJ16213, FLJ45857, NET42"	ENSG00000165816	"Von Willebrand factor A domain containing 2"	Q5GFL6	10	114239330-114291513	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.3"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 11.3;HaCaT: 5.4;SCLC-21H: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037847	Uncertain				"Secreted to extracellular matrix"					"HPA037847: AB_10670961"	"unprognostic (6.03e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.14e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	1.5	2.2	1.8	0.4	3.9	1.0	3.2	5.3	2.0	2.1	3.6	2.5	1.4	14.3	5.5	10.8	2.6	0.3	2.2	1.6	1.0	0.3	8.4	0.4	4.1	1.7	2.3	6.0	0.1	4.1	0.6	2.4	7.4	1.1	0.1	16.3	1.6	0.4	6.7	2.1	0.1	2.3	1.6	12.4	2.3	2.2	1.2	0.8	1.3	1.5	2.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	11.3	0.0	0.4	0.0	5.4	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	1.8	1.0	3.2	2.2	1.6	4.1	1.7	2.4	2.2
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.8	8.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	1.6	0.1	11.2	1.5	0.0	0.2	6.4	0.0	0.0	0.0	7.4	0.0	3.5	18.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	5.8	0.1	0.1	7.1	0.2	0.0	0.0	9.1	0.0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0										
WNT5A	hWNT5A	ENSG00000114251	"Wnt family member 5A"	P41221	3	55465715-55490539	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell line enhanced"	"Detected in many"		"BJ: 42.1;BJ hTERT+: 58.0;HeLa: 44.3;SiHa: 65.7;U-87 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.34e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.58e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.63e-2)"	2.1	0.8	3.4	3.8	2.0	0.0	3.4	2.5	3.8	6.1	2.3	1.6	6.8	2.2	19.6	2.8	15.8	4.8	5.0	2.3	2.6	2.0	2.7	1.6	3.6	4.6	2.3	1.3	8.2	5.3	0.1	1.9	25.6	2.0	5.0	2.1	1.0	26.8	18.2	1.1	2.3	2.5	4.2	4.8	2.5	2.2	1.6	2.5	1.9	2.7	13.1	6.8	21.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.0	7.2	0.0	42.1	58.0	8.6	15.2	0.2	0.0	1.2	0.1	23.9	0.0	1.8	0.0	9.0	0.0	1.1	1.1	44.3	0.0	6.7	0.0	0.0	4.7	1.1	26.0	1.4	0.0	0.0	20.6	20.8	0.0	0.0	0.0	2.1	2.5	0.0	2.6	0.1	1.1	1.4	0.0	0.2	65.7	8.0	0.0	0.0	0.0	0.0	14.6	2.6	13.2	3.3	4.9	0.0	0.4	47.2	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.0	2.5	3.8	2.6	2.0	2.3	1.3	2.0	2.5
WWC1	"KIAA0869, KIBRA, PPP1R168"	ENSG00000113645	"WW and C2 domain containing 1"	Q8IX03	5	168291651-168472303	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 29.9;RPTEC TERT1: 66.6;SK-BR-3: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038016, HPA038017"	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA038016: AB_10697091, HPA038017: AB_10669513"	"unprognostic (3.60e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.38e-2)"	"prognostic favourable (1.95e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-1)"	2.9	0.9	17.6	2.2	23.5	0.7	13.1	4.8	14.2	4.3	6.8	11.4	10.2	14.3	2.3	4.7	10.1	10.7	8.9	0.9	15.2	12.9	27.1	16.5	11.8	2.1	16.0	9.2	1.4	15.5	9.8	3.8	15.8	12.2	10.2	4.2	10.0	78.7	13.3	0.6	9.3	15.0	1.3	9.9	1.0	12.5	1.4	10.4	0.0	17.9	3.8	6.2	4.1	3.9	0.4	0.2	1.2	0.3	0.3	0.3	1.5	12.3	14.1	2.3	0.1	0.0	0.0	24.9	0.9	0.2	4.4	4.0	29.9	18.6	0.0	15.2	0.3	8.8	4.8	11.6	5.2	0.0	4.7	0.0	7.2	7.3	0.2	1.0	0.0	1.5	3.5	8.3	7.4	0.0	0.0	1.8	0.3	13.8	0.0	0.0	3.4	2.1	0.0	0.1	7.2	66.6	17.2	7.9	2.9	16.7	34.9	4.3	17.3	1.0	0.0	0.7	8.8	0.1	9.1	0.2	0.0	0.0	0.8	0.0	2.2	1.2	0.3	0.2	0.3	0.1	0.2	0.3	0.3	0.1	0.0	0.4	0.2	0.2	0.9	0.3	0.1	0.2	0.3	1.5	17.6	23.5	4.8	14.2	15.2	12.9	16.0	9.2	12.2	10.4
XBP1	XBP2	ENSG00000100219	"X-box binding protein 1"	P17861	22	28794555-28800597	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 321.9;salivary gland: 176.0"	"Cell line enhanced"	"Detected in all"		"MCF7: 108.1;SK-BR-3: 101.6;T-47d: 118.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																																			15.6	14.3	5.4	20.5	7.2	20.6	75.2	4.2	5.9	39.3	21.9	4.2	73.1	15.6	14.7	26.4	16.9	17.6	22.1	22.9	4.8	5.3	23.1	104.0	23.7	37.3	7.4	3.6	19.0	321.9	10.9	27.4	31.3	8.7	29.3	19.6	8.7	176.0	72.2	15.5	12.6	27.8	10.1	7.3	37.2	39.7	7.4	6.7	30.5	42.7	12.1	47.5	29.2	24.9	10.0	22.1	44.2	7.6	25.0	29.9	9.6	8.6	5.8	8.4	12.9	15.9	17.5	21.3	15.1	25.9	15.1	20.1	9.4	12.1	32.9	7.4	13.9	12.0	15.5	7.4	13.1	14.6	9.8	9.9	5.2	40.1	34.5	18.5	9.5	10.9	44.5	10.0	43.3	12.0	8.8	41.5	9.1	108.1	2.5	17.6	5.8	9.2	18.9	9.2	44.6	13.8	12.0	11.1	10.7	9.1	101.6	39.3	118.2	21.4	6.8	8.7	8.4	9.2	5.3	70.7	49.9	19.7	11.6	23.8	13.0	44.2	7.6	6.1	22.9	4.0	29.9	10.0	16.5	23.6	6.9	8.2	16.4	13.7	0.6	25.0	2.8	22.1	5.5	9.6	5.4	7.2	4.2	5.9	4.8	5.3	7.4	3.6	8.7	6.7
ZNF124	"HZF-16, HZF16"	ENSG00000196418	"Zinc finger protein 124"	Q15973	1	247121975-247172016	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.7;salivary gland: 23.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA031127	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA031127: AB_10602685"	"unprognostic (3.97e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (1.03e-4)"	1.9	1.1	1.2	1.9	1.0	2.8	2.1	1.9	1.4	1.6	3.9			3.5	4.1	2.3	1.7	1.7	1.8	1.5	1.5	1.7	3.4	1.9	2.8	3.0	1.8		3.1	3.9	0.5	0.8	2.2		2.3	4.0		23.4	1.2	1.1	2.2	4.2	1.8	2.1	5.2	2.6	2.8			2.4		3.4	3.1	1.8	10.6	12.6	10.0	14.7	9.9	12.3	6.3	3.6	2.7	7.8	10.3	2.9	1.8	19.7	3.7	2.2	4.0	4.0	4.1	3.3	7.3	4.5	3.0	3.9	9.3	3.0	5.7	0.4	2.6	6.4	3.3	8.8	2.9	11.4	7.4	2.3	2.4	3.9	3.8	5.7	9.0	5.1	4.9	3.1	11.8	7.4	20.2	6.4	12.4	6.3	5.2	3.8	10.9	12.2	12.4	5.5	4.3	3.7	3.2	18.3	6.4	3.0	4.5	3.3	6.7	4.5	5.4	10.8	1.2	11.7	6.2	6.2	8.8	10.0	7.0	9.9	10.1	10.6	9.1	8.5	12.6	6.7	12.3	11.8	2.0	9.9	14.7	9.9	6.7	6.3										
